Cobiz Financial (COBZ) 10-K 16 Feb 18 2017 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2017	Feb. 09, 2018	Jun. 30, 2017
Document And Entity Information
Entity Registrant Name	COBIZ FINANCIAL INC
Entity Central Index Key	1,028,734
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2017
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2,017
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$ 656,663,768
Entity Common Stock, Shares Outstanding		42,228,467

Consolidated Financial Statemen

Consolidated Financial Statements - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Assets
Cash and due from banks	$ 78,735	$ 69,333
Interest-bearing deposits and federal funds sold	1,445	26,717
Total cash and cash equivalents	80,180	96,050
Investment securities available for sale (cost of $164,012 and $130,308, respectively)	166,753	132,981
Investment securities held to maturity (fair value of $360,071 and $363,178, respectively)	362,544	366,041
Other investments	10,119	11,365
Total investments	539,416	510,387
Loans - net of allowance for loan losses of $37,941 and $33,293, respectively	3,107,622	2,900,812
Intangible assets - net of amortization of $7,704 and $7,104, respectively	726	1,326
Bank-owned life insurance	55,040	53,674
Premises and equipment - net of depreciation of $37,459 and $38,269, respectively	10,827	11,019
Accrued interest receivable	14,150	12,223
Deferred income taxes, net	13,114	19,901
Other real estate owned - net of valuation allowance of $8,666 and $8,666, respectively	5,079	5,079
Other assets	20,118	19,842
TOTAL ASSETS	3,846,272	3,630,313
Liabilities
Noninterest-bearing demand	1,473,650	1,282,463
Interest-bearing demand	737,934	714,062
Money market	875,936	861,856
Savings	21,453	19,561
Certificates of deposits	116,247	151,841
Total deposits	3,225,220	3,029,783
Securities sold under agreements to repurchase	52,959	27,639
Other short-term borrowings	77,640	106,230
Accrued interest and other liabilities	29,808	33,074
Subordinated notes payable - net of unamortized discount and issuance costs of $805 and $889, respectively	59,195	59,111
Junior subordinated debentures	72,166	72,166
TOTAL LIABILITIES	3,516,988	3,328,003
Commitments and contingencies
Shareholders' Equity
Preferred stock, $.01 par value; 2,000,000 shares authorized; none issued and outstanding
Common stock, $.01 par value; 100,000,000 shares authorized; 42,217,318 and 41,555,208 issued and outstanding, respectively	418	411
Additional paid-in capital	202,111	197,758
Retained earnings	126,896	103,575
Accumulated other comprehensive income (loss) (AOCI), net of income tax of $(85) and $348, respectively	(141)	566
TOTAL SHAREHOLDERS' EQUITY	329,284	302,310
TOTAL LIABILITIES AND EQUITY	$ 3,846,272	$ 3,630,313

Consolidated Financial Stateme3

Consolidated Financial Statements (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Consolidated Financial Statements
Investment securities available for sale, cost	$ 164,012	$ 130,308
Investment securities held to maturity, fair value	360,071	363,178
Allowance for loan losses	37,941	33,293
Intangible assets, amortization	7,704	7,104
Premises and equipment, depreciation	37,459	38,269
Other real estate owned assets, allowance	8,666	8,666
Subordinated notes payable, unamortized discount and issuance costs	$ 805	$ 889
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, shares authorized	2,000,000	2,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	42,217,318	41,555,208
Common stock, shares outstanding	42,217,318	41,555,208
Accumulated other comprehensive income, tax	$ (85)	$ 348

Consolidated Statements of Inco

Consolidated Statements of Income - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
INTEREST INCOME:
Interest and fees on loans	$ 127,995	$ 114,612	$ 107,622
Interest and dividends on investment securities:
Taxable securities	13,488	11,713	12,487
Nontaxable securities	781	730	609
Dividends on securities	675	561	432
Interest on federal funds sold and other	248	166	116
Total interest income	143,187	127,782	121,266
INTEREST EXPENSE:
Interest on deposits	4,019	3,854	3,640
Interest on short-term borrowings and securities sold under agreements to repurchase	1,205	494	214
Interest on subordinated debentures and notes payable	7,389	7,383	5,736
Total interest expense	12,613	11,731	9,590
NET INTEREST INCOME BEFORE PROVISION FOR LOAN LOSSES	130,574	116,051	111,676
Provision for loan losses	3,285	(2,101)	6,420
NET INTEREST INCOME AFTER PROVISION FOR LOAN LOSSES	127,289	118,152	105,256
NONINTEREST INCOME:
Service charges	6,624	6,059	5,862
Investment advisory income	6,220	5,714	5,832
Insurance income	13,181	12,568	12,047
Other income	7,976	9,819	6,926
Total noninterest income	34,001	34,160	30,667
NONINTEREST EXPENSE:
Salaries and employee benefits	75,088	71,471	69,526
Occupancy expenses, premises and equipment	14,665	14,966	13,079
Amortization of intangibles	600	600	600
FDIC and other assessments	1,310	1,692	1,813
Net (gain) on securities, other assets and other real estate owned	(507)	(121)	(369)
Other expense	16,738	16,623	15,528
Total noninterest expense	107,894	105,231	100,177
INCOME BEFORE INCOME TAXES	53,396	47,081	35,746
Provision for income taxes	20,478	12,182	9,606
NET INCOME FROM CONTINUING OPERATIONS	32,918	34,899	26,140
DISCONTINUED OPERATIONS:
Loss from discontinued operations			(113)
Benefit for income taxes			(42)
Net loss from discontinued operations			(71)
NET INCOME	32,918	34,899	26,069
NET INCOME AVAILABLE TO COMMON SHAREHOLDERS	$ 32,918	$ 34,899	$ 25,749
EARNINGS PER COMMON SHARE:
Basic earnings per share	$ 0.79	$ 0.84	$ 0.63
Diluted earnings per share	$ 0.78	$ 0.84	$ 0.62

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Net income	$ 32,918	$ 34,899	$ 26,069
Cash flow hedges:
Net unrealized gain (loss)	(201)	(3,504)	(905)
Reclassification to operations	651	1,060	1,082
Total	450	(2,444)	177
Total other comprehensive loss items	(1,140)	(4,382)	(1,687)
Cash flow hedges:
Net unrealized gain (loss)	(76)	(1,332)	(344)
Reclassification to operations	246	404	411
Total tax expense (benefit)	170	(928)	67
Total income tax provision	(433)	(1,665)	(642)
Other comprehensive loss, net of tax	(707)	(2,717)	(1,045)
Comprehensive income	32,211	32,182	25,024
Available for sale securities
Other comprehensive income (loss) items:
Net unrealized gain (loss)	317	(13)	358
Reclassification to operations	(249)	(94)	(318)
Net unrealized holding gains transferred to held to maturity			(8,821)
Total	68	(107)	(8,781)
Income tax provision:
Net unrealized gain (loss)	120	(5)	136
Reclassification to operations	(94)	(36)	(121)
Net unrealized holding gains transferred to held to maturity			(3,352)
Total tax expense (benefit)	26	(41)	(3,337)
Held to maturity securities
Other comprehensive income (loss) items:
Reclassification to operations	(1,658)	(1,831)	(1,904)
Net unrealized holding gains transferred to held to maturity			8,821
Total	(1,658)	(1,831)	6,917
Income tax provision:
Reclassification to operations	(629)	(696)	(724)
Net unrealized holding gains transferred to held to maturity			3,352
Total tax expense (benefit)	$ (629)	$ (696)	$ 2,628

Consolidated Statements Of Equi

Consolidated Statements Of Equity - USD ($) $ in Thousands	Preferred Stock	Common Stock	Additional Paid-In Capital	Retained Earnings	Accumulated Comprehensive Income	Total
BALANCE - beginning of period at Dec. 31, 2014	$ 1	$ 401	$ 245,020	$ 59,019	$ 4,328	$ 308,769
BALANCE - beginning of period (shares) at Dec. 31, 2014	57,366	40,770,390
Options exercised, value		$ 5	1,270			1,275
Options exercised, shares		166,589
Employee stock purchase plan, value		$ 1	457			458
Employee stock purchase plan, shares		39,309
Shares withheld in net settlement of restricted stock		$ (1)	(470)	(736)		(1,207)
Shares withheld in net settlement of restricted stock (shares)		(103,763)
Restricted stock awards, net of forfeitures, shares		249,594
Stock-based compensation expense			3,324			3,324
Tax benefit from stock-based compensation			532			532
Redemption of preferred stock	$ (1)		(57,365)			(57,366)
Redemption of preferred stock (in shares)	(57,366)
Dividends paid-common				(6,953)		(6,953)
Dividends paid/accumulated-preferred stock				(320)		(320)
Other comprehensive income (loss), net of income taxes of $433, $1665 and $642 respectively					(1,045)	(1,045)
Net income				26,069		26,069
BALANCE - end of period at Dec. 31, 2015		$ 406	192,768	77,079	3,283	273,536
BALANCE - end of period (shares) at Dec. 31, 2015		41,122,119
Options exercised, value		$ 2	1,678			1,680
Options exercised, shares		216,268
Employee stock purchase plan, value		$ 1	437			438
Employee stock purchase plan, shares		36,813
Shares withheld in net settlement of restricted stock		$ (1)	(359)	(531)		(891)
Shares withheld in net settlement of restricted stock (shares)		(77,855)
Restricted stock awards, net of forfeitures		$ 3	(3)
Restricted stock awards, net of forfeitures, shares		257,863
Stock-based compensation expense			3,213			3,213
Cumulative effect of adopting of ASU 2016-09 | ASU 2016-09			24	(14)		10
Dividends paid-common				(7,858)		(7,858)
Other comprehensive income (loss), net of income taxes of $433, $1665 and $642 respectively					(2,717)	(2,717)
Net income				34,899		34,899
BALANCE - end of period at Dec. 31, 2016		$ 411	197,758	103,575	566	302,310
BALANCE - end of period (shares) at Dec. 31, 2016		41,555,208
Options exercised, value		$ 1	1,083			$ 1,084
Options exercised, shares		109,136				109,136
Employee stock purchase plan, value			497			$ 497
Employee stock purchase plan, shares		29,967
Shares withheld in net settlement of restricted stock		$ (1)	(313)	(812)		(1,126)
Shares withheld in net settlement of restricted stock (shares)		(66,134)
Restricted stock awards, net of forfeitures		$ 3	(3)
Restricted stock awards, net of forfeitures, shares		156,842
Stock-based compensation expense			3,093			3,093
Warrant exercised		$ 4	(4)
Warrant exercised (in shares)		432,299
Dividends paid-common				(8,785)		(8,785)
Other comprehensive income (loss), net of income taxes of $433, $1665 and $642 respectively					(707)	(707)
Net income				32,918		32,918
BALANCE - end of period at Dec. 31, 2017		$ 418	$ 202,111	$ 126,896	$ (141)	$ 329,284
BALANCE - end of period (shares) at Dec. 31, 2017		42,217,318

Consolidated Statements Of Equ7

Consolidated Statements Of Equity (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Consolidated Statements Of Equity
Dividends paid-common share	$ 0.21	$ 0.19	$ 0.17
Dividends paid/accumulated-preferred stock, percentage rate			1.00%
Dividends paid/accumulated-preferred stock, liquidation value per share			$ 1,000
Other comprehensive loss, income taxes	$ 433	$ 1,665	$ 642

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 32,918	$ 34,899	$ 26,069
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, amortization and accretion	5,297	4,446	4,112
Provision for loan losses	3,285	(2,101)	6,420
Stock-based compensation	3,093	3,213	3,324
Deferred income taxes	7,218	3,985	(1,572)
Bank-owned life insurance	(1,366)	(1,367)	(1,334)
Net gain on securities, other assets and other real estate owned	(507)	(121)	(369)
Other operating activities, net	(2,189)	(869)	(1,761)
Changes in operating assets and liabilities:
Other assets	(1,866)	(2,959)	(529)
Other liabilities	56	4,416	(237)
Net cash provided by operating activities	45,939	43,542	34,123
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of other investments	(22,411)	(15,720)	(13,765)
Proceeds from other investments	24,389	19,152	14,428
Purchase of investment securities available for sale	(80,878)	(6,962)	(28,049)
Purchase of investment securities held to maturity	(74,794)	(89,016)	(108,052)
Maturity, call and principal payments on investment securities available for sale	46,857	27,322	36,919
Maturity, call and principal payments on investment securities held to maturity	73,252	66,830	68,960
Purchase of bank-owned life insurance		(3,195)
Net proceeds from sale of loans, OREO and repossessed assets	1,726	60	2,499
Acquisition of client relationships			(75)
Loan originations and repayments, net	(211,173)	(240,092)	(291,573)
Purchase of premises and equipment	(3,267)	(9,381)	(1,547)
Other investing activities, net	653	348
Net cash used in investing activities	(245,646)	(250,654)	(320,255)
CASH FLOWS FROM FINANCING ACTIVITIES:
Net increase in demand, money market and savings accounts	231,031	289,228	307,430
Net decrease in certificates of deposits	(35,594)	(1,157)	(58,009)
Net increase (decrease) in short-term borrowings	(28,590)	(25,770)	19,531
Net increase (decrease) in securities sold under agreements to repurchase	25,320	(19,820)	(2,517)
Redemption of preferred stock			(57,366)
Net proceeds from issuance of subordinated notes payable			59,250
Proceeds from issuance of common stock	1,581	2,118	1,733
Taxes paid in net settlement of restricted stock	(1,126)	(891)	(1,207)
Dividends paid on common stock	(8,785)	(7,858)	(6,953)
Dividends paid on preferred stock			(463)
Other financing activities, net			450
Net cash used in financing activities	183,837	235,850	261,879
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(15,870)	28,738	(24,253)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	96,050	67,312	91,565
CASH AND CASH EQUIVALENTS, END OF PERIOD	$ 80,180	$ 96,050	$ 67,312

Nature of Operations and Signif

Nature of Operations and Significant Accounting Policies	12 Months Ended
	Dec. 31, 2017
Nature of Operations and Significant Accounting Policies
Nature Of Operations and Significant Accounting Policies	COBIZ FINANCIAL INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL AT AND FOR THE YEARS ENDED DECEMBER 31, 2017, 2016 AND 2015 1. Nature of Operations and Significant Accounting Policies CoBiz Financial Inc. is a financial holding company headquartered in Denver, Colorado which provides a broad range of banking and related services through its wholly owned subsidiaries: CoBiz Bank (Bank); CoBiz Insurance, Inc.; and CoBiz IM, Inc. (CoBiz IM); all collectively referred to as the “Company” or “CoBiz.” The operations of the Company comprise predominantly the Bank, which operates in its Colorado market areas under the name Colorado Business Bank and in its Arizona market areas under the name Arizona Business Bank. Organization - The Bank is a commercial banking institution with seven locations in the Denver metropolitan area; one in Boulder; one near Vail; one in Colorado Springs; one in Fort Collins; and four in the Phoenix metropolitan area. As a state chartered bank, deposits are insured by the Bank Insurance Fund of the FDIC and the Bank is subject to supervision, regulation and examination by the Federal Reserve, Colorado Division of Banking and the FDIC. Pursuant to such regulations, the Bank is subject to special restrictions, supervisory requirements and potential enforcement actions. CoBiz Insurance, Inc. provides commercial and personal P&C insurance brokerage, and risk management consulting services to small and medium-sized businesses and individuals; and employee benefits consulting, insurance brokerage and related administrative support to employers. CoBiz IM provides wealth planning and investment management to institutions and individuals through its SEC-registered investment advisor subsidiary, CoBiz Wealth, LLC. CoBiz GMB, Inc. provided investment banking services to middle-market companies through its wholly-owned subsidiary, GMB, until its discontinuation on March 31, 2015. The operating results of GMB for 2015 have been presented as discontinued operations. See Note 2 – Discontinued Operations for additional information on the discontinued operations of GMB. Use of Estimates – The consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States and, where applicable, prevailing practices within the financial services industry. In preparing the consolidated financial statements, the Company is required to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ significantly from those estimates. Reclassifications – Certain reclassifications have been made to prior years’ consolidated financial statements and related notes to conform to current year presentation including: the effects of discontinued operations and the aggregation of certain line items in the consolidated statements of cash flows. Refer to Note 2 – Discontinued Operations for additional information. The following is a summary of certain of the Company’s significant accounting and reporting policies. Basis of Presentation — The consolidated financial statements include entities in which the Parent has a controlling financial interest. These entities include; the Bank; CoBiz Insurance, Inc.; and CoBiz IM. Intercompany balances and transactions are eliminated in consolidation. The Company determines whether it has a controlling financial interest in an entity by first evaluating whether the entity is a voting interest entity or a VIE. The voting interest model is used when the equity investment is sufficient to absorb the expected losses and the equity investment has all of the characteristics of a controlling financial interest. Under the voting interest model, the party with the controlling voting interest consolidates the legal entity. The VIE model is used when any of the following conditions exist: the equity investment at risk is not sufficient to finance the entity’s activities without additional subordinated financial support; the holders of the equity investment do not have a controlling voting interest; or the holders of the equity investment are not obligated to absorb the expected losses or residual returns of the legal entity. An enterprise is considered to have a controlling financial interest of a VIE if it has both the power to direct the activities that most significantly impact economic performance and the obligation to absorb losses, or receive benefits, that are significant to the VIE. An enterprise that has a controlling financial interest is considered the primary beneficiary and must consolidate the VIE. The Company was not the primary beneficiary of a VIE at December 31, 2017 or December 31, 2016. Cash and Cash Equivalents — The Company considers all liquid investments with original maturities of three months or less to be cash equivalents. Cash and cash equivalents include amounts that the Company is required to maintain at the Federal Reserve Bank of Kansas City (Federal Reserve Bank) to meet certain regulatory reserve balance requirements. At December 31, 2017 and 2016, the Company had reserve requirements of $17.1 million and $24.3 million, respectively. The following table shows supplemental disclosures of certain cash and noncash items: For the year ended December 31, (in thousands) 2017 2016 2015 Cash paid during the period for: Interest $ 12,574 $ 11,826 $ 9,256 Income taxes, net 14,742 8,950 9,919 Other noncash activities: Loans transferred to held for sale 1,726 60 1,628 Conversion or exchange of AFS securities 18,023 - - Trade date accounting for investment securities - 1,553 795 Available for sale securities transferred to held to maturity - - 288,598 Lessor-paid tenant improvement allowance 358 - - Investments — The Company classifies its investment securities as held to maturity, available for sale or trading, according to management’s intent. Investment security transactions are recorded on a trade date basis. At December 31, 2017 and 2016, the Company had no trading securities. Available for sale securities consist of bonds, notes and debentures (including corporate debt and TPS) not classified as held to maturity securities and are reported at fair value as determined by quoted market prices. Unrealized holding gains and losses, net of tax, are reported as a net amount in AOCI until realized. Investment securities held to maturity consist of residential mortgage-backed securities (MBS), bonds, notes, debentures for which the Company has the positive intent and ability to hold to maturity and are reported at cost, adjusted for amortization or accretion of premiums and discounts. Premiums and discounts, adjusted for prepayments as applicable, are recognized in interest income. Other than temporary declines in the fair value of individual investment securities held to maturity and available for sale are charged against earnings. Gains and losses on disposal of investment securities are determined using the specific identification method. Other-than-temporary-impairment (OTTI) on debt securities is separated between the amount that is credit related (credit loss component) and the amount due to all other factors. The credit loss component is recognized in earnings and is the difference between a security’s amortized cost basis and the discounted present value of expected future cash flows. The amount due to all other factors is recognized in other comprehensive income (loss) (OCI). See Note 3 – Investments. Bank Stocks — Federal Home Loan Bank of Topeka (FHLB), Federal Reserve Bank and other correspondent bank stocks are accounted for under the cost method. See Note 3 – Investments. Loans Held for Investment — Loans that the Company has the intent and ability to hold for the foreseeable future or until maturity or pay-off are reported at their outstanding principal balance adjusted for any charge-offs, the allowance for loan losses, deferred fees and costs on originated loans, and unamortized premiums or discounts on purchased loans. Interest is accrued and credited to income daily based on the principal balance outstanding. Loans that are 30 days or more past due based on payments received and applied to the loan are considered delinquent, excluding loans that are cash-secured. The accrual of interest income is generally discontinued when a loan becomes 90 days past due as to principal and interest. When a loan is designated as nonaccrual, the current period’s accrued interest receivable is charged against current earnings while any portions relating to prior periods are charged against the allowance for loan losses. Interest payments received on nonaccrual loans are generally applied to the principal balance of the loan. Loans are returned to accrual status when all the principal and interest amounts contractually due are brought current and future payments are reasonably assured and there has been demonstrated performance in accordance with contractual terms. The Company may elect to continue the accrual of interest when the loan is in the process of collection and the realizable value of collateral is sufficient to cover the principal balance and accrued interest. Loans Held for Sale — Loans held for sale include loans the Company has demonstrated the ability and intent to sell. Loans held for sale are primarily nonperforming loans. Loans held for sale are carried at the lower of cost or fair value and are evaluated on a loan-by-loan basis. Impaired Loans — Impaired loans, with the exception of groups of smaller-balance homogenous loans that are collectively evaluated for impairment, are defined as loans for which, based on current information and events, it is probable that the Company will be unable to collect the scheduled payments of principal or interest when due according to the contractual terms of the loan agreement. Factors considered by management in determining impairment include payment status, collateral value, and the probability of collecting scheduled principal and interest payments when due. Loans that experience insignificant payment delays of less than 90 days and monthly payment shortfalls of less than 10% of the contractual payment on a consumer loan generally are not classified as impaired if the Company ultimately expects to recover its full investment. The Company determines the significance of payment delays and payment shortfalls on a case-by-case basis, taking into consideration all of the circumstances surrounding the loan and the borrower, including the length of the delay, the reasons for the delay, the borrower’s prior payment record, and the amount of the shortfall in relation to the principal and interest owed. Impairment is measured on a loan-by-loan basis by the present value of expected future cash flows discounted at the loan’s effective interest rate, the loan’s obtainable market price or the fair value of the collateral if the loan is collateral dependent. Loans that are deemed to be impaired are evaluated in accordance with Accounting Standards Codification (ASC) Topic 310-10-35, Receivables – Subsequent Measurement (ASC 310) and ASC Topic 450-20, Loss Contingencies (ASC 450). Included in impaired loans are troubled debt restructurings. A troubled debt restructuring is a formal restructure of a loan where the Company, for economic or legal reasons related to the borrower’s financial difficulties, grants a concession to the borrower. The concessions may be granted in various forms, including but not limited to reduction in the stated interest rate, reduction in the loan balance or accrued interest, or extension of the maturity date. Troubled debt restructurings are evaluated in accordance with ASC Topic 310-40, Troubled Debt Restructurings by Creditors. Interest payments on impaired loans are typically applied to principal unless collectability of principal is reasonably assured. Loans that have been modified in a formal restructuring are typically returned to accrual status when there has been a sustained period of performance (generally six months) under the modified terms, the borrower has shown the ability and willingness to repay and the Company expects to collect all amounts due under the modified terms. Loan Origination Fees and Costs — Loan fees and certain costs of originating loans are deferred and the net amount is amortized over the contractual life of the related loans in accordance with ASC Topic 310-20, Nonrefundable Fees and Other Costs. Allowance for Loan Losses — The allowance for loan losses (ALL) is established as losses are estimated to have occurred through a provision for loan losses charged against earnings. Loan losses are charged against the allowance when management believes the uncollectability of a loan balance is confirmed. Subsequent recoveries, if any, are credited to the allowance. The ALL is evaluated on a regular basis by management and is based upon management’s periodic review of the collectability of the loans in light of historical experience, the nature and volume of the loan portfolio, adverse situations that may affect the borrower’s ability to repay, estimated value of any underlying collateral, and prevailing economic conditions. This evaluation is inherently subjective as it requires estimates that are susceptible to significant revision as new information becomes available. Allowance for Credit Losses — The allowance for credit losses is established as losses are estimated to have occurred through a provision for credit losses charged to earnings. The allowance for credit losses represents management’s recognition of a separate reserve for off-balance sheet loan commitments and letters of credit. While the allowance for loan losses is recorded as a contra-asset to the loan portfolio on the consolidated balance sheets, the allowance for credit losses is recorded under the caption “Accrued interest and other liabilities”. Although the allowances are presented separately on the balance sheets, any losses incurred from credit losses would be reported as a charge-off in the allowance for loan losses, as any loss would be recorded after the off-balance sheet commitment had been funded. See Note 4 – Loans. Intangible Assets — Intangible assets, primarily consisting of customer contracts and relationships, are being amortized by the straight-line method over 10 to 15 years. See Note 6 – Intangible Assets. Bank-Owned Life Insurance (BOLI) – The Bank invested in BOLI policies to fund certain future employee benefit costs and are recorded at net realizable value. Changes in the amount that could be realized, including death benefits in excess of the carrying amount, are recorded in the consolidated statements of income under the caption “Other Income.” Premises and Equipment – Premises and equipment are stated at cost less accumulated depreciation and amortization, which is calculated using the straight-line method over the estimated useful lives of generally three to ten years. Leasehold improvements are capitalized and amortized using the straight-line method over the terms of the respective leases or the estimated useful lives of the improvements, whichever is shorter. The Company reviews the carrying value of property and equipment for indications of impairment in accordance with ASC Topic 360-10-35, Impairment or Disposal of Long-Lived Assets. See Note 5 – Premises and Equipment. Other Assets – Included in other assets are certain investments (Funds), where the Company has the ability to exercise significant influence or has ownership between 20% and 50% that are accounted for under the equity method. The Funds are equity method investments licensed as Small Business Investment Companies that invest primarily in subordinated debt securities. In certain circumstances, the Funds may also receive warrants or other equity positions as part of their investments. There were no significant transactions between the Company and the Funds for the years ended December 31, 2017, 2016, and 2015. The Company recognized income from the Funds of $1.2 million, $2.5 million, and $1.3 million for the years ended December 31, 2017, 2016, and 2015, respectively, which is included in “Other Income” in the consolidated statements of income. Repossessed Assets – Assets acquired through repossession are held for sale and initially recorded at estimated fair value at the date of repossession. Subsequent to repossession, valuations are periodically performed by management and the assets are carried at the lower of carrying amount or fair value less costs to sell. Repossessed assets are reported in the consolidated balance sheets under the caption “Other Assets.” There were no repossessed assets at December 31, 2017 and 2016. Other Real Estate Owned (OREO) – OREO held for sale acquired through foreclosure, physical possession or in settlement of debt is valued at estimated fair value, less estimated costs to sell, at the date of receipt. Subsequent to foreclosure, OREO is carried at the lower of carrying amount or fair value less costs to sell. Subsequent declines in value are charged to operations. There was no significant activity in the valuation allowance on OREO for the years ended December 31, 2017, 2016, and 2015. Securities Sold Under Agreements to Repurchase – The Company sells certain securities under agreements to repurchase with its customers. The agreements transacted with its customers are utilized as an overnight investment product. These agreements are treated as secured borrowings, where the agreements are reflected as a liability of the Company and the securities underlying the agreements are reflected as a Company asset in accordance with ASC Topic 860, Transfers and Servicing. See Note 8 – Borrowed Funds. Derivative Instruments — Derivative financial instruments are accounted for at fair value. The Company utilizes interest rate swaps to hedge a portion of its exposure to interest rate changes. These instruments are accounted for as cash flow hedges, as defined by ASC Topic 815, Derivatives and Hedging (ASC 815). The Company also uses interest rate swaps to hedge against adverse changes in fair value on fixed-rate loans. These instruments are accounted for as fair value hedges in accordance with ASC 815. The net cash flows from the cash flow and fair value hedges are classified in operating activities within the consolidated statements of cash flows with the hedged items. The Company also offers an interest rate hedge program that includes various derivative products, including swaps, to customers of the Bank. The fair value amounts recognized for derivative instruments and the fair value amounts recognized for the right to reclaim or obligation to return cash collateral are not offset when represented under a master netting arrangement. The Company also uses foreign currency forward contracts (FX forwards) giving it the right to sell underlying currencies at specified future dates and predetermined prices in order to mitigate foreign exchange risk associated with long positions. FX forwards are carried at fair value with changes in value recognized in current earnings as the contracts are not designated as hedging instruments. See Note 10 – Derivatives. Self-Insurance Reserves – The Company self-insures a portion of its employee medical costs. The Company maintains a liability for incurred-but-not-reported claims based on assumptions as to eligible employees, historical claims experience and lags in claims reporting. Investment Advisory Income – Fees earned from providing investment advisory services are based on the market value of assets under management and are collected at the end of each quarter. Insurance Income – Insurance income includes commissions on the sale of life and property and casualty insurance policies, and other employee benefit products earned as an agent for unaffiliated insurance underwriters. Property and casualty income is primarily recognized upon policy origination and renewal dates. Benefits brokerage income is recognized on a monthly basis as the customer pays their insurance premiums . Loss From Discontinued Operations, Net of Income Taxes – Loss from discontinued operations, net of income taxes for the year ended December 31, 2017, 2016 and 2015 includes the closure of GMB, which is discussed in Note 2 – Discontinued Operations. Income Taxes – A deferred income tax liability or asset is recognized for temporary differences which exist in the recognition of certain income and expense items for financial statement reporting purposes in periods different than for tax reporting purposes. The provision for income taxes is based on the amount of current and deferred income taxes payable or refundable at the date of the financial statements as measured by the provisions of current tax laws. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized. The ultimate realization of deferred tax assets depends on the generation of future taxable income during the period in which related temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, taxes paid in prior carryback years, projected future taxable income and tax planning strategies in its assessment of a valuation allowance. See Note 11 – Income Taxes. Stock-Based Compensation — Pursuant to ASC Topic 718, Compensation – Stock Compensation (ASC 718), the Company recognizes the fair value of stock-based awards to employees as compensation cost over the requisite service period. See Note 15 – Employee Benefit and Stock Compensation Plans. Earnings Per Common Share — Basic and diluted earnings per share is based on the two-class method prescribed in ASC Topic 260, Earnings Per Share (ASC 260). The weighted-average number of shares outstanding used to compute diluted earnings per share include the number of additional common shares that would be outstanding if the potential dilutive common shares and common share equivalents had been issued at the beginning of the period. See Note 14 – Earnings per Common Share. Segment Information - The Company has disclosed separately the results of operations relating to its segments in Note 19 – Segments. Fair Value Measurements — The Company measures financial assets, financial liabilities, nonfinancial assets and nonfinancial liabilities pursuant to ASC Topic 820, Fair Value Measurements and Disclosures (ASC 820). ASC 820 defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. See Note 18 - Fair Value Measurements. Recent Accounting Pronouncements — In May 2014, the FASB issued ASU 2014-09 (ASU 2014-09), Revenue from Contracts with Customers. The core principle of ASU 2014-09 is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The guidance also specifies the accounting for some costs to obtain or fulfill a contract with a customer, as well as enhanced disclosure requirements. In August 2015, the FASB issued ASU 2015-14 which deferred the effective date of ASU 2014-09 to fiscal years, and interim reporting periods within those fiscal years, beginning after December 15, 2017. In March 2016, the FASB issued ASU 2016-08 which clarified the revenue recognition implementation guidance on principal versus agent considerations and is effective during the same period as ASU 2014-09. In April 2016, the FASB issued ASU 2016-10 which clarified the revenue recognition guidance regarding the identification of performance obligations and the licensing implementation and is effective during the same period as ASU 2014-09. In May 2016, the FASB issued ASU 2016-12 which narrowly amended the revenue recognition guidance regarding collectability, noncash consideration, presentation of sales tax and transition. ASU 2016-12 is effective during the same period as ASU 2014-09. In evaluating the effects of these ASUs on its financial statements and disclosures, the Company has determined the following: · The primary revenue lines subject to these ASUs are deposit service charges, investment advisory income and insurance income, which totaled $26.0 million in 2017. · The adoption of these ASUs did not have a material impact on the Company’s financial statements. The Company’s first quarter interim filing will be updated with the new required disclosures. · The Company will adopt ASU 2014-09 using the modified retrospective method. In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) (ASU 2016-02). ASU 2016-02 is intended to increase transparency and comparability among organizations by recognizing lease assets and liabilities on the balance sheet and disclosing key information about lease arrangements. For public business entities, this ASU is effective for annual periods and interim periods within those annual periods beginning after December 15, 2018. The Company is currently evaluating the effects of ASU 2016-02 on its financial statements and disclosures by taking inventory of all existing lease arrangements. Preliminarily, the Company expects the primary impact of ASU 2016-02 will relate to its office locations, all of which are designated as operating leases. The Company has future operating lease obligations for its locations of $30.4 million that are being evaluated as potential lease assets and liabilities, as defined in ASU 2016-02. The Company has formed a lease implementation team that includes members of accounting, facilities and operations to review lease contracts and the requirements of ASU 2016-02. In June 2016, the FASB issued ASU 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (ASU 2016-13). The objective of ASU 2016-13 is to provide financial statement users with decision-useful information about the expected credit losses on financial instruments and other commitments to extend credit. ASU 2016-13 includes provisions that require financial assets measured at amortized cost (such as loans and held to maturity (HTM) debt securities) to be presented at the net amount expected to be collected. This will be accomplished through recognition of an estimate of all current expected credit losses. The estimate will include forecasted information for the timeframe that an entity is able to develop reasonable and supportable forecasts. This is a change from the current practice of recognizing incurred losses based on the probable initial recognition threshold under current GAAP. In addition, credit losses AFS debt securities will be recorded through an allowance for credit losses rather than as a write-down. Under ASU 2016-13, an entity will be able to record reversals of credit losses in current period income when the estimate of credit losses declines, whereas current GAAP prohibits reflecting those improvements in current period earnings. ASU 2016-13 is effective for annual periods and interim periods within those annual periods beginning after December 15, 2019, and early adoption is permitted for fiscal years, including interim periods, beginning after December 15, 2018. ASU 2016-13 will be applied through a cumulative effect adjustment to retained earnings (modified-retrospective approach), except for debt securities for which an other-than-temporary impairment had been recognized before the effective date. A prospective transition approach is required for these debt securities. The Company is currently evaluating the effects of ASU 2016-13 on its financial statements and disclosures, and expects ASU 2016-13 to add complexity and costs to its current credit loss evaluation process. In planning for the implementation of ASU 2016-13, the Company has formed a CECL implementation team that includes the CFO, Chief Credit Officer and members of credit, accounting, finance, information technology. The team meets on a weekly basis and is currently evaluating software solutions, data requirements and loss methodologies. In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (ASU 2016-15), regarding how certain cash receipts and cash payments are presented and classified in the statements of cash flows. ASU 2016-15 addresses eight specific cash flow issues with the objective of reducing the existing diversity in practice. The amendments of ASU 2016-15 are effective for public business entities for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. Amendments in this ASU should be applied using a retrospective transition method to each period presented. The Company is evaluating the effects ASU 2016-15 will have on its financial statements and disclosures, and does not expect these effects to be material. In December 2016, the FASB issued ASU 2016-20, Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customers (ASU 2016-20). The amendments in ASU 2016-20 affect certain aspects of the guidance issued in ASU 2014-06 including loan guarantee fees, contract costs, provisions for losses on construction-type and production-type contracts, disclosure of remaining performance obligations, contract modifications, contract asset vs. receivable, refund liability, advertising costs, fixed odds wagering contracts in the casino industry, and costs capitalized for advisors to private funds and public funds. The effective date of these amendments are at the same date that ASU 2014-09, which is discussed above, is effective. In February 2017, the FASB issued ASU 2017-05, Other Income – Gains and Losses from the Derecognition of Nonfinancial Assets (Subtopic 610-20) (ASU 2017-05). ASU 2017-05 is intended to clarify that Subtopic 610-20 applies to the derecognition of nonfinancial assets and in substance nonfinancial assets unless other specific guidance applies. ASU 2017-05 also adds guidance for partial sales of nonfinancial assets and eliminates rules specifically addressing sales of real estate. For public business entities, this ASU is effective for annual periods and interim periods within those annual periods beginning after December 15, 2017. The Company is currently evaluating the effects of ASU 2017-05 on its financial statements and disclosures. In March 2017, the FASB issued ASU 2017-08, Receivables – Nonrefundable Fees and Other Costs (Subtopic 310-20) (ASU 2017-08). ASU 2017-08 amends the amortization period for certain purchased callable debt securities held at a premium. Prior to the issuance of this guidance, premiums were amortized as an adjustment of yield over the contractual life of the instrument. ASU 2017-08 requires premiums on purchased callable debt securities that have explicit, noncontingent call features that are callable at fixed prices to be amortized to the earliest call date. There are no accounting changes for securities held at a discount. This ASU is effective for annual periods and interim periods within those annual periods beginning after December 15, 2018, and early adoption is permitted. ASU 2017-08 will be applied through a cumulative effect adjustment through equity (modified-retrospective approach). The Company is currently evaluating the effects of ASU 2017-08 on its financial statements and disclosures. In May 2017, the FASB issued ASU 2017-09, Compensation – Stock Compensation (Topic 718), Scope of Modification Accounting (ASU 2017-09). ASU 2017-09 clarifies when changes to the terms and conditions of share-based payment awards must be treated as modifications. Specifically, the new guidance permits companies to make certain changes to awards without accounting for them as modifications. ASU 2017-09 is effective for annual periods beginning after December 31, 2017 and will be applied prospectively to an award modified after the effective date. The Company is currently evaluating the effects of ASU 2017-09 on its financial statements and disclosures. In August 2017, the FASB issued ASU 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities (ASU 2017-12). The purpose of this updated guidance is to better align a company’s financial reporting for hedging activities with the economic objectives of those activities. ASU 2017-12 is effective for annual periods and inter

Discontinued Operations

Discontinued Operations	12 Months Ended
	Dec. 31, 2017
Discontinued Operations
Discontinued Operations	2. Discontinued Operations During the first quarter of 2015, the Company ceased operations of GMB due to increasing regulatory compliance costs and in order to focus on activities that provide recurring revenue. The net carrying value of the assets and liabilities of GMB was $0.8 million and were transferred to the parent Company at the end of the first quarter of 2015. The results of operations for GMB have been presented as discontinued operations in 2015. The table below presents the results of the discontinued operations of GMB for the year ended December 31, 2015. Net loss before income taxes approximates total cash flows from operating activities of the discontinued operations. Cash flows from investing activities were not material. For the year ended December 31, (in thousands) 2015 Noninterest income $ 623 Noninterest expense 736 Loss before income taxes (113) Benefit for income taxes (42) Loss from discontinued operations $ (71)

Investments

Investments	12 Months Ended
	Dec. 31, 2017
Investments
Investments	3. Investments The amortized cost and estimated fair values of investment securities are summarized as follows: December 31, 2017 December 31, 2016 Gross Gross Gross Gross Amortized unrealized unrealized Fair Amortized unrealized unrealized Fair (in thousands) cost gains losses value cost gains losses value Available for sale securities (AFS): Trust preferred securities $ 20,318 $ 1,870 $ 205 $ 21,983 $ 36,450 $ 1,707 $ 533 $ 37,624 Corporate debt securities 140,445 1,153 103 141,495 90,593 1,505 21 92,077 Municipal securities 3,249 41 15 3,275 3,265 33 18 3,280 Total AFS $ 164,012 $ 3,064 $ 323 $ 166,753 $ 130,308 $ 3,245 $ 572 $ 132,981 Held to maturity securities (HTM): Mortgage-backed securities $ 318,128 $ 118 $ 3,262 $ 314,984 $ 319,978 $ 186 $ 2,531 $ 317,633 Trust preferred securities 10,721 783 18 11,486 10,620 522 267 10,875 Municipal securities 33,695 73 167 33,601 35,443 10 783 34,670 Total HTM $ 362,544 $ 974 $ 3,447 $ 360,071 $ 366,041 $ 718 $ 3,581 $ 363,178 During the first quarter of 2015, the Company transferred MBS and municipal securities with a book value of $279.8 million and fair value of $288.6 million from AFS to HTM. There were no transfers of securities between the AFS and HTM categories in 2017 or 2016. Transfers of securities from AFS to HTM were made at fair value at the time of transfer. The unamortized portion of the $8.8 million unrealized holding gain at the time of transfer is retained in AOCI and in the carrying value of HTM securities. Accordingly, the balance of HTM securities in the “Amortized cost” column in the table above includes net unamortized unrealized gains of $3.4 million and $5.1 million at December 31, 2017 and 2016, respectively. Such amounts are amortized over the remaining life of the securities. Proceeds from the sale of investments and the gain (loss) recognized on securities sold or called are summarized as follows: For the year ended December 31, (in thousands) 2017 2016 2015 Proceeds $ - $ - $ - Gains 254 100 343 Losses (5) (6) (25) The amortized cost and estimated fair value of investments in debt securities at December 31, 2017, by contractual maturity are shown below. Expected maturities can differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without penalties. Available for sale Held to maturity Amortized Fair Amortized Fair (in thousands) cost value cost value Due in one year or less $ 8,385 $ 8,390 $ 1,718 $ 1,712 Due after one year through five years 99,998 100,948 23,578 23,572 Due after five years through ten years 29,446 29,975 - - Due after ten years 26,183 27,440 19,120 19,803 Mortgage-backed securities - - 318,128 314,984 $ 164,012 $ 166,753 $ 362,544 $ 360,071 The Company uses investment securities to collateralize public and governmental deposits. Investment securities with an approximate fair value of $164.4 million and $143.6 million were pledged to secure these deposits of $116.5 million and $95.8 million at December 31, 2017 and 2016, respectively. Changes in interest rates and market liquidity may cause adverse fluctuations in the market price of securities resulting in temporary unrealized losses. In reviewing the realizable value of its securities in a loss position, the Company considered the following factors: (1) the length of time and extent to which the market had been less than cost; (2) the financial condition and near-term prospects of the issuer; (3) investment downgrades by rating agencies; and (4) whether it is more likely than not that the Company will have to sell the security before a recovery in value. When it is probable that the Company will be unable to collect all amounts due according to the contractual terms of the security, and the fair value of the investment security is less than its amortized cost, an other-than-temporary impairment is recognized in earnings. For debt securities that are considered other-than temporarily impaired and that the Company does not intend to sell and will not be required to sell prior to recovery of the amortized cost basis, OTTI is recognized. OTTI is separated into the amount that is credit related (credit loss component) and the amount due to all other factors. The credit loss component is recognized in earnings and is the difference between a security’s amortized cost basis and the discounted present value of expected future cash flows. The amount due to all other factors is recognized in OCI. There were 181 and 165 securities in the tables below at December 31, 2017 and 2016, respectively, in an unrealized loss position. December 31, 2017 Less than 12 months 12 months or greater Total Fair Unrealized Fair Unrealized Fair Unrealized (in thousands) value loss value loss value loss AFS Trust preferred securities $ 700 $ 43 $ 7,020 $ 162 $ 7,720 $ 205 Corporate debt securities 40,068 94 1,216 9 41,284 103 Municipal securities 1,252 15 - - 1,252 15 Total AFS $ 42,020 $ 152 $ 8,236 $ 171 $ 50,256 $ 323 HTM Mortgage-backed securities $ 182,974 $ 1,457 $ $ $ 287,438 $ 3,262 Trust preferred securities - - 864 18 864 18 Municipal securities 20,445 163 684 4 21,129 167 Total HTM $ 203,419 $ 1,620 $ $ $ 309,431 $ 3,447 December 31, 2016 Less than 12 months 12 months or greater Total Fair Unrealized Fair Unrealized Fair Unrealized (in thousands) value loss value loss value loss AFS Trust preferred securities $ 14,979 $ 526 $ 995 $ 7 $ 15,974 $ 533 Corporate debt securities 14,482 21 - - 14,482 21 Municipal securities 1,214 18 - - 1,214 18 Total AFS $ 30,675 $ 565 $ 995 $ 7 $ 31,670 $ 572 HTM Mortgage-backed securities $ 217,604 $ 2,107 $ $ 424 $ 269,936 $ 2,531 Trust preferred securities 4,175 94 700 173 4,875 267 Municipal securities 30,207 783 - - 30,207 783 Total HTM $ 251,986 $ 2,984 $ $ 597 $ 305,018 $ 3,581 There was no OTTI recognized in earnings during the years ended December 31, 2017, 2016 and 2015. Other investments at December 31, 2017 and 2016, consist of the following: December 31, (in thousands) 2017 2016 Bank stocks — at cost $ 7,945 $ 9,192 Investment in statutory trusts — equity method 2,174 2,173 $ 10,119 $ 11,365 Bank stocks consist primarily of stock in the FHLB which is part of the Federal Home Loan Bank System. The purpose of the FHLB investment relates to maintenance of a borrowing base with the FHLB. FHLB stock holdings are largely dependent upon the Company’s liquidity position. To the extent the need for wholesale funding increases or decreases, the Company may purchase additional or sell excess FHLB stock, respectively. The Company evaluates impairment in this investment based on the ultimate recoverability of the par value and at December 31, 2017 and 2016, did not consider the investment to be other-than-temporarily impaired.

Loans

Loans	12 Months Ended
	Dec. 31, 2017
Loans
Loans	4. Loans The following disclosure reports the Company’s loan portfolio segments and classes. Segments are groupings of similar loans at a level which the Company has adopted systematic methods of documentation for determining its allowance for loan and credit losses. Classes are a disaggregation of the portfolio segments. The Company’s loan portfolio segments are: · Commercial loans – Commercial loans consist of loans to small and medium-sized businesses in a wide variety of industries. The Bank’s areas of emphasis in commercial lending include, but are not limited to, loans to wholesalers, manufacturers, municipalities, and construction and business services companies. Commercial loans are generally collateralized by inventory, accounts receivable, equipment, real estate and other commercial assets, and may be supported by other credit enhancements such as personal guarantees. Risk arises primarily due to a difference between expected and actual cash flows of the borrowers. However, the recoverability of the Company’s investment in these loans is also dependent on other factors primarily dictated by the type of collateral securing these loans. The fair value of the collateral securing these loans may fluctuate as market conditions change. In the case of loans secured by accounts receivable, the recovery of the Company’s investment is dependent upon the borrowers’ ability to collect amounts due from its customers. · Real estate - mortgage loans – Real estate mortgage loans include various types of loans for which the Company holds real property as collateral. Commercial real estate lending activity is typically restricted to owner-occupied properties or to investor properties that are owned by customers with a current banking relationship. The primary risks of real estate mortgage loans include the borrower’s inability to pay, material decreases in the value of the real estate that is being held as collateral and significant increases in interest rates, which may make the real estate mortgage loan unprofitable. Real estate loans may be more adversely affected by conditions in the real estate markets or in the general economy. · Construction & land – The Company originates loans to finance construction projects including one- to four-family residences, multifamily residences, commercial office, senior housing, and industrial projects. Residential construction loans are due upon the sale of the completed project and are generally collateralized by first liens on the real estate and have floating interest rates. Construction loans are considered to have higher risks due to construction completion and timing risk, and the ultimate repayment being sensitive to interest rate changes, governmental regulation of real property and the availability of long-term financing. Additionally, economic conditions may impact the Company’s ability to recover its investment in construction loans. Adverse economic conditions may negatively impact the real estate market which could affect the borrowers’ ability to complete and sell the project. Additionally, the fair value of the underlying collateral may fluctuate as market conditions change. The Company also originates loans for the acquisition and future development of land for residential building projects, as well as finished lots prepared to enter the construction phase. The primary risks include the borrower’s inability to pay and the inability of the Company to recover its investment due to a decline in the fair value of the underlying collateral. · Consumer loans – The Company provides a broad range of consumer loans to customers, including personal lines of credit, home equity loans, residential mortgage loans and automobile loans. Repayment of these loans is dependent on the borrowers’ ability to pay and the fair value of the underlying collateral. · Other loans – Other loans include lending products, such as taxable and tax-exempt leasing, not defined as commercial, real estate, acquisition and development, construction, or consumer loans. The loan portfolio segments at December 31, 2017 and 2016 were as follows: December 31, (in thousands) 2017 2016 Commercial $ 1,250,356 $ 1,217,001 Real estate - mortgage 1,250,423 1,171,596 Construction & land 266,081 175,738 Consumer 282,101 266,947 Other 98,916 103,616 Loans held for investment 3,147,877 2,934,898 Allowance for loan losses (37,941) (33,293) Unearned net loan fees (2,314) (793) Total net loans $ 3,107,622 $ 2,900,812 The Company routinely acquires participating interests in loans originated by other banks. At December 31, 2017 and 2016, overdraft demand deposits totaling $0.2 million and $0.6 million, respectively, were reclassified from deposits to loans. The Company maintains a loan review program independent of the lending function that is designed to reduce and control risk in lending. It includes the continuous monitoring of lending activities with respect to underwriting and processing new loans, preventing insider abuse and timely follow-up and corrective action for loans showing signs of deterioration in quality. The Company also has a systematic process to evaluate individual loans and pools of loans within our loan portfolio. The Company maintains a loan grading system whereby each loan is assigned a grade between 1 and 8, with 1 representing the highest quality credit, 7 representing a nonaccrual loan where collection or liquidation in full is highly questionable and improbable, and 8 representing a loss that has been or will be charged-off. Grades are assigned based upon the degree of risk associated with repayment of a loan in the normal course of business pursuant to the original terms. Loans that are graded 5 or lower are categorized as non-classified credits while loans graded 6 and higher are categorized as classified credits. Loan grade changes are evaluated on a monthly basis. Loans above a certain dollar amount that are adversely graded are reported to the Special Assets Group manager and the Chief Credit Officer along with current financial information, a collateral analysis and an action plan. The loan portfolio showing total non-classified and classified balances by loan class at December 31, 2017 and 2016 is summarized below: At December 31, 2017 (in thousands) Non-classified Classified Total Commercial Manufacturing $ 82,275 $ 2,912 $ 85,187 Finance and insurance 40,796 1,722 42,518 Health care 161,162 2,623 163,785 Real estate services 124,861 3,986 128,847 Construction 67,232 758 67,990 Public administration 239,230 847 240,077 Other 468,562 53,390 521,952 1,184,118 66,238 1,250,356 Real estate - mortgage Residential & commercial owner-occupied 481,061 3,574 484,635 Residential & commercial investor 765,210 578 765,788 1,246,271 4,152 1,250,423 Construction & land 266,081 - 266,081 Consumer 279,191 2,910 282,101 Other 97,542 1,374 98,916 Total loans held for investment $ 3,073,203 $ 74,674 $ 3,147,877 Unearned net loan fees (2,314) Net loans held for investment $ 3,145,563 At December 31, 2016 (in thousands) Non-classified Classified Total Commercial Manufacturing $ 96,465 $ 153 $ 96,618 Finance and insurance 49,764 587 50,351 Health care 153,468 555 154,023 Real estate services 125,531 513 126,044 Construction 55,471 3,247 58,718 Public administration 254,861 1,136 255,997 Other 437,219 38,031 475,250 1,172,779 44,222 1,217,001 Real estate - mortgage Residential & commercial owner-occupied 469,027 6,496 475,523 Residential & commercial investor 695,170 903 696,073 1,164,197 7,399 1,171,596 Construction & land 172,816 2,922 175,738 Consumer 265,307 1,640 266,947 Other 101,894 1,722 103,616 Total loans held for investment $ 2,876,993 $ 57,905 $ 2,934,898 Unearned net loan fees (793) Net loans held for investment $ 2,934,105 Transactions in the ALL by segment for the years ended December 31, 2017, 2016 and 2015 are summarized below: For the year ended December 31, (in thousands) 2017 2016 2015 Allowance for loan losses, beginning of period Commercial $ 15,398 $ 24,215 $ 14,614 Real estate - mortgage 11,475 10,372 12,463 Construction & land 1,997 2,111 2,316 Consumer 2,803 2,592 2,329 Other 945 643 488 Unallocated 675 753 555 Total 33,293 40,686 32,765 Provision Commercial $ 1,237 $ (2,334) $ 9,950 Real estate - mortgage 1,029 1,072 (3,017) Construction & land 998 (1,279) (1,253) Consumer (122) 216 374 Other (119) 302 168 Unallocated 262 (78) 198 Total 3,285 (2,101) 6,420 Charge-offs Commercial $ (823) $ (7,767) $ (588) Real estate - mortgage - - (186) Construction & land - - (107) Consumer (99) (37) (130) Other - - (285) Total (922) (7,804) (1,296) Recoveries Commercial $ 1,025 $ 1,284 $ 239 Real estate - mortgage 186 31 1,112 Construction & land 1,039 1,165 1,155 Consumer 35 32 19 Other - - 272 Total 2,285 2,512 2,797 Allowance for loan losses, end of period Commercial $ 16,837 $ 15,398 $ 24,215 Real estate - mortgage 12,690 11,475 10,372 Construction & land 4,034 1,997 2,111 Consumer 2,617 2,803 2,592 Other 826 945 643 Unallocated 937 675 753 Total $ 37,941 $ 33,293 $ 40,686 The Company estimates the ALL in accordance with ASC 310 for purposes of evaluating loan impairment on a loan-by-loan basis and ASC 450 for purposes of collectively evaluating loan impairment by grouping loans with common risk characteristics (i.e. risk classification, past-due status, type of loan, and collateral). The ALL is comprised of the following components: · Specific Reserves – The Company continuously evaluates its reserve for loan losses to maintain an adequate level to absorb loan losses incurred in the loan portfolio. Reserves on loans identified as impaired, including troubled debt restructurings, are based on discounted expected cash flows using the loan’s initial effective interest rate, the observable market value of the loan or the fair value of the collateral for certain collateral-dependent loans. The fair value of the collateral is determined in accordance with ASC 820. Loans are considered to be impaired in accordance with the provisions of ASC 310, when it is probable that all amounts due in accordance with the contractual terms will not be collected. Factors contributing to the determination of specific reserves include the financial condition of the borrower, changes in the value of pledged collateral and general economic conditions. Troubled debt restructurings meet the definition of an impaired loan under ASC 310 and therefore, troubled debt restructurings are subject to impairment evaluation on a loan-by-loan basis. For collateral dependent loans that have been specifically identified as impaired, the Company measures fair value based on third-party appraisals, adjusted for estimated costs to sell the property. Upon impairment, the Company will obtain a new appraisal if one had not been previously obtained in the last 12 months. For credits over $2.0 million, the Company typically engages an additional third-party appraiser to review the appraisal. For credits under $2.0 million, the Company’s internal appraisal department reviews the appraisal. All appraisals are reviewed for adherence to regulations and mathematical accuracy reasonableness based on recent sales transactions that may have occurred subsequent to or right at the time of the appraisal. Based on this analysis the appraised value may be adjusted downward if there is evidence that the appraised value may not be indicative of fair value. Each appraisal is updated on an annual basis, either through a new appraisal or through the Company’s comprehensive internal review process. Values are reviewed and monitored internally and fair value is re-assessed at least quarterly or more frequently when events or circumstances occur that indicate a change in fair value. · General Reserves – General reserves are considered part of the allocated portion of the allowance. The Company uses a comprehensive loan grading process for our loan portfolios. Based on this process, a loss factor is assigned to each pool of graded loans. A combination of loss experience and external loss data is used in determining the appropriate loss factor. This estimate represents the probable incurred losses within the portfolio. In evaluating the adequacy of the ALL, management considers historical losses (Migration), as well as other factors including changes in: · Lending policies and procedures · National and local economic and business conditions and developments · Nature and volume of portfolio · Trends of the volume and severity of past-due and classified loans · Trends in the volume of nonaccrual loans, troubled debt restructurings, and other loan modifications · Credit concentrations Troubled debt restructurings have a direct impact on the allowance to the extent a loss has been recognized in relation to the loan modified. This is consistent with the Company’s consideration of Migration in determining general reserves. The aforementioned factors enable management to recognize environmental conditions contributing to incurred losses in the portfolio, which have not yet manifested in Migration. Management believes Migration history adequately captures a great percentage of probable incurred losses within the portfolio. In addition to the allocated reserve for graded loans, a portion of the allowance is determined by segmenting the portfolio into product groupings with similar risk characteristics. Part of the segmentation involves assigning increased reserve factors to those lending activities deemed higher-risk such as leverage-financings, unsecured loans, certain loans lacking personal guarantees, senior housing, speculative residential construction and multifamily loans. · Unallocated Reserves – The unallocated reserve, which is judgmentally determined, is maintained to recognize the imprecision in estimating and measuring loss when evaluating reserves for individual loans or pools of loans. The unallocated reserve consists of a missed grade component that is intended to capture the inherent risk that certain loans may be assigned an incorrect loan grade. In assessing the reasonableness of management’s assumptions, consideration is given to select peer ratios, industry standards and directional consistency of the ALL. Ratio analysis highlights divergent trends in the relationship of the ALL to nonaccrual loans, to total loans and to historical charge-offs. Although these comparisons can be helpful as a supplement to assess reasonableness of management assumptions, they are not, by themselves, sufficient basis for determining the adequacy of the ALL. While management utilizes its best judgment and information available, the ultimate adequacy of the allowance is dependent upon a variety of factors beyond the Company’s control, including the performance of our loan portfolio, the economy, changes in interest rates and the view of the regulatory authorities toward loan classifications. The following tables summarize loans held for investment and the ALL on the basis of the impairment method at December 31, 2017 and 2016: At December 31, 2017 At December 31, 2016 Individually Individually evaluated for Collectively evaluated for evaluated for Collectively evaluated for impairment impairment impairment impairment Loans Allowance Loans Allowance Loans Allowance Loans Allowance held for for loan held for for loan held for for loan held for for loan (in thousands) investment losses investment losses investment losses investment losses Commercial $ 56,566 $ 5,862 $ 1,194,005 $ 10,975 $ 20,279 $ 2,220 $ 1,197,453 $ 13,178 Real estate - mortgage 1,331 109 1,248,166 12,581 3,758 147 1,167,365 11,328 Construction & land 1,071 91 263,330 3,943 1,919 109 172,532 1,888 Consumer 1,366 148 280,783 2,469 294 98 266,719 2,705 Other - - 98,945 826 - - 103,786 945 Unallocated - - - 937 - - - 675 Total $ 60,334 $ 6,210 $ 3,085,229 $ 31,731 $ 26,250 $ 2,574 $ 2,907,855 $ 30,719 Information on impaired loans at December 31, 2017 and 2016 is reported in the following tables: At December 31, 2017 Recorded Recorded Recorded investment investment Unpaid investment with a with no principal in impaired related related Related (in thousands) balance loans allowance allowance allowance Commercial Manufacturing $ 3,302 $ 3,302 $ 3,302 $ - $ 238 Finance and insurance 473 473 17 456 17 Healthcare 718 718 459 259 207 Real estate services 7,982 7,982 7,982 - 544 Construction 1,689 1,457 977 480 71 Public administration 313 313 313 - 27 Other 42,660 42,321 41,030 1,291 4,758 57,137 56,566 54,080 2,486 5,862 Real estate - mortgage Residential & commercial owner-occupied 1,159 1,159 1,102 57 94 Residential & commercial investor 172 172 172 - 15 1,331 1,331 1,274 57 109 Construction & land 1,071 1,071 1,071 - 91 Consumer 1,366 1,366 212 1,154 148 Total $ 60,905 $ 60,334 $ 56,637 $ 3,697 $ 6,210 At December 31, 2016 Recorded Recorded Recorded investment investment Unpaid investment with a with no principal in impaired related related Related (in thousands) balance loans allowance allowance allowance Commercial Manufacturing $ 2,095 $ 2,072 $ 2,071 $ 1 $ 114 Finance and insurance 25 25 25 - 25 Healthcare 189 189 189 - 11 Real estate services 6,268 6,268 6,268 - 350 Construction 2,166 2,166 1,932 234 149 Other 10,716 9,559 9,066 493 1,571 21,459 20,279 19,551 728 2,220 Real estate - mortgage Residential & commercial owner-occupied 1,391 1,391 1,122 269 64 Residential & commercial investor 2,367 2,367 2,367 - 83 3,758 3,758 3,489 269 147 Construction & land 1,919 1,919 1,919 - 109 Consumer 294 294 195 99 98 Total $ 27,430 $ 26,250 $ 25,154 $ 1,096 $ 2,574 For the year ended December 31, 2017 2016 2015 Average Average Average recorded recorded recorded investment Interest investment Interest investment Interest in impaired income in impaired income in impaired income (in thousands) loans recognized loans recognized loans recognized Commercial Manufacturing $ 2,455 $ 138 $ 3,383 $ 234 $ 5,643 $ 306 Finance and insurance 380 16 30 - 164 24 Healthcare 503 43 194 12 33 11 Real estate services 6,355 262 6,996 261 8,006 283 Construction 1,558 104 1,873 140 1,666 106 Public administration 105 5 - - - - Other 22,896 1,435 12,804 619 7,507 1,034 34,252 2,003 25,280 1,266 23,019 1,764 Real estate - mortgage Residential & commercial owner-occupied 1,217 41 1,777 114 1,762 130 Residential & commercial investor 1,547 55 3,722 127 5,104 182 2,764 96 5,499 241 6,866 312 Construction & land 1,655 55 2,336 93 2,935 104 Consumer 489 5 448 19 1,444 202 Other 36 5 - - 26 11 Total $ 39,196 $ 2,164 $ 33,563 $ 1,619 $ 34,290 $ 2,393 Interest income recognized on impaired loans noted in the table above, primarily represents interest earned on troubled debt restructurings that meet the definition of an impaired loan and are subject to disclosure. Interest income disclosed represents income recognized during the years ended December 31, 2017, 2016, and 2015 on impaired loans, regardless of when the loans became impaired. Interest income recognized on impaired loans using the cash-basis method of accounting during the years ended December 31, 2017, 2016 and 2015 was immaterial. Interest income that would have been recorded had nonaccrual loans performed in accordance with their original contract terms during 2017, 2016, and 2015 was immaterial. The table below summarizes transactions as it relates to troubled debt restructurings for the years ended December 31, 2017: (in thousands) Performing Nonperforming Total Balance at December 31, 2015 $ 28,196 $ 13,837 $ 42,033 New restructurings 8,563 3,266 11,829 Change in accrual status (912) 912 - Paydowns (12,235) (7,883) (20,118) Net charge-offs - (7,591) (7,591) Balance at December 31, 2016 23,612 2,541 26,153 New restructurings 38,958 2,402 41,360 Change in accrual status 269 (269) - Paydowns (10,022) (951) (10,973) Net charge-offs - (41) (41) Balance at December 31, 2017 $ 52,817 $ 3,682 $ 56,499 The below table provides information regarding troubled debt restructurings that occurred during years ended December 31, 2017, 2016 and 2015. Pre-modification outstanding recorded investment reflects the Company’s recorded investment immediately before the modification. Post-modification outstanding recorded investment represents the Company’s recorded investment at the end of the reporting period. The tables below do not include loans restructured and paid-off during the periods presented. For the year ended December 31, 2017 For the year ended December 31, 2016 Pre-modification Post-modification Pre-modification Post-modification outstanding outstanding outstanding outstanding Number of recorded recorded Number of recorded recorded ($ in thousands) contracts investment investment contracts investment investment Commercial Manufacturing 1 $ 1,366 $ 1,366 1 $ 50 $ 22 Finance and insurance 1 456 456 - - - Health care 3 577 522 1 100 100 Real estate services 1 3,274 2,899 - - - Construction - - - 4 1,995 1,844 Public administration 1 320 313 - - - Other 17 37,032 34,065 9 7,388 5,275 24 43,025 39,621 15 9,533 7,241 Consumer 1 83 72 1 77 72 Total 25 $ 43,108 $ 39,693 16 $ 9,610 $ 7,313 For the year ended December 31, 2015 Pre-modification Post-modification outstanding outstanding Number of recorded recorded ($ in thousands) contracts investment investment Commercial Manufacturing 2 $ 491 $ 437 Health care 1 200 125 Construction 3 1,738 1,029 Other 15 19,809 15,975 21 22,238 17,566 Real estate - mortgage Residential & commercial owner-occupied 1 1,000 1,000 Consumer 1 148 130 Total 23 $ 23,386 $ 18,696 Troubled debt restructurings during the years ended December 31, 2017, 2016 and 2015, resulted primarily from the extension of repayment terms and interest rate reductions. For the years ended December 31, 2017 and 2015, the Company did not charge-off any troubled debt restructurings modified during those years. For the year ended December 31, 2016, the Company charged-off $1.1 million in loans restructured during the year. Loans modified as troubled debt restructurings within the previous 12 months having a payment default during the years ended December 31, 2017, 2016 and 2015 were immaterial. At December 31, 2017 and 2016 there were $4.0 million and $1.6 million in outstanding commitments on restructured loans, respectively. The Company’s recorded investment on nonaccrual loans by class at December 31, 2017 and 2016 is reported in the following table: At December 31, (in thousands) 2017 2016 Commercial Manufacturing $ - $ 2 Finance and insurance 473 25 Health care 718 - Construction 681 234 Other 4,313 1,941 Total commercial 6,185 2,202 Real estate - mortgage Residential & commercial owner-occupied 57 269 Total real estate - mortgage 57 269 Consumer 1,275 167 Total nonaccrual loans $ 7,517 $ 2,638 The following tables summarize the aging of the Company’s loan portfolio at December 31, 2017 and 2016: At December 31, 2017 Recorded investment in loans 30 - 59 60 - 89 90 days or more Days past Days past 90+ Days Total past past due and (in thousands) due due past due due Current Total loans accruing Commercial Manufacturing $ - $ - $ - $ - $ 85,187 $ 85,187 $ - Finance and insurance - 456 213 669 41,849 42,518 213 Health care 370 - 113 483 163,302 163,785 - Real estate services 1,503 - 135 1,638 127,209 128,847 135 Construction 721 600 681 2,002 65,988 67,990 - Public administration - - - - 240,077 240,077 - Other 3,463 459 2,302 6,224 515,728 521,952 - 6,057 1,239,340 1,250,356 348 Real estate - mortgage Residential & commercial owner-occupied 426 689 - 1,115 483,520 484,635 - Residential & commercial investor 875 299 - 1,174 764,614 765,788 - 1,301 988 - 2,289 1,248,134 1,250,423 - Construction & land 730 - - 730 265,351 266,081 - Consumer 1,423 15 1,107 2,545 279,556 282,101 - Other - 2 - 2 98,914 98,916 - Total loans held for investment $ 9,511 $ $ $ $ 3,131,295 $ 3,147,877 $ 348 Unearned net loan fees (2,314) Net loans held for investment $ 3,145,563 At December 31, 2016 Recorded investment in loans 30 - 59 60 - 89 90 days or more Days past Days past 90+ Days Total past past due and (in thousands) due due past due due Current Total loans accruing Commercial Manufacturing $ - $ - $ - $ - $ 96,618 $ 96,618 $ - Finance and insurance 456 - 25 481 49,870 50,351 - Health care 500 - - 500 153,523 154,023 - Real estate services - - - - 126,044 126,044 - Construction 260 - - 260 58,458 58,718 - Public administration - - - - 255,997 255,997 - Other 2,941 200 - 3,141 472,109 475,250 - 4,157 200 25 4,382 1,212,619 1,217,001 - Real estate - mortgage Residential & commercial owner-occupied 204 161 - 365 475,158 475,523 - Residential & commercial investor - 225 - 225 695,848 696,073 - 204 386 - 590 1,171,006 1,171,596 - Construction & land - - 657 657 175,081 175,738 657 Consumer 4 63 75 142 266,805 266,947 - Other - - - - 103,616 103,616 - Total loans held for investment $ 4,365 $ 649 $ 757 $ 5,771 $ 2,929,127 $ 2,934,898 $ 657 Unearned net loan fees (793) Net loans held for investment $ 2,934,105 In the ordinary course of business, the Company makes various direct and indirect loans to officers and directors of the Company. Activity with respect to officer and director loans is as follows for the years ended December 31, 2017 and 2016. (in thousands) 2017 2016 Balance - beginning of year $ 34,995 $ 34,301 New loan and advances 56,859 48,110 Principal paydowns and payoffs (57,789) (47,416) Balance - end of year $ 34,065 $ 34,995

Premises And Equipment

Premises And Equipment	12 Months Ended
	Dec. 31, 2017
Premises And Equipment
Premises And Equipment	5. Premises and Equipment The major classes of premises and equipment at December 31, 2017 and 2016, are summarized as follows: (in thousands) 2017 2016 Land $ - $ 230 Buildings - 230 Leasehold improvements 11,104 10,425 Furniture, fixtures, and equipment 37,182 38,403 Premises and equipment, gross 48,286 49,288 Accumulated depreciation (37,459) (38,269) Premises and equipment, net $ 10,827 $ 11,019 In 2017, the Company sold the one building it owned. The Company recorded depreciation expense of $3.3 million, $2.9 million and $2.7 million during the years ended December 31, 2017, 2016 and 2015, respectively.

Intangible Assets

Intangible Assets	12 Months Ended
	Dec. 31, 2017
Intangible Assets
Intangible Assets	6. Intangible Assets At December 31, 2017 and 2016, the Company’s intangible assets and related amortization consisted of the following: Customer contracts, lists (in thousands) and relationships At December 31, 2015 $ 1,926 Amortization (600) At December 31, 2016 1,326 Amortization (600) At December 31, 2017 $ 726 The Company recorded amortization expense of $0.6 million for the years ended December 31, 2017, 2016 and 2015. Amortization expense on intangible assets for each of the five succeeding years is in the following table. (in thousands) 2018 $ 206 2019 201 2020 136 2021 91 2022 40 Total $ 674

Deposits

Deposits	12 Months Ended
	Dec. 31, 2017
Deposits
Deposits	7. Deposits In the ordinary course of business, the Company takes various deposits from employees, officers and directors of the Company. Related party deposits totaled $52.7 million and $80.2 million at December 31, 2017 and 2016, respectively. Maturities of certificates of deposit by remaining maturity at December 31, 2017, are as follows: (in thousands) Amount Maturing in: 2018 $ 105,586 2019 6,038 2020 2,283 2021 1,701 2022 639 Total $ 116,247 The aggregate amount of certificates of deposit in denominations that meet or exceed the $250,000 FDIC insurance limit was $49.6 million and $55.7 million at December 31, 2017 and 2016, respectively. The Company participates in the Certificate of Deposit Account Registry Service (CDARS) and Insured Cash Sweep (ICS) programs provided through a third party. These programs are designed to provide full FDIC insurance on accounts placed through a reciprocal exchange with other banks participating in the programs. The Company had $28.8 million and $44.2 million of reciprocal time deposits through the CDARS program outstanding at the end of 2017 and 2016, respectively. The Company had $316.1 million and $283.6 million of reciprocal demand deposits through the ICS program outstanding at the end of 2017 and 2016, respectively.

Borrowed Funds

Borrowed Funds	12 Months Ended
	Dec. 31, 2017
Borrowed Funds
Borrowed Funds	8. Borrowed Funds Securities sold under agreements to repurchase at December 31, 2017 and 2016 are summarized as follows: At December 31, (in thousands) 2017 2016 Securities sold under agreements to repurchase (secured by pledge of mortgage-backed securities with an estimated fair value of $54,018 and $28,192, respectively) $ 52,959 $ 27,639 Other short-term borrowings 77,640 106,230 The Company enters into sales of securities under agreements to repurchase. The amounts received under these agreements represent short-term borrowings and are reflected as a liability in the consolidated balance sheets. The securities underlying these agreements are included in investment securities in the consolidated balance sheets. The Company has no control over the market value of the securities, which fluctuates due to market conditions. However, the Company is obligated to promptly transfer additional securities if the market value of the securities falls below the repurchase agreement price. The Company manages this risk by maintaining an unpledged securities portfolio that it believes is sufficient to cover a decline in the market value of the securities sold under agreements to repurchase. Securities sold under agreements to repurchase averaged $59.6 million and $46.0 million during 2017 and 2016, respectively. The maximum amounts outstanding at any month-end during 2017 and 2016 were $69.9 million and $71.0 million, respectively. At December 31, 2017 and 2016, the weighted‑average interest rate was 0.06% and 0.07%, respectively. The assets underlying the securities sold under agreements to repurchase are GNMA, FNMA and FHLMC mortgage-backed securities. All securities sold under agreements to repurchase had a maturity date of less than three months. The Company has a revolving Line of Credit (LOC) agreement with an aggregate principal sum of up to $20.0 million bearing interest at 1-month LIBOR plus 225 basis points (2.25%). The Company pays a quarterly commitment fee of 0.35% per annum on the unused portion of the LOC. The LOC matures in May 2018, at which time any outstanding amounts are due and payable. The LOC is used for general corporate purposes and backup liquidity. Although the credit facility is unsecured, the Company has agreed not to sell, pledge or transfer any part of its right, title or interest in the Bank. At December 31, 2017 and 2016, there was no amount outstanding on the revolving LOC. The Company has a line of credit with the FHLB with a rolling one-year term that matures every July with automatic renewals unless canceled. There was $73.0 million and $106.2 million outstanding on the FHLB line of credit at December 31, 2017 and 2016. The average FHLB line of credit balance was $107.3 million and $82.8 million during 2017 and 2016, respectively. The line of credit is collateralized by either qualifying loans or investment securities not otherwise pledged as collateral. At December 31, 2017, the FHLB line of credit was collateralized by loans of $877.9 million with a lending value of $605.4 million. At December 31, 2016, the FHLB line of credit was collateralized by loans of $861.0 million with a lending value of $598.5 million. The variable-rate on the line of credit was 1.47% and 0.72% at December 31, 2017 and 2016, respectively. The Company has also pledged $823.4 million of loans at December 31, 2017 to the Federal Reserve Bank of Kansas City as collateral for borrowing through the discount window lending program. At December 31, 2017 and 2016, there was no amount outstanding with the discount window. The Company has approved federal fund purchase lines with eight banks with an aggregate credit line of $180.0 million. There was $4.6 million outstanding on the federal funds purchase lines at the end 2017 and no amount outstanding at the end of 2016. The average balance of federal funds purchased was $1.5 million and $2.0 million during 2017 and 2016, respectively.

Long-Term Debt

Long-Term Debt	12 Months Ended
	Dec. 31, 2017
Long-Term Debt
Long-Term Debt	9. Long-Term Debt Outstanding subordinated debentures and notes payable at December 31, 2017 and 2016, are summarized as follows: At December 31, (in thousands) 2017 2016 Interest rate Maturity date Earliest call date Junior subordinated debentures: CoBiz Statutory Trust I $ $ 3-month LIBOR + 2.95% September 17, 2033 March 17, 2018 CoBiz Capital Trust II 3-month LIBOR + 2.60% July 23, 2034 January 23, 2018 CoBiz Capital Trust III 3-month LIBOR + 1.45% September 30, 2035 March 30, 2018 Total junior subordinated debentures $ $ Other long-term debt: Subordinated notes payable ($60,000 face amount) $ 59,195 $ 59,111 Fixed 5.625% June 25, 2030 June 25, 2025 Effective for interest payments beginning in February 2010, the Company fixed the interest rate on its junior subordinated debentures through a series of interest rate swaps. For further discussion of the interest rate swaps and the corresponding terms, see Note 10 - Derivatives. In September 2003, the Company created a wholly owned trust, CoBiz Statutory Trust I, formed under the laws of the State of Connecticut (the Statutory Trust). The Statutory Trust issued $20.0 million of trust preferred securities bearing an interest rate based on a spread above three-month LIBOR. Simultaneously with the issuance, the Company purchased a minority interest in the Statutory Trust for $0.6 million. The Statutory Trust invested the proceeds thereof in $20.6 million of junior subordinated debentures of CoBiz that also bear an interest rate based on a spread above three‑month LIBOR. The securities and junior subordinated debentures provide cumulative distributions at a floating rate that is reset each quarter on March 17, June 17, September 17 and December 17. The junior subordinated debentures will mature and the capital securities must be redeemed on September 17, 2033, which may be shortened to any quarterly distribution date, if certain conditions are met (including the Company having received prior approval from the Federal Reserve and any other required regulatory approvals) and notice is given at least 30 and not more than 60 days prior to the redemption date. In May 2004, the Company created a wholly owned trust, CoBiz Capital Trust II, formed under the laws of the State of Delaware (the Capital Trust II). The Capital Trust II issued $30.0 million of trust preferred securities bearing an interest rate based on a spread above three-month LIBOR. Simultaneously with the issuance, the Company purchased a minority interest in the Capital Trust II for $0.9 million. The Capital Trust II invested the proceeds thereof in $30.9 million of junior subordinated debentures of CoBiz that also bear an interest rate based on a spread above three-month LIBOR. The securities and junior subordinated debentures provide cumulative distributions at a floating rate that is reset each quarter on January 23, April 23, July 23 and October 23. The junior subordinated debentures will mature and the capital securities must be redeemed no later than July 23, 2034, if certain conditions are met (including the Company having received prior approval from the Federal Reserve and any other required regulatory approvals). In August 2005, the Company created a wholly owned trust, CoBiz Capital Trust III, formed under the laws of the State of Delaware (the Capital Trust III). The Capital Trust III issued $20.0 million of trust preferred securities bearing an interest rate based on a spread above three-month LIBOR. Simultaneously with the issuance, the Company purchased a minority interest in the Capital Trust III for $0.6 million. The Capital Trust III invested the proceeds thereof in $20.6 million of junior subordinated debentures of CoBiz that also bear an interest rate based on a spread above three‑month LIBOR. The securities and junior subordinated debentures provide cumulative distributions at a floating rate that is reset each quarter on March 30, June 30, September 30 and December 30. The junior subordinated debentures will mature and the capital securities must be redeemed no later than September 30, 2035, if certain conditions are met (including the Company having received prior approval from the Federal Reserve and any other required regulatory approvals). The Company records the distributions of the junior subordinated debentures in interest expense on the consolidated statements of income. All of the outstanding junior subordinated debentures may be prepaid if certain events occur, including a change in tax status or regulatory capital treatment of trust preferred securities. In each case, redemption will be made at par, plus the accrued and unpaid distributions thereon through the redemption date. The Basel III capital rules contain a provision that preserves the current capital treatment of trust preferred securities issued by bank holding companies with less than $15 billion in total assets. Although the accounts of the Statutory Trust, Capital Trust II and Capital Trust III are not included in the Company’s consolidated financial statements, $70.0 million in trust preferred securities issued by the trusts are included in Common equity Tier 1 capital for regulatory purposes as grandfathered under Basel III. See Note 17 – Regulatory Matters. In June 2015, the Company completed an offering of $60.0 million of unsecured 5.625% Fixed-to-Floating Rate Subordinated Notes (Notes) due on June 25, 2030. The Notes bear a 5.625% annual fixed-rate through June 25, 2025 and thereafter an annual floating rate equal to three-month LIBOR plus 317 basis points (3.17%). The Notes contain a call option that allows the Company to repay the Notes prior to their contractual maturity. The call option is available on June 25, 2025 and quarterly thereafter at 100% of the principal amount. Proceeds, net of an original discount and debt issuance costs of $1.1 million, were $58.9 million. Debt issuance costs incurred in conjunction with the offering were $0.3 million. The Notes have an effective interest rate of 5.85%. The Company has adopted ASU 2015-03, Interest – Imputation of Interest (Subtopic 835-30), that requires debt issuance costs to be reported as a direct deduction from the face of the note and not as a deferred charge. The discount and related debt issuance costs will be amortized into interest expense using the interest method over a 10-year term to the first call date.

Derivatives

Derivatives	12 Months Ended
	Dec. 31, 2017
Derivatives
Derivatives	10. Derivatives ASC 815 contains the authoritative guidance on accounting and reporting standards for derivative instruments, including certain derivative instruments embedded in other contracts, and hedging activities. As required by ASC 815, the Company records all derivatives on the consolidated balance sheets at fair value. The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity and credit risk, primarily by managing the amount, sources, and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and unknown cash amounts, the value of which are determined by interest rates. The Company’s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company’s known or expected cash receipts and its known or expected cash payments principally related to certain variable-rate loan assets and variable-rate borrowings. The Company also enters into derivative financial instruments to protect against adverse changes in fair value on fixed-rate loans. The Company’s objective in using derivatives is to minimize the impact of interest rate fluctuations on the Company’s net interest income. To accomplish this objective, the Company uses interest-rate swaps as part of its cash flow hedging strategy. The Company also offers an interest rate hedge program that includes various derivative products, including swaps, to assist its customers in managing their interest rate risk profile . In order to eliminate the interest-rate risk associated with offering these products, the Company enters into derivative contracts with third parties to offset the customer contracts. These customer accommodation interest rate swap contracts are not designated as hedging instruments. The Company has also expanded its product offering by adding international banking products, which exposes the Company to foreign exchange risk. The Company utilizes foreign exchange forward contracts to manage the risk associated with fluctuation in foreign exchange rates. The Company has agreements with its derivative counterparties that contain a provision where if the Company defaults on any of its indebtedness, including default where repayment of the indebtedness has not been accelerated by the lender, then the Company could also be declared in default on its derivative obligations. Also, the Company has agreements with certain of its derivative counterparties that contain a provision where if the Bank fails to maintain its status as a well or adequately capitalized institution, then the counterparty could terminate the derivative positions and the Company would be required to settle its obligations under the agreements. At December 31, 2017, the fair value of derivatives in a net liability position, including accrued interest but excluding any adjustment for nonperformance risk, related to these agreements was $7.0 million. The Company has minimum collateral posting thresholds with certain of its derivative counterparties and has posted collateral of $7.6 million against its obligations under these agreements. At December 31, 2017, the Company was not in default under any of its debt or capitalization covenants. The table below presents the fair value of the Company’s derivative financial instruments as well as the classification within the consolidated balance sheets. Asset derivatives Liability derivatives Fair value at December 31, Fair value at December 31, Balance sheet Balance sheet (in thousands) classification 2017 2016 classification 2017 2016 Derivatives designated as hedging instruments under ASC 815: Cash flow hedge - interest rate swap Other assets $ 113 $ - Accrued interest and other liabilities $ 6,732 $ 7,639 Fair value hedge - interest rate swap Other assets 628 476 Accrued interest and other liabilities 633 845 Derivatives not designated as hedging instruments under ASC 815: Interest rate swap Other assets $ 2,081 $ 2,755 Accrued interest and other liabilities $ 2,176 $ 2,736 Foreign exchange forward contracts Other assets 28 52 Accrued interest and other liabilities 44 5 The tables below include information about financial instruments and collateral that are eligible for offset. At December 31, 2017 Gross Gross Gross amounts not offset amounts of amounts Financial Net (in thousands) recognized assets offset Net amounts Instruments Collateral Amount Derivatives designated as hedges (1) $ 741 $ - $ 741 $ (741) $ - $ - Derivatives not designated as hedges (1) 2,109 - 2,109 (1,222) - 887 Total $ 2,850 $ - $ 2,850 $ (1,963) $ - $ 887 At December 31, 2017 Gross Gross Gross amounts not offset amounts of amounts Financial Net (in thousands) recognized liabilities offset Net amounts Instruments Collateral Amount Derivatives designated as hedges (2) $ (7,365) $ - $ (7,365) $ 741 $ 6,624 $ - Derivatives not designated as hedges (2) (2,220) - (2,220) 1,222 968 (30) Securities sold under agreements to repurchase (3) (52,959) - (52,959) - 52,959 - Total $ (62,544) $ - $ (62,544) $ 1,963 $ 60,551 $ (30) At December 31, 2016 Gross Gross Gross amounts not offset amounts of amounts Financial Net (in thousands) recognized assets offset Net amounts Instruments Collateral Amount Derivatives designated as hedges (1) $ 476 $ - $ 476 $ (476) $ - $ - Derivatives not designated as hedges (1) 2,807 - 2,807 (967) - 1,840 Total $ 3,283 $ - $ 3,283 $ (1,443) $ - $ 1,840 At December 31, 2016 Gross Gross Gross amounts not offset amounts of amounts Financial Net (in thousands) recognized liabilities offset Net amounts Instruments Collateral Amount Derivatives designated as hedges (2) $ (8,484) $ - $ (8,484) $ 476 $ 8,008 $ - Derivatives not designated as hedges (2) (2,741) - (2,741) 967 1,668 (106) Securities sold under agreements to repurchase (3) (27,639) - (27,639) - 27,639 - Total $ (38,864) $ - $ (38,864) $ 1,443 $ 37,315 $ (106) (1) Included in other assets (2) Included in accrued interest and other liabilities (3) Separately stated in consolidated balance sheets Cash Flow Hedges of Interest Rate Risk — For hedges of the Company’s variable-rate loan assets, interest-rate swaps designated as cash flow hedges involve the receipt of fixed-rate amounts from a counterparty in exchange for the Company making variable-rate payments over the life of the agreements without exchange of the underlying notional amount. During the first quarter of 2016, the Company terminated five interest rate swaps with a notional value of $75.0 million that had fixed the interest rate on a portion of its 1-month LIBOR loan portfolio. Upon termination, the Company had an unrealized gain of $1.3 million in AOCI. The unrealized gain will continue to be reported in AOCI, and will be reclassified to interest income over a period of three years. In October 2016, the Company entered into two interest rate swaps to hedge the risk of changes in cash flow on its LIBOR-based loan portfolio. The interest rate swaps have a weighted average term of six years and have a combined notional value of $100.0 million. The Company will pay a variable rate based on 1-month LIBOR and receive a weighted average fixed-rate of 1.20%. For hedges of the Company’s variable-rate borrowings, interest-rate swaps designated as cash flow hedges involve the receipt of variable-rate amounts from a counterparty in exchange for the Company making fixed-rate payments. The Company executed a series of interest-rate swap transactions in 2009 in order to fix the effective interest rate for payments due on its junior subordinated debentures with the objective of reducing the Company’s exposure to adverse changes in cash flows relating to payments on its LIBOR-based floating rate debt. Select critical terms of the cash flow hedges are as follows: (in thousands) Notional Fixed-rate Termination date Hedged item - Junior subordinated debentures issued by: CoBiz Statutory Trust I $ 20,000 4.99 % March 17, 2022 CoBiz Capital Trust II $ 30,000 5.99 % April 23, 2020 CoBiz Capital Trust III $ 20,000 5.02 % March 30, 2024 Based on the Company’s ongoing assessments (including at inception of the hedging relationship), it is probable that there will be sufficient variable interest payments through the maturity date of the swaps. The Company also monitors the risk of counterparty default on an ongoing basis. The Company uses a regression analysis and the “Hypothetical Derivative” method described in ASC 815 for both prospective and retrospective assessments of hedge effectiveness on a quarterly basis. The Company also uses the Hypothetical Derivative methodology to measure hedge ineffectiveness each period. The effective portion of changes in the fair value of derivatives designated and that qualify as cash flow hedges is recorded in AOCI and is subsequently reclassified into earnings in the period that the hedged forecasted transaction affects earnings. The ineffective portion of the change in fair value of the derivatives is recognized directly in earnings. The Company’s derivatives did not have any hedge ineffectiveness recognized in earnings during the years ended December 31, 2017 and 2016. Amounts reported in AOCI related to derivatives will be reclassified to interest income as interest payments are received/paid on the Company’s variable-rate assets. Payments received/paid on variable-rate liabilities will be reclassified to interest expense. During the next 12 months, the Company estimates that $0.3 million and $0.8 million will be reclassified as a decrease to interest income and an increase to interest expense, respectively. Fair Value Hedges of Fixed-Rate Assets – The Company is exposed to changes in the fair value of certain of its fixed-rate assets due to changes in benchmark interest rates based on LIBOR. The Company uses interest rate swaps to manage its exposure to changes in fair value on certain fixed-rate loans. Interest rate swaps designated as fair value hedges involve the receipt of variable-rate payments from a counterparty in exchange for the Company’s fixed-rate payments over the life of the agreements without the exchange of the underlying notional amount. Certain interest-rate swaps met the criteria to qualify for the shortcut method of accounting. Under the shortcut method of accounting no ineffectiveness is assumed. For interest-rate swaps not accounted for under the shortcut method, the Company performs ongoing retrospective and prospective effectiveness assessments (including at inception) using a regression analysis to compare periodic changes in fair value of the swaps to periodic changes in fair value of the fixed-rate loans attributable to changes in the benchmark interest rate. At December 31, 2017, the Company had interest rate swaps with a notional amount of $59.2 million used to hedge the change in the fair value of 11 commercial loans. At December 31, 2016, the Company had interest rate swaps with a notional amount of $55.4 million used to hedge the change in the fair value of ten commercial loans. For derivatives that are designated and qualify as fair value hedges that are not accounted for under the shortcut method, the gain or loss on the derivative as well as the gain or loss on the hedged item attributable to the hedged risk are recognized in earnings. The net amount recognized in noninterest expense during the years ended December 31, 2017, 2016 and 2015 representing hedge ineffectiveness was immaterial. Non-designated Hedges — Derivatives not designated as hedges are not speculative and primarily result from a service the Company provides to its customers. The Company executes interest-rate swaps with commercial banking customers to facilitate their respective risk management strategies. Those interest-rate swaps are simultaneously hedged by offsetting interest-rate swaps that the Company executes with a third party, such that the Company minimizes its net risk exposure resulting from such transactions. As the interest-rate swaps associated with this program do not meet the strict hedge accounting requirements, changes in the fair value of both the customer swaps and the offsetting swaps are recognized directly in earnings. At December 31, 2017, the Company had 102 interest-rate swaps with an aggregate notional amount of $279.0 million related to this program. Gains and losses arising from changes in the fair value of these swaps are included in “Other income” in the consolidated statement of operations. During the years ended December 31, 2017, 2016 and 2015 the Company recorded immaterial gains and losses. The Company’s product offerings also include international banking products that create foreign currency exchange-rate risk exposure. At December 31, 2017, the Company’s foreign currencies were the British pound; Euro; Swiss franc; Mexican peso; Japanese yen; and Australian, Canadian and New Zealand dollars. In order to economically reduce the risk associated with the fluctuation of foreign exchange rates, the Company utilizes short-term foreign exchange forward contracts to lock in exchange rates so the gain or loss on the forward contracts approximately offsets the transaction gain or loss. These contracts are not designated as hedging instruments. Ineffectiveness in the economic hedging relationship may occur as the foreign currency holdings are revalued based upon changes in the currency’s spot rate, while the forward contracts are revalued using the currency’s forward rates. Forward contracts in gain positions are recorded at fair value in ‘other’ assets, while contracts in loss positions are recorded in ‘other’ liabilities in the consolidated balance sheets. Net changes in the fair value of the forward contracts are recognized through earnings, and are included in “Other income” in the consolidated statement of operations. At December 31, 2017, the Company had entered into forward contracts with a notional amount of $4.8 million that mature in the first two months of 2018. During the years ended December 31, 2017, 2016 and 2015, the Company recorded immaterial gains and losses on these forward contracts.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2017
Income Taxes
Income Taxes	11. Income Taxes The components of consolidated income tax expense (benefit) for the years ended December 31, 2017, 2016 and 2015 are as follows: For the year ended December 31, (in thousands) 2017 2016 2015 Current tax provision: Federal tax $ 11,332 $ 6,823 $ 11,346 State tax 1,928 1,374 668 Total current tax provision 13,260 8,197 12,014 Deferred tax provision (benefit): Federal tax 82 3,532 (2,793) State tax (14) 453 (248) Net deferred tax asset remeasurement 7,150 - - Net operating loss carryforward - - 633 Total deferred tax provision (benefit) 7,218 3,985 (2,408) Provision for income taxes $ 20,478 $ 12,182 $ 9,606 Benefit related to discontinued operations $ - $ - $ (42) On December 22, 2017, President Trump signed the TCJA into law. Among other things, the TCJA reduces the corporate federal tax rate from 35% to 21%. The change in the federal tax rate required the Company to remeasure its deferred tax assets and liabilities, resulting in a decrease to the net deferred tax asset, with a corresponding increase to tax expense of $7.2 million. Included in the remeasurement of deferred tax assets and liabilities were items that were originally established through OCI. This results in a disproportionate tax effect for those items still recorded in AOCI. Under current GAAP, those items would continue to be reported in AOCI until such time as the underlying transactions were settled and would then be reclassified as a component of the provision for income taxes. However, in February 2018, the FASB voted to approve an ASU that would allow companies to reclassify the stranded tax effects from the TCJA from AOCI to retained earnings. Also on December 22, 2017, the SEC issued Staff Accounting Bulletin 118 (SAB 118), which provides guidance on accounting for the TCJA’s impact. SAB 118 provides a measurement period, which in no case should extend beyond one year from the TCJA enactment, during which a company acting in good faith may complete the accounting for the impacts of the TCJA. In accordance with SAB 118, the Company will reflect the income tax effects of the TCJA in the reporting period in which the accounting is complete. The Company's accounting for the impact on its net deferred tax assets is based upon reasonable estimates of the tax effects of the TCJA; however, its estimates may change upon the finalization of its implementation and additional interpretive guidance from regulatory authorities. Among other things, the Company needs to obtain year-end partnership statements. The Company will complete its accounting for the TCJA during 2018 as provided in SAB 118 and will reflect any adjustments to its provisional amounts as an adjustment to the provision for taxes in the reporting period in which the amounts are finally determined. At December 31, 2017, the Company did not have any net operating loss carryforwards from any tax jurisdiction. The deferred tax benefit relating to discontinued operations includes deferred tax expense of $0.8 million for the year ended December 31, 2015. A deferred tax asset or liability is recognized for the tax consequences of temporary differences in the recognition of revenue and expense, and unrealized gains and losses, for financial and tax reporting purposes. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some or all of the deferred tax assets may not be realized. The Company conducted an analysis to assess the need of a valuation allowance at December 31, 2017, 2016 and 2015. As part of this assessment, all available evidence, including both positive and negative, was considered to determine whether based on the weight of such evidence, a valuation allowance for deferred tax assets was needed. In accordance with ASC Topic 740-10, Income Taxes (ASC 740), a valuation allowance is deemed to be needed when, based on the weight of the available evidence, it is more likely than not (a likelihood of more than 50%) that some portion or all of a deferred tax asset will not be realized. The future realization of the tax benefit depends on the existence of sufficient taxable income within the carryback and carryforward periods. At December 31, 2017 and 2016, the Company was in a positive three-year cumulative income position, had availability in its carryback years to absorb potential deferred income tax asset reversals and had financial forecasts of pre-tax income that were sufficient to absorb the deferred income tax assets. Accordingly, the Company determined that a valuation allowance was not warranted at December 31, 2017 and 2016. In the first quarter of 2016, the Company adopted ASU 2016-09, Improvements to Employee Share-Based Payment Accounting, which requires the recognition of all excess tax benefits or tax deficiencies in the income statement as income tax expense/benefit. Upon exercise or vesting of a share-based award, an excess tax benefit will be recognized if the tax deduction exceeds the compensation expense that was previously recorded for financial statement purposes. Under previous GAAP, any excess tax benefits were recognized in additional paid-in capital to offset current-period and subsequent-period tax deficiencies. Tax benefits of $0.7 million and $0.3 million were recorded during the years ended December 31, 2017 and 2016 as a result of share awards vested/exercised during the respective years. The net change in deferred taxes related to investment securities available for sale and cash flow hedges is included in other comprehensive income. The temporary differences, tax effected, which give rise to the Company’s net deferred tax assets at December 31, 2017 and 2016 are as follows: At December 31, (in thousands) 2017 2016 Deferred tax assets: Allowance for loan and credit losses $ 9,342 $ 12,625 Intangible assets 858 1,403 Other real estate owned 2,120 3,276 Deferred loan fees 201 185 Other accrued liabilities 1,206 1,709 Stock-based compensation 582 971 Interest on nonaccrual loans 97 216 Employee bonus 526 2,271 Investment securities and derivatives 54 - Other 268 710 Total deferred tax assets $ 15,254 $ 23,366 Deferred tax liabilities: Deferred initial direct loan costs $ (1,061) $ (1,602) Property, plant and equipment (651) (1,106) Prepaid assets (363) (356) FHLB stock dividends (65) (53) Investment securities and derivatives - (348) Total deferred tax liabilities $ (2,140) $ (3,465) Net deferred tax assets $ 13,114 $ 19,901 A reconciliation of the statutory tax rate to the Company’s effective income tax rate for the years ended December 31, 2017, 2016 and 2015 is shown below: For the year ended December 31, (in thousands) 2017 2016 2015 Statutory rate 35.00 % 35.00 % 35.00 % Increase (decrease) resulting from: State income taxes - net of federal income tax effect 2.37 % 2.64 % 2.57 % Tax exempt income (12.08) % (11.69) % (11.55) % Nondeductible compensation 0.20 % 0.19 % 0.25 % Meals and entertainment 0.38 % 0.42 % 0.64 % Share-based compensation (1.14) % (0.62) % - % Other - net 0.24 % (0.06) % (0.03) % Net deferred tax asset remeasurement 13.39 % - % - % Effective income tax rate 38.36 % 25.88 % 26.88 % ASC 740 prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. At December 31, 2017, 2016 and 2015, the Company did not have any unrecognized benefits. Penalties and interest are classified as income tax expense when incurred. There were no interest and penalties accrued during the years ended December 31, 2017, 2016 and 2015. The Company files income tax returns in the U.S. federal jurisdiction and in several state jurisdictions. The following are the major tax jurisdictions in which the Company and its affiliates operate and the earliest Jurisdiction Tax year United States Colorado Arizona

Shareholders' Equity

Shareholders' Equity	12 Months Ended
	Dec. 31, 2017
Shareholders' Equity
Shareholders' Equity	12. Shareholders’ Equity Common Stock – At December 31, 2017 and 2016, the Company has reserved the following shares of its authorized but unissued common stock for possible future issuance in connection with the following: At December 31, 2017 2016 Exercise of outstanding stock options 199,946 285,999 Exercise of outstanding stock warrants - 895,968 Future granting of option and stock awards 2,311,829 2,421,120 Future stock purchases through ESPP 167,099 197,066 2,678,874 3,800,153 Preferred Stock, Series C — On September 7, 2011, the Company amended its Articles of Incorporation to establish the Senior Non-Cumulative Perpetual Preferred Stock, Series C (Series C Preferred Stock) and fix the powers; preferences; and relative, participating, optional and other special rights, and the qualifications, limitations and restrictions, of the shares of Series C Preferred Stock. On September 8, 2011, the Company entered into and consummated the transactions contemplated by a Securities Purchase Agreement (Purchase Agreement) with the U.S. Secretary of the Treasury (Treasury) under the Small Business Lending Fund (SBLF), a $30 billion fund established under the Small Business Jobs Act of 2010 that was designed to encourage lending to small businesses by providing capital to qualified community banks with assets of less than $10 billion. Pursuant to the Purchase Agreement, the Company issued and sold to the Treasury, for an aggregate purchase price of $57.4 million, 57,366 shares of the Company’s Series C Preferred Stock, par value $0.01 per share, having a liquidation value of $1,000 per share. On July 22, 2015, all Series C Preferred Stock was redeemed at the liquidation value of $1,000 per share plus accrued dividends with an aggregate payment of $57.4 million. Warrant — The Company issued a warrant on December 19, 2008 as part of the Company’s participation in the federal Troubled Asset Relief Plan (TARP) Capital Purchase Program under the Emergency Economic Stabilization Act of 2008. The warrant had a 10-year term and allowed for the purchase of 895,968 shares of the Company’s common stock at an exercise price of $10.79 per share. On October 20, 2017, the warrant was exercised in a cashless transaction and the Company issued 432,299 shares of common stock in full settlement of the warrant. Dividends — The Company’s ability to pay dividends to its shareholders is generally dependent upon the payment of dividends by the Bank to the Parent. The Bank cannot pay dividends to the extent it would be deemed undercapitalized by the FDIC after making such dividend. At December 31, 2017, the Bank was not otherwise restricted in its ability to pay a dividend to the Parent as its earnings in the current and prior two years, net of dividends paid during those years, was $81.1 million. Dividends on the Company’s capital stock (common and preferred stock, if any) are prohibited under the terms of the junior subordinated debenture agreements (see Note 9 – Long-Term Debt) if the Company is in continuous default on its payment obligations to the capital trusts, has elected to defer interest payments on the debentures or extends the interest payment period. At December 31, 2017, the Company was not in default on any of the junior subordinated debenture issuances. Dividends declared per common share for the years ended December 31, 2017, 2016 and 2015 were $0.21, $0.19 and $0.17, respectively. Dividends on the Series C Preferred Stock for the year ended December 31, 2015 were $0.3 million.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income (Loss) Reclassifications	12 Months Ended
	Dec. 31, 2017
Accumulated Other Comprehensive Income (Loss) Reclassifications
Accumulated Other Comprehensive Income (Loss) Reclassifications	13. Accumulated Other Comprehensive Income (Loss) Reclassifications The following table provides information on reclassifications out of accumulated other comprehensive income: Year ended December 31, AOCI component (in thousands) 2017 2016 2015 Affected line item in the consolidated statements of income Available for sale securities: Realized gain $ 249 $ 94 $ 318 Net (gain) loss on securities, other assets and OREO Taxes (94) (36) (121) Provision for income taxes Subtotal 155 58 197 Held to maturity securities: Amortization of net unrealized gain on HTM securities 1,658 1,831 1,904 Interest on taxable / nontaxable securities Taxes (629) (696) (724) Provision for income taxes Subtotal 1,029 1,135 1,180 Cash flow hedges: Loans 668 630 927 Interest and fees on loans Debt (1,319) (1,690) (2,009) Interest on subordinated debentures and notes payable Realized loss (651) (1,060) (1,082) Taxes 246 404 411 Provision for income taxes Subtotal (405) (656) (671) Total reclassifications for the period $ 779 $ 537 $ 706 Accumulated other comprehensive income (in thousands) Available for sale securities Held to maturity securities Cash flow hedges Total Balance at December 31, 2014 $ 7,168 $ - $ (2,840) $ 4,328 Other comprehensive income (loss) items 222 - (561) (339) Reclassifications (197) (1,180) 671 (706) Transfers (5,469) 5,469 - - Other comprehensive income (loss), net of tax (5,444) 4,289 110 (1,045) Balance at December 31, 2015 1,724 4,289 (2,730) 3,283 Other comprehensive loss items (8) - (2,172) (2,180) Reclassifications (58) (1,135) 656 (537) Other comprehensive loss, net of tax (66) (1,135) (1,516) (2,717) Balance at December 31, 2016 1,658 3,154 (4,246) 566 Other comprehensive income (loss) items 197 - (125) 72 Reclassifications (155) (1,029) 405 (779) Other comprehensive income (loss), net of tax 42 (1,029) 280 (707) Balance at December 31, 2017 $ 1,700 $ 2,125 $ (3,966) $ (141)

Earnings per Common Share

Earnings per Common Share	12 Months Ended
	Dec. 31, 2017
Earnings per Common Share
Earnings per Common Share	14. Earnings per Common Share Earnings per common share is calculated based on the two-class method prescribed in ASC 260, Earnings per Share . The two-class method is an allocation of undistributed earnings to common stock and securities that participate in dividends with common stock. The Company’s restricted stock awards are considered participating securities as the unvested awards have non-forfeitable rights to dividends, paid or unpaid, on unvested awards. The impact of participating securities is included in the common shareholder basic earnings per share for all periods presented as the Company had positive earnings in those periods. Income available to common shareholders together with weighted average shares outstanding used in the calculation of basic and diluted earnings per common share are as follows: Year ended December 31, (in thousands, except share amounts) 2017 2016 2015 Net income from continuing operations $ 32,918 $ 34,899 $ 26,140 Net loss from discontinued operations - - (71) Net income 32,918 34,899 26,069 Preferred stock dividends - - (320) Net income available to common shareholders 32,918 34,899 25,749 Dividends and undistributed earnings allocated to participating securities (326) (397) (331) Earnings allocated to common shares (1) $ 32,592 $ 34,502 $ 25,418 Weighted average common shares - issued 41,819,903 41,379,894 40,991,762 Average unvested restricted share awards (413,042) (470,414) (522,238) Weighted average common shares outstanding - basic 41,406,861 40,909,480 40,469,524 Dilutive potential common shares 340,707 215,433 255,524 Weighted average common shares outstanding - diluted 41,747,568 41,124,913 40,725,048 Weighted average antidilutive securities outstanding (2) 22,794 125,022 154,714 Earnings per common share: Basic - continuing $ 0.79 $ 0.84 $ 0.63 Diluted - continuing $ 0.78 $ 0.84 $ 0.62 Basic - discontinued $ - $ - $ - Diluted - discontinued $ - $ - $ - Basic $ 0.79 $ 0.84 $ 0.63 Diluted $ 0.78 $ 0.84 $ 0.62 (1) Earnings allocated to common shareholders for basic EPS under the two-class method may differ from earnings allocated for diluted EPS when use of the treasury method results in greater dilution than the two-class method. (2) Antidilutive stock options and restricted share awards excluded from the diluted earnings per share computation.

Employee Benefit and Stock Comp

Employee Benefit and Stock Compensation Plans	12 Months Ended
	Dec. 31, 2017
Employee Benefit and Stock Compensation Plans
Employee Benefit And Stock Compensation Plans	15. Employee Benefit and Stock Compensation Plans Stock Options and Awards — The Company has adopted an equity plan to reward and provide long-term incentives for directors and key employees of the Company. The term of all options issued may not exceed 10 years. The Company issues options and awards with a service vesting requirement, which is typically a three-year period. The Company issues new shares upon exercise of a stock option award. The 2005 Plan authorizes the issuance of 5,250,000 shares. Under the 2005 Plan, the Compensation Committee of the Company has the authority to determine the identity of the key employees, consultants and directors who shall be granted options; the option price, which shall not be less than 85% of the fair market value of the common stock on the date of grant; and the manner and times at which the options shall be exercisable. Shares available for grant under the 2005 Plan at December 31, 2017, totaled 2,311,829. During 2017, 2016 and 2015, the Company recognized compensation expense from continuing operations of $3.1 million, $3.2 million and $3.3 million, respectively, for stock-based compensation awards for which the requisite service was rendered during the year. The Company recognizes forfeitures as they occur. The Company recognized an income tax benefit of $1.1 million, $1.2 million and $1.2 million on compensation expense for 2017, 2016 and 2015, respectively. In addition, the Company recognized excess tax benefits of $0.7 million and $0.3 million as a reduction to income tax expense in 2017 and 2016, respectively. ASC 718 requires the Company to select a valuation technique that meets the measurement criteria set forth in the standard. Valuation techniques that meet the criteria for estimating the fair values of employee stock options include a lattice model and a closed-form model (for example, the Black-Scholes formula). The Company uses the Black-Scholes option pricing model (Black-Scholes) to estimate the fair value of stock options. Restricted stock award fair values are based on the closing price of the Company stock on the award date. The fair value of each option grant is estimated on the date of grant using the Black-Scholes. The risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury yield in effect at the time of grant. The expected term of options granted is based on the options’ vesting schedule and the Company’s historical exercise patterns for different employee groups and represents the period of time that options granted are expected to be outstanding. Expected volatilities are based on the historical volatility of the Company’s stock and vesting period of the option to be issued. The dividend yield is determined by annualizing the dividend rate as a percentage of the Company’s stock price. The following weighted-average assumptions were used for grants issued during the years ended December 31, 2017, 2016 and 2015: 2017 2016 2015 Range Range Range Weighted Weighted Weighted average Low High average Low High average Low High Risk-free interest rate 1.83 % 1.60 % 2.18 % 1.38 % 0.87 % 1.99 % 1.38 % 0.99 % 1.84 % Expected dividend yield 1.19 % 1.08 % 1.28 % 1.47 % 1.27 % 1.66 % 1.36 % 1.25 % 1.41 % Expected volatility 26.08 % 25.80 % 27.03 % 28.61 % 25.92 % 34.27 % 33.15 % 25.90 % 37.65 % Expected life (years) 4.8 3.9 4.0 The following table summarizes changes in stock option awards for the year ended December 31, 2017: 2017 Weighted average Stock Option Awards Shares exercise price Outstanding - beginning of year 285,999 $ 10.45 Granted 45,333 17.57 Exercised (109,136) 9.93 Forfeited (22,250) 12.28 Outstanding - end of year 199,946 $ 12.14 Exercisable - end of year 108,702 $ 10.16 There were 199,946 options vested or expected to vest with a weighted average price of $12.14 at December 31, 2017. The weighted-average remaining terms at December 31, 2017 for options outstanding, vested or expected to vest and options exercisable at the end of the period were 4.2, 4.0 and 4.0 years, respectively. The aggregate intrinsic value for options outstanding, vested or expected to vest, and options exercisable at December 31, 2017 was $1.6 million, $1.6 million and $1.1 million, respectively. The weighted average grant date fair value of options granted during the years ended December 31, 2017, 2016 and 2015 was $4.05, $2.77 and $2.57, respectively. The total intrinsic value of options exercised during the years ended December 31, 2017, 2016 and 2015 was $0.8 million, $1.1 million and $0.8 million, respectively. The following table summarizes the Company’s outstanding stock options: Options outstanding Options exercisable Weighted Weighted Weighted average average average Number exercise remaining Number exercise Range of exercise price outstanding price life (years) exercisable price $6.00 - $9.56 46,200 $ 46,200 $ $9.87 - $11.34 48,000 35,001 $11.45 - $12.59 40,667 9,584 $12.70 - $16.89 43,746 17,917 $17.20 - $21.14 21,333 - - 199,946 $ 108,702 $ The following table summarizes changes in restricted stock awards for the year ended December 31, 2017: 2017 Weighted average grant date Restricted Stock Awards Shares fair value Unvested - beginning of year 467,203 $ 11.50 Granted 207,841 17.14 Vested (253,530) 11.93 Forfeited (50,999) 13.77 Unvested - end of year 370,515 $ 13.98 The weighted average grant date fair value of restricted stock awards granted during the years ended December 31, 2017, 2016 and 2015, was $17.14, $11.54 and $11.52, respectively. The fair value of restricted stock amounts vested during the years ended December 31, 2017, 2016 and 2015 was $4.3 million, $3.3 million and $4.5 million, respectively. At December 31, 2017, there was $3.4 million of total unrecognized compensation cost related to unvested share-based compensation awards granted under the 2005 Plan. The cost is expected to be recognized over a weighted-average period of 1.8 years. Employee Stock Purchase Plan (ESPP) — The ESPP was established in January 2000 and is administered by the Compensation Committee of the Company. Employees may elect to have a percentage of their payroll deducted and applied to the purchase of Common Stock at a discount. In addition, the Company may make a matching contribution up to 50% of an employee’s deduction toward the purchase of additional Common Stock. No matching contribution was made for the years presented in the table below. For the year ended December 31, 2017 2016 2015 Available ESPP shares - beginning of year 197,066 233,879 273,188 Purchases (29,967) (36,813) (39,309) Available ESPP shares - end of year 167,099 197,066 233,879 Employee 401(k) Plan — The Company has a defined contribution plan covering substantially all its employees. Employees may contribute up to the maximum allowed by the Internal Revenue Service. The Company may also make discretionary contributions within the limits of the 401(k) Plan and Internal Revenue Service limitations. The Company matched 4.5%, 4.5% and 3.0% of eligible compensation for the years ended December 31, 2017 2016 and 2015. Employer contributions charged to expense for the years ended December 31, 2017, 2016 and 2015 were $2.2 million, $1.8 million and $1.3 million, respectively, and are included in the consolidated statements of income under the caption “Salaries and employee benefits.”

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2017
Commitments and Contingencies
Commitments And Contingencies	16. Commitments and Contingencies Lease Commitments — The Company has various operating lease agreements for office space. Generally, leases are subject to rent escalation provisions in subsequent years and have renewal options at the end of the initial lease terms. Leasehold improvements are amortized over the useful life of the improvements or the lease term if shorter. Rent expense (excluding ancillary charges for common area expense, maintenance, etc.) for the years ended December 31, 2017, 2016 and 2015, was $4.7 million, $5.8 million and $4.9 million, respectively. The Company entered into sublease agreements for two leased locations and at December 31, 2017, future minimum sublease payments to be received are $0.8 million. A director holds interests in a bank location currently leased by the Company and interests in the building where the Company leased its former corporate offices. Rent payments under the related party leases were $0.2 million for the year ended December 31, 2017 and $2.1 million for the years ended December 31, 2016 and 2015, respectively. The Company was current on these lease obligations at all times. Future contractual obligations of $0.1 million will be paid to entities controlled by the director and are included in the table below of future minimum lease payments under all non-cancelable operating leases. Year ending December 31, (in thousands) Amount 2018 $ 5,493 2019 4,476 2020 3,756 2021 2,375 2022 2,343 Thereafter 11,998 Total $ 30,441 In January 2016, the Company entered into a new lease for facilities at 1401 Lawrence Street, Denver, Colorado. The leased space became the primary executive offices for the Company and includes approximately 44,000 square feet space of office space and 4,000 square feet of ground level retail space for a banking facility. The Company took possession of the space on June 1, 2016 and commenced operations from that location in November 2016. The lease term is for 12 years with first year base rent of $1.5 million escalating 2% annually. The lease is cancelable after nine years subject to a termination fee of up to $1.6 million. Financial Instruments With Off-Balance Sheet Risk — In the normal course of business, the Company has entered into financial instruments which are not reflected in the accompanying consolidated financial statements: At December 31, (in thousands) 2017 2016 Commitments to originate commercial or real estate construction loans and unused lines of credit granted to customers $ 975,903 $ 887,627 Commitments to originate consumer loans — personal lines of credit and equity lines $ 40,682 $ 41,376 Overdraft protection plans $ 21,188 $ 22,919 Letters of credit $ 30,032 $ 26,631 Unfunded commitments for unconsolidated investments $ 5,916 $ 6,664 Company guarantees $ 4,249 $ 3,127 Commitments to Originate — The Company makes contractual commitments to extend credit and provide standby letters of credit which are binding agreements to lend money to its customers at predetermined interest rates for a specific period of time. These commitments are not held for sale. The credit risk involved in issuing these financial instruments is essentially the same as that involved in granting on-balance sheet financial instruments. As such, the Company’s exposure to credit loss in the event of nonperformance by the counterparty to the financial instrument is represented by the contractual amounts of those instruments. However, the Company applies the same credit policies, standards, and ongoing reassessments in making commitments and conditional obligations as it does for loans. In addition, the amount and type of collateral obtained, if deemed necessary upon extension of a loan commitment or standby letter of credit, is essentially the same as the collateral requirements provided for loans. Additional risk associated with providing these commitments arises when they are drawn upon, such as the demands on liquidity the Company would experience if a significant portion were drawn down at the same time. However, this is considered unlikely, as many commitments expire without being drawn upon and therefore do not necessarily represent future cash requirements. Overdraft Protection Plans — The Company provides personal credit lines on customer accounts to advance funds to cover overdrafts. Letters of Credit — The Company provides standby and commercial letters of credit during the normal course of business. Standby letters of credit guarantee performance of a customer to a third party while commercial letters of credit guarantee payments on behalf of our customers. Unfunded Commitments for Unconsolidated Investments — The Company has committed to purchase up to $11.5 million in limited partnership interests of four entities, of which $5.9 million was unfunded at December 31, 2017. Certain shareholders and directors also have interests in some of these entities. Company Guarantees — The Company guarantees, to the issuing merchant banks, the credit card debt transactions for certain customers. The Company also provides guarantees to the FHLB for certain forgivable loans used to support affordable housing in our market areas. Federal Reserve Bank Stock — The fair value of the Federal Reserve Bank stock approximates its carrying value, which is based on the redemption provisions of the Federal Reserve Bank. At December 31, 2017, the Company held 83,553 shares of Federal Reserve Bank stock with a fair value of $4.2 million (subscription value of $50). This investment represents 50% of the par value due to the Federal Reserve Bank to become a member bank and the stock cannot be sold, traded, or pledged as collateral for loans. Although the probability is remote, the remaining 50% or $4.2 million due to the Federal Reserve Bank may be callable at its discretion. Employment Contracts — Certain officers of the Company have entered into employment agreements providing for salaries and fringe benefits. In addition, severance is provided in the event of termination for other than cause, and under certain changes in control, a payment is required. Indemnification Agreements — The Company is subject to certain indemnification obligations in conjunction with agreements signed with officers and directors of the Company. The indemnification agreements require the Company to indemnify against judgments, fines, penalties and amounts paid in settlements incurred in connection with civil or criminal action or proceedings, as it relates to their services to the Company. To the extent the Company maintains an insurance policy or policies providing directors’ and officers’ liability insurance, the indemnitee will be covered to the maximum extent of the coverage available for any director or officer of the Company. However, certain indemnification payments may not be covered under the Company’s directors’ and officers’ insurance coverage. The rights of the indemnitee under the indemnification agreement are in addition to any rights the indemnitee may have under the Company’s articles of incorporation or bylaws. While the likelihood is remote, payments under these indemnification agreements could materially affect net income in a particular quarter or annual period. Other Matters — The Company is involved in various lawsuits which have arisen in the normal course of business. It is management’s opinion, based upon advice of legal counsel, that the ultimate outcome of these lawsuits will not have a material impact upon the financial condition, cash flow or results of operations of the Company.

Regulatory Matters

Regulatory Matters	12 Months Ended
	Dec. 31, 2017
Regulatory Matters
Regulatory Matters	17. Regulatory Matters The Company and the Bank are subject to various regulatory capital requirements administered by the federal banking agencies. Failure to meet minimum capital requirements can trigger certain mandatory – and possibly additional discretionary – actions by regulators that, if undertaken, could have a direct material effect on the Company’s financial condition and results of operations. Under capital adequacy guidelines and the regulatory framework for prompt corrective action, the Company and the Bank must meet specific capital guidelines that involve quantitative measures of the Company and the Bank’s assets, liabilities and certain off-balance-sheet items as calculated under regulatory accounting practices. The Company and the Bank’s capital amounts and classification are also subject to qualitative judgments by the regulators regarding components, risk weightings and other factors. Quantitative measures established by regulation to ensure capital adequacy require the Company and the Bank to maintain minimum amounts and ratios (set forth in the following table) of regulatory capital (as defined in the regulations) to risk-weighted assets and of regulatory capital to average assets. At December 31, 2017 and 2016, management believes the Company and Bank meet all capital adequacy requirements to which they are subject. In January 2015, the Company implemented the Basel III capital rules adopted by the federal banking agencies in 2014. Basel III imposed higher minimum capital requirements, created a new Common Equity Tier 1 capital requirement, established a Capital Conservation Buffer (CCB) and changed the risk-weighting guidelines for various assets types. The CCB, which became effective in 2016, is designed to establish a capital range above minimum requirements to insulate banks from periods of stress and impose constraints on dividends, share repurchases and discretionary bonus payments when capital levels fall below prescribed levels. The minimum CCB in 2016 is 0.625% and increases 0.625% annually through 2019 to 2.5%. At December 31, 2017, the most recent notification from the Federal Reserve categorized the Bank as well-capitalized under the regulatory framework for prompt corrective action. To be categorized as well-capitalized the Bank must maintain minimum total risk-based, Common Equity Tier 1 risk-based, Tier 1 risk-based, and Tier 1 leverage ratios as set forth in the following table. There are no conditions or events that management believes have changed the Bank’s categories. The following table presents the actual and required capital ratios at December 31, 2017 and 2016 under the Basel III capital rules. At December 31, 2017 At December 31, 2016 Capitalized ratio Ratios Ratios Minimum ratio plus (in thousands) Bank Company Bank Company Well(1) fully phased-in CCB Common equity tier 1 capital 12.2 % 9.9 % 11.9 % 9.8 % 6.5 % 7.0 % Tier 1 capital 12.2 % 11.8 % 11.9 % 11.6 % 8.0 % 8.5 % Total capital 13.2 % 14.6 % 12.9 % 14.5 % 10.0 % 10.5 % Tier 1 leverage 10.5 % 10.1 % 10.4 % 10.2 % 5.0 % 4.0 % (1) The ratios for the well-capitalized requirement are only applicable to the Bank. However, the Company manages its capital position as if the requirement applies to the consolidated entity and has presented the ratios as if they also applied to the Company.

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Dec. 31, 2017
Fair Value Measurements
Fair Value Measurements	18. Fair Value Measurements ASC 820 emphasizes that fair value is a market-based measurement, not an entity-specific measurement. Therefore, a fair value measurement should be determined based on the assumptions that market participants would use in pricing an asset or liability. As a basis for considering market participant assumptions in fair value measurements, ASC 820 establishes a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Levels 1 and 2 of the hierarchy) and the reporting entity’s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy). · Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. · Level 2 inputs are inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs may include quoted prices for similar assets and liabilities in active markets, as well as inputs that are observable for the asset or liability (other than quoted prices), such as interest rates, foreign exchange rates and yield curves that are observable at commonly quoted intervals. · Level 3 inputs are unobservable inputs for the asset or liability, which is typically based on an entity’s own assumptions, as there is little, if any, related market activity. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability. The Company evaluates fair value measurement inputs on an ongoing basis in order to determine if there is a change of sufficient significance to warrant a transfer between levels. For example, changes in market activity or the addition of new unobservable inputs could, in the Company’s judgment, cause a transfer to either a higher or lower level. A description of the valuation methodologies used for financial instruments measured at fair value, as well as the general classification of such instruments pursuant to the valuation hierarchy, is set forth below. Available for Sale Securities – At December 31, 2017, the Company held, as part of its investment portfolio, available for sale securities reported at fair value consisting of municipal securities, corporate debt securities, and TPS. The fair value of the majority of municipal securities are determined using widely accepted valuation techniques including matrix pricing and broker-quote based applications. Inputs include benchmark yields, reported trades, issuer spreads, prepayment speeds and other relevant items. As a result, the Company has determined that these valuations fall within Level 2 of the fair value hierarchy. The Company also holds TPS that are recorded at fair value based on unadjusted quoted market prices for identical securities in an active market. The majority of the TPS are actively traded in the market and as a result, the Company has determined that the valuation of these securities falls within Level 1 of the fair value hierarchy. The Company holds certain TPS and corporate debt securities for which unadjusted market prices are not available or the market is not active and are therefore classified as Level 2 or 3. In the second quarter of 2016, the Company transferred a TPS from Level 2 to Level 3 due to the lack of recent market activity. The Company uses broker-dealer quotes, valuations based on similar but not identical securities, or the most recent market trade (which may not be current) to price these securities. Unrealized gains on TPS Level 3 transfers and total net unrealized gains recognized in AOCI at December 31, 2017 and 2016 were immaterial. Derivative Financial Instruments – The Company uses interest-rate swaps as part of its cash flow strategy to manage its interest-rate risk. The valuation of these instruments is determined using widely accepted valuation techniques as discussed further below. The fair values of interest-rate swaps are determined using the market standard methodology of netting the discounted future fixed cash receipts (or payments) and the discounted expected variable cash payments (or receipts). The variable cash payments (or receipts) are based on an expectation of future interest rates (forward curves) derived from observable market interest rate curves. Pursuant to guidance in ASC 820, credit valuation adjustments are incorporated into the valuation to appropriately reflect both the Company’s own nonperformance risk and the respective counterparty’s nonperformance risk in the fair value measurements. In adjusting the fair value of its derivative contracts for the effect of nonperformance risk, the Company has considered the impact of netting and any applicable credit enhancements, such as collateral postings and thresholds. The Company uses Level 2 and Level 3 inputs to determine the valuation of its derivatives portfolio. The valuation of derivative instruments is determined using widely accepted valuation techniques including discounted cash flow analysis on the expected cash flows of each derivative. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs (Level 2 inputs), including interest rate curves and implied volatilities. The estimates of fair value are made using a standardized methodology that nets the discounted expected future cash receipts and cash payments (based on observable market inputs). Level 3 inputs include the credit valuation adjustments which use estimates of current credit spreads to evaluate the likelihood of default by the Company and its counterparties. At December 31, 2017 and 2016, the Company assessed the impact of the Level 3 inputs on the overall derivative valuations in terms of the significance of the credit valuation adjustments in basis points and as a percentage of the overall derivative portfolio valuation and the overall notional value. The Company’s assessment determined that credit valuation adjustments were not significant to the overall valuation of the portfolio. In addition, the significance of the credit value adjustments and overall derivative portfolio to the Company’s financial statements was considered. As a result of the insignificance of the credit value adjustments to the derivative portfolio valuations and the Company’s financial statements, the Company classified the derivative valuations in their entirety in Level 2. The Company uses foreign exchange forward contracts to mitigate exchange-rate risk arising from the Company’s foreign currency holdings to support its international banking product offering. Fair value measurements of these assets or liabilities are priced based on spot and forward foreign currency rates and the credit worthiness of the contract counterparty. These contracts are classified in Level 2. The following tables present the Company’s assets and liabilities measured at fair value on a recurring basis at December 31, 2017 and 2016, aggregated by the level in the fair value hierarchy within which those measurements fall. Fair value measurements using: Quoted prices in Significant other Significant active markets for observable unobservable Balance at identical assets inputs inputs (in thousands) December 31, 2017 (Level 1) (Level 2) (Level 3) Assets Available for sale securities: Trust preferred securities $ 21,983 $ 363 $ 12,521 $ 9,099 Corporate debt securities 141,495 - 141,495 - Municipal securities 3,275 - 3,275 - Total available for sale securities $ 166,753 $ 363 $ 157,291 $ 9,099 Derivatives: Cash flow hedge $ 113 $ - $ 113 $ - Fair value hedge 628 - 628 - Non-designated hedges 2,081 - 2,081 - Foreign exchange forward contracts 28 - 28 - Total derivative assets $ 2,850 $ - $ 2,850 $ - Liabilities Derivatives: Cash flow hedge $ 6,732 $ - $ 6,732 $ - Fair value hedge 633 - 633 - Non-designated hedges 2,176 - 2,176 - Foreign exchange forward contracts 44 - 44 - Total derivative liabilities $ 9,585 $ - $ 9,585 $ - Fair value measurements using: Quoted prices in Significant other Significant active markets for observable unobservable Balance at identical assets inputs inputs (in thousands) December 31, 2016 (Level 1) (Level 2) (Level 3) Assets Available for sale securities: Trust preferred securities $ 37,624 $ 4,283 $ 23,893 $ 9,448 Corporate debt securities 92,077 - 92,077 - Municipal securities 3,280 - 3,280 - Total available for sale securities $ 132,981 $ 4,283 $ 119,250 $ 9,448 Derivatives: Fair value hedge $ 476 $ - $ 476 $ - Non-designated hedges 2,755 - 2,755 - Foreign exchange forward contracts 52 - 52 - Total derivative assets $ 3,283 $ - $ 3,283 $ - Liabilities Derivatives: Cash flow hedge $ 7,639 $ - $ 7,639 $ - Fair value hedge 845 - 845 - Non-designated hedges 2,736 - 2,736 - Foreign exchange forward contracts 5 - 5 - Total derivative liabilities $ 11,225 $ - $ 11,225 $ - A reconciliation of the beginning and ending balances of assets measured at fair value, on a recurring basis, using Level 3 inputs follows: For the year ended December 31, (in thousands) 2017 2016 Beginning balance $ 9,448 $ 5,810 Transfers and purchases - 3,276 Net accretion 117 89 Sales / calls / maturities (1,000) - Unrealized gain included in comprehensive income 534 273 Ending balance $ 9,099 $ 9,448 Assets and liabilities measured on a nonrecurring basis Fair value is used on a nonrecurring basis to evaluate certain financial assets and financial liabilities in specific circumstances. Similarly, fair value is used on a nonrecurring basis for nonfinancial assets and nonfinancial liabilities such as foreclosed assets, other real estate owned, intangible assets, nonfinancial assets and liabilities evaluated in a goodwill impairment analysis and other nonfinancial assets measured at fair value for purposes of assessing impairment. A description of the valuation methodologies used for financial and nonfinancial assets and liabilities measured at fair value, as well as the general classification of such assets and liabilities pursuant to the valuation hierarchy, is set forth below. Impaired Loans – Certain collateral-dependent impaired loans are reported at the fair value of the underlying collateral. Impairment is measured based on the fair value of the collateral, which is typically derived from appraisals that take into consideration prices in observed transactions involving similar assets and similar locations. Each appraisal is updated on an annual basis, either through a new appraisal, a new evaluation, or through the Company’s comprehensive internal review process. Appraised values are reviewed and monitored internally and fair value is assessed at least quarterly or more frequently when circumstances occur that indicate a change in fair value has occurred. The Company classified these impaired loans as Level 3. Other Real Estate Owned (OREO) – OREO represents real property taken by the Company either through foreclosure or through a deed in lieu thereof from the borrower. The fair value of OREO is based on property appraisals adjusted at management’s discretion to reflect a further decline in the fair value of properties since the time the appraisal analysis was performed. The inputs used to determine the fair value of OREO fall within Level 3. The Company may include within OREO other repossessed assets received as partial satisfaction of a loan. Other repossessed assets are not material and do not typically have readily determinable market values and are considered Level 3 inputs. The following tables present the Company’s nonfinancial assets measured at fair value on a nonrecurring basis at December 31, 2017 and 2016, aggregated by the level in the fair value hierarchy within which those measurements fall. Fair value measurements using: Quoted prices in Significant other Significant active markets for observable unobservable identical assets inputs inputs (in thousands) Total (Level 1) (Level 2) (Level 3) At December 31, 2017 Impaired loans $ 3,792 $ - $ - $ 3,792 OREO $ 5,351 $ - $ - $ 5,351 At December 31, 2016 Impaired loans $ 1,425 $ - $ - $ 1,425 OREO $ 5,351 $ - $ - $ 5,351 Gains and losses, which include the provision for losses on impaired loans, recorded in relation to assets and liabilities measured on a nonrecurring basis are presented below: Gain (loss) for the year ended December 31, (in thousands) 2017 2016 2015 Impaired loans $ 398 $ 2,831 $ (5,980) OREO - - 69 In accordance with ASC 310, the fair value of OREO recorded as an asset is reduced by estimated selling costs. The following table is a reconciliation of the fair value measurement of OREO disclosed pursuant to ASC 820 to the amount recorded on the condensed consolidated balance sheet: At December 31, (in thousands) 2017 2016 OREO recorded at fair value $ 5,351 $ 5,351 Estimated selling costs (272) (272) OREO $ 5,079 $ 5,079 Valuation adjustments on OREO and additional gains or losses at the time OREO is sold are recognized in current earnings under the caption “Net gain on securities, other assets and other real estate owned.” There were no OREO transactions for the years ended December 31, 2017 and 2016. The following table provides information describing the valuation processes used to determine recurring and nonrecurring fair value measurements categorized within Level 3 of the fair value hierarchy. At December 31, 2017 Fair Value Weighted Category (in thousands) Valuation Technique Unobservable Input Average Range Trust preferred securities $ 9,099 Market approach Discount to carrying value using broker quotes or observable prices on similar securities 7% 5% - 15% Impaired loans: Commercial $ 2,581 Sales comparison (1) Management discount for asset type 59% 0% - 98% Real estate - mortgage 57 Sales comparison (2) Sales comparison adjustments (4)% NA Consumer 1,154 Sales comparison (2) Sales comparison adjustments (11)% (7)% - (20)% Total impaired loans $ 3,792 OREO: Commercial $ 190 Property appraisals (2) Management discount for property type 0% NA Construction & land 5,161 Property appraisals (2) Management discount for property type 17% NA Total OREO $ 5,351 At December 31, 2016 Fair Value Weighted Category (in thousands) Valuation Technique Unobservable Input Average Range Trust preferred securities $ 9,448 Market approach Discount to carrying value using broker quotes or observable prices on similar securities 13% 1% - 28% Impaired loans: Commercial $ 1,057 Sales comparison (1) Management discount for asset type 59% 0% - 76% Real estate - mortgage 269 Sales comparison (2) Sales comparison adjustments 18% NA Consumer 99 Sales comparison (2) Sales comparison adjustments (1)% (11)% - 10% Total impaired loans $ 1,425 OREO: Commercial $ 190 Property appraisals (2) Management discount for property type 0% NA Construction & land 5,161 Property appraisals (2) Management discount for property type 17% NA Total OREO $ 5,351 (1) Discount represents management discounts applied to market valuation of various business assets, including accounts receivable and inventory. (2) The fair value of OREO and collateral-dependent impaired loans is based on third-party property appraisals. The majority of the appraisals utilize at least two valuation approaches or a combination of approaches including a market approach, where prices and other relevant information generated by market transactions involving similar or comparable properties are used to determine fair value. Appraisals may include an ‘as is’ and ‘upon completion’ valuation scenarios. Adjustments are routinely made in the appraisal process by third-party appraisers to adjust for differences between the comparable sales and income data. Adjustments also result from the consideration of relevant economic and demographic factors with the potential to affect property values. Also, prospective values are based on the market conditions which exist at the date of inspection combined with informed forecasts based on current trends in supply and demand for the property types under appraisal. Positive adjustments disclosed in this table represent increases to the sales comparison and negative adjustment represent decreases. The following table includes the estimated fair value of the Company’s financial instruments. The methodologies for estimating the fair value of financial assets and financial liabilities measured at fair value on a recurring and nonrecurring basis are discussed above. The methodologies for estimating the fair value for other financial assets and financial liabilities are discussed below. The estimated fair value amounts have been determined by the Company using available market information and appropriate valuation methodologies. However, considerable judgment is required to interpret market data in order to develop the estimates of fair value. Accordingly, the estimates presented herein are not necessarily indicative of the amounts the Company could realize in a current market exchange. The use of different market assumptions and/or estimation methodologies may have a material effect on the estimated fair value amounts at December 31, 2017 and 2016. December 31, 2017 December 31, 2016 Carrying Estimated Carrying Estimated (in thousands) value fair value value fair value Financial assets: Cash and cash equivalents $ 80,180 $ 80,180 $ 96,050 $ 96,050 Investment securities available for sale 166,753 166,753 132,981 132,981 Investment securities held to maturity 362,544 360,071 366,041 363,178 Other investments 2,174 2,174 2,173 2,173 Loans — net 3,107,622 3,080,935 2,900,812 2,868,091 Accrued interest receivable 14,150 14,150 12,223 12,223 Derivatives 2,850 2,850 3,283 3,283 Financial liabilities: Deposits $ 3,225,220 $ 3,224,417 $ 3,029,783 $ 3,029,226 Securities sold under agreements to repurchase 52,959 49,436 27,639 26,101 Short-term borrowings 77,640 77,640 106,230 106,230 Accrued interest payable 1,077 1,077 1,038 1,038 Subordinated notes payable 59,195 58,451 59,111 58,681 Junior subordinated debentures 72,166 72,166 72,166 72,166 Derivatives 9,585 9,585 11,225 11,225 The fair value estimation methodologies utilized by the Company for financial instruments and the classification level within the fair value hierarchy that those instruments fall are summarized as follows: Cash and Cash Equivalents — The carrying amount of cash and cash equivalents is a reasonable estimate of fair value which is classified as Level 2. Other Investments — Included in this category are the Company’s investments in other equity method investments. Due to restrictions on transferability, it is not practical to estimate fair value on the Bank stocks which are excluded from the table above. The fair value of other equity method investments approximates fair value and is classified as Level 2. Loans — The fair value of loans is estimated by discounting future contractual cash flows using estimated market rates at which similar loans would be made to borrowers with similar credit ratings and for the same remaining maturities. In computing the estimate of fair value for all loans, the estimated cash flows and/or carrying value have been reduced by specific and general reserves for loan losses. The fair value of loans disclosed in the table above, which is not the exit price, is classified as Level 3 within the fair value hierarchy. Accrued Interest Receivable/Payable — The fair value of accrued interest receivable/payable approximates the carrying amount due to the short-term nature of these amounts and is classified in the same level hierarchy as the underlying assets/liabilities. Deposits — The fair value of certificates of deposit is estimated by discounting the expected life using an index of the U.S. Treasury curve. Non-maturity deposits are reflected at their carrying value for purposes of estimating fair value. The fair value of all deposits is classified as Level 2. Securities Sold Under Agreements to Repurchase — Estimated fair value is based on discounting cash flows and is classified as Level 2. Short-Term Borrowings — The estimated fair value of short-term borrowings approximates their carrying value, due to their short-term nature and is classified as Level 2. Subordinated Notes Payable — The estimated fair value of subordinated notes payable is based on discounting cash flows for comparable instruments and is classified as Level 3. Junior Subordinated Debentures — The estimated fair value of junior subordinated debentures approximates their carrying value, due to the variable interest rate paid on the debentures and is classified as Level 2. Commitments to Extend Credit and Standby Letters of Credit — The Company’s off-balance sheet commitments are funded at current market rates at the date they are drawn upon. It is management’s opinion that the fair value of these commitments would approximate their carrying value, if drawn upon, and are classified as Level 3. The fair value estimates presented herein are based on pertinent information available to management at December 31, 2017 and 2016. Although management is not aware of any factors that would significantly affect the estimated fair value amounts, such amounts have not been comprehensively revalued for purposes of these financial statements since that date and, therefore, current estimates of fair value may differ significantly from the amounts presented herein.

Segments

Segments	12 Months Ended
	Dec. 31, 2017
Segments
Segments	19. Segments The Company’s segments consist of Commercial Banking, Fee-Based Lines and Corporate Support and Other. The Commercial Banking segment consists of the operations of CoBiz Bank, a full-service business banking institution. Services provided include commercial, real estate, and private banking as well as treasury management, interest-rate hedging, and depository products. The Fee-Based Lines segment consists of businesses offering products and services that are financial in nature and for which revenues are based on a percentage of an underlying basis such as managed assets or paid premiums. Activities in this segment include investment advisory through CoBiz Wealth, LLC and insurance brokerage through CoBiz Insurance, Inc. CoBiz Wealth, LLC provides investment management advisory services to affluent individuals, families and businesses. CoBiz Insurance, Inc. offers property and casualty (P&C) and employee benefit group insurance (EB) broker agency to small to mid-sized employers, commercial enterprises and individual lines to their owners. As discussed in Note 2 – Discontinued Operations, the Company ceased the operations of GMB in the first quarter of 2015. The results of GMB’s operations are reported within the Fee-Based Lines segment as discontinued operations for 2015. The Corporate Support and Other segment consist of activities that are not directly attributable to the other reportable segments and include centralized bank operations and the activities of the Parent. The financial information for each business segment reflects that information which is specifically identifiable or which is allocated based on an internal allocation method. Results of operations and selected financial information by segment are as follows: For the year ended December 31, 2017 Corporate Commercial Fee-Based Support and (in thousands) Banking Lines Other Consolidated Income Statement Total interest income $ 142,845 $ 2 $ 340 $ 143,187 Total interest expense 5,265 14 7,334 12,613 Provision for loan losses 3,425 - (140) 3,285 Noninterest income 13,811 19,401 789 34,001 Noninterest expense 34,116 17,248 56,530 107,894 Management fees and allocations 32,982 1,269 (34,251) - Provision (benefit) for income taxes 41,866 1,269 (22,657) 20,478 Net income (loss) $ 39,002 $ (397) $ (5,687) $ 32,918 Depreciation and amortization $ 2,764 $ 573 $ 320 $ 3,909 Identifiable assets at December 31, 2017 $ 3,812,546 $ 8,341 $ 25,385 $ 3,846,272 For the year ended December 31, 2016 Corporate Commercial Fee-Based Support and (in thousands) Banking Lines Other Consolidated Income Statement Total interest income $ 127,403 $ 2 $ 377 $ 127,782 Total interest expense 4,427 25 7,279 11,731 Provision for loan losses (1,816) - (285) (2,101) Noninterest income 14,050 18,282 1,828 34,160 Noninterest expense 38,159 17,422 49,650 105,231 Management fees and allocations 27,912 1,673 (29,585) - Provision (benefit) for income taxes 32,606 372 (20,796) 12,182 Net income (loss) from continuing operations 40,165 (1,208) (4,058) 34,899 Loss from discontinued operations, net of tax - - - - Net income (loss) $ 40,165 $ (1,208) $ (4,058) $ 34,899 Depreciation and amortization $ 2,613 $ 807 $ 112 $ 3,532 Identifiable assets at December 31, 2016 $ 3,593,528 $ 11,053 $ 25,732 $ 3,630,313 For the year ended December 31, 2015 Corporate Commercial Fee-Based Support and (in thousands) Banking Lines Other Consolidated Income Statement Total interest income $ 119,896 $ 2 $ 1,368 $ 121,266 Total interest expense 3,947 44 5,599 9,590 Provision for loan losses 6,837 - (417) 6,420 Noninterest income 11,427 17,879 1,361 30,667 Noninterest expense 37,849 16,331 45,997 100,177 Management fees and allocations 25,225 1,334 (26,559) - Provision (benefit) for income taxes 27,679 643 (18,716) 9,606 Net income (loss) from continuing operations 29,786 (471) (3,175) 26,140 Income from discontinued operations, net of tax - (71) - (71) Net income (loss) $ 29,786 $ (542) $ (3,175) $ 26,069 Depreciation and amortization $ 2,430 $ 792 $ 33 $ 3,255 Identifiable assets at December 31, 2015 $ 3,317,977 $ 10,554 $ 23,236 $ 3,351,767

Condensed Financial Statements

Condensed Financial Statements Of Parent Company	12 Months Ended
	Dec. 31, 2017
Condensed Financial Statements Of Parent Company
Condensed Financial Statements Of Parent Company	20. Condensed Financial Statements of Parent Company Condensed financial statements pertaining only to CoBiz Financial Inc. are presented below. Investments in subsidiaries are stated using the equity method of accounting. Condensed Balance Sheets At December 31, (in thousands) 2017 2016 Assets: Cash on deposit at subsidiary bank $ 17,639 $ 16,588 Investment in bank subsidiary 406,474 377,104 Investment in non-bank subsidiaries 21,830 25,792 Accounts receivable from bank subsidiary 7,238 7,916 Accounts receivable from non-bank subsidiaries 443 1,398 Other 14,540 17,350 Total assets $ 468,164 $ 446,148 Liabilities and shareholders' equity: Liabilities: Accounts payable to bank subsidiary $ 2,657 $ 3,902 Accounts payable to non-bank subsidiaries 290 4,306 Subordinated notes payable 59,195 59,111 Junior subordinated debentures 72,166 72,166 Other liabilities 4,572 4,353 Total liabilities 138,880 143,838 Shareholders' equity 329,284 302,310 Total liabilities and shareholders' equity $ 468,164 $ 446,148 Condensed Statements of Income For the years ended December 31, (in thousands) 2017 2016 2015 Income: Management fees $ 1,050 $ 3,908 $ 3,872 Dividends from bank subsidiary 10,649 8,861 8,221 Dividends from non-bank subsidiaries 5,054 1,070 2,962 Interest income 131 171 195 Other income 807 1,847 1,380 Total income 17,691 15,857 16,630 Expense: Salaries and employee benefits 1,471 4,147 4,518 Interest expense 7,389 7,383 5,737 Other expense 1,752 2,260 2,614 Total expense 10,612 13,790 12,869 Income before income taxes 7,079 2,067 3,761 Benefit for income taxes (2,020) (2,898) (2,751) Net income before equity in undistributed earnings of subsidiaries 9,099 4,965 6,512 Equity in undistributed earnings of subsidiaries 23,819 29,934 19,557 Net income $ 32,918 $ 34,899 $ 26,069 Condensed Statements of Cash Flows For the years ended December 31, (in thousands) 2017 2016 2015 Cash flows from operating activities: Net income $ 32,918 $ 34,899 $ 26,069 Equity in undistributed earnings of subsidiaries (23,819) (29,934) (19,557) Stock-based compensation 402 631 620 Change in other assets and liabilities (438) 2,509 (7,480) Net cash provided by (used in) operating activities 9,063 8,105 (348) Cash flows from investing activities: Net advances (to) from subsidiaries 766 (2,162) 1,095 Other (448) (2,829) (27) Net cash provided by (used in) investing activities 318 (4,991) 1,068 Cash flows from financing activities: Proceeds from issuance of common stock, net 1,581 2,118 1,733 Taxes paid in net settlement of restricted stock (1,126) (891) (1,207) Proceeds from issuance of notes payable - - 59,250 Redemption of preferred stock - - (57,366) Dividends paid on common stock (8,785) (7,858) (6,953) Dividends paid on preferred stock - - (463) Other - - (104) Net cash used in financing activities (8,330) (6,631) (5,110) Net increase (decrease) in cash and cash equivalents 1,051 (3,517) (4,390) Cash and cash equivalents - beginning of year 16,588 20,105 24,495 Cash and cash equivalents - end of year $ 17,639 $ 16,588 $ 20,105

Supplemental Financial Data

Supplemental Financial Data	12 Months Ended
	Dec. 31, 2017
Supplemental Financial Data
Supplemental Financial Data	21. Supplemental Financial Data Other income and Other expense as shown in the consolidated statements of income is detailed in the following schedules to the extent the components exceed one percent of the aggregate of total interest income and other income. Other noninterest income Year ended December 31, (in thousands) 2017 2016 2015 Loan fees $ 2,515 $ 2,853 $ 1,787 Other customer service fees 2,900 2,704 2,497 Bank-owned life insurance 1,366 1,367 1,334 Other investments 1,234 2,477 1,312 Derivative valuation (175) 281 (24) Other 136 137 20 Total $ 7,976 $ 9,819 $ 6,926 Other noninterest expense Year ended December 31, (in thousands) 2017 2016 2015 Marketing and business development $ 2,699 $ 2,879 $ 2,799 Service contracts 5,506 5,281 4,545 Professional fees 3,519 2,917 2,818 Office supplies and delivery 1,175 1,357 1,461 Other 3,839 4,189 3,905 Total $ 16,738 $ 16,623 $ 15,528

Selected Quarterly Financial Da

Selected Quarterly Financial Data (Unaudited)	12 Months Ended
	Dec. 31, 2017
Selected Quarterly Financial Data
Selected Quarterly Financial Data	22. Selected Quarterly Financial Data (Unaudited) The table below sets forth unaudited financial information for each quarter of the last two years. Certain reclassifications have been made to prior period amounts to conform to current year presentation. Earnings per common share as noted below have not been separated between continuing and discontinued operations, as disclosed in Note 14 – Earnings per Common Share. 2017 2016 (in thousands) Q4(1) Q3 Q2 Q1 Q4 Q3(2) Q2 Q1 Interest income $ 37,753 $ 36,947 $ 35,406 $ 33,081 $ 32,779 $ 32,308 $ 31,500 $ 31,195 Interest expense 3,031 3,178 3,401 3,003 2,891 2,907 2,967 2,966 Net interest income 34,722 33,769 32,005 30,078 29,888 29,401 28,533 28,229 Income before income taxes 14,411 15,312 12,988 10,685 11,825 13,812 11,729 9,715 Net income $ 3,622 $ 11,193 $ 9,489 $ 8,614 $ 8,733 $ 10,269 $ 8,532 $ 7,365 Basic earnings per share(3) $ 0.09 $ 0.27 $ 0.23 $ 0.21 $ 0.21 $ 0.25 $ 0.21 $ 0.18 Diluted earnings per share(3) $ 0.09 $ 0.27 $ 0.23 $ 0.20 $ 0.21 $ 0.25 $ 0.21 $ 0.18 (1) Net income for the fourth quarter of 2017 was reduced due to a $7.2 million increase to income tax expense as a result of the TCJA. (2) Net income for the third quarter of 2016 benefited from noninterest income of $1.4 million on other investments and a $1.2 million provision for loan loss reversal. (3) Due to rounding, the sum of the quarterly earnings per share amounts may not equal earnings per share for the year as disclosed elsewhere in this report.

Nature Of Operations and Sign31

Nature Of Operations and Significant Accounting Policies (Policy)	12 Months Ended
	Dec. 31, 2017
Nature of Operations and Significant Accounting Policies
Use Of Estimates	Use of Estimates – The consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States and, where applicable, prevailing practices within the financial services industry. In preparing the consolidated financial statements, the Company is required to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ significantly from those estimates.
Reclassifications	Reclassifications – Certain reclassifications have been made to prior years’ consolidated financial statements and related notes to conform to current year presentation including: the effects of discontinued operations and the aggregation of certain line items in the consolidated statements of cash flows. Refer to Note 2 – Discontinued Operations for additional information.
Basis of Presentation	Basis of Presentation — The consolidated financial statements include entities in which the Parent has a controlling financial interest. These entities include; the Bank; CoBiz Insurance, Inc.; and CoBiz IM. Intercompany balances and transactions are eliminated in consolidation. The Company determines whether it has a controlling financial interest in an entity by first evaluating whether the entity is a voting interest entity or a VIE. The voting interest model is used when the equity investment is sufficient to absorb the expected losses and the equity investment has all of the characteristics of a controlling financial interest. Under the voting interest model, the party with the controlling voting interest consolidates the legal entity. The VIE model is used when any of the following conditions exist: the equity investment at risk is not sufficient to finance the entity’s activities without additional subordinated financial support; the holders of the equity investment do not have a controlling voting interest; or the holders of the equity investment are not obligated to absorb the expected losses or residual returns of the legal entity. An enterprise is considered to have a controlling financial interest of a VIE if it has both the power to direct the activities that most significantly impact economic performance and the obligation to absorb losses, or receive benefits, that are significant to the VIE. An enterprise that has a controlling financial interest is considered the primary beneficiary and must consolidate the VIE. The Company was not the primary beneficiary of a VIE at December 31, 2017 or December 31, 2016.
Cash and Cash Equivalents	Cash and Cash Equivalents — The Company considers all liquid investments with original maturities of three months or less to be cash equivalents. Cash and cash equivalents include amounts that the Company is required to maintain at the Federal Reserve Bank of Kansas City (Federal Reserve Bank) to meet certain regulatory reserve balance requirements. At December 31, 2017 and 2016, the Company had reserve requirements of $17.1 million and $24.3 million, respectively. The following table shows supplemental disclosures of certain cash and noncash items: For the year ended December 31, (in thousands) 2017 2016 2015 Cash paid during the period for: Interest $ 12,574 $ 11,826 $ 9,256 Income taxes, net 14,742 8,950 9,919 Other noncash activities: Loans transferred to held for sale 1,726 60 1,628 Conversion or exchange of AFS securities 18,023 - - Trade date accounting for investment securities - 1,553 795 Available for sale securities transferred to held to maturity - - 288,598 Lessor-paid tenant improvement allowance 358 - -
Investments	Investments — The Company classifies its investment securities as held to maturity, available for sale or trading, according to management’s intent. Investment security transactions are recorded on a trade date basis. At December 31, 2017 and 2016, the Company had no trading securities. Available for sale securities consist of bonds, notes and debentures (including corporate debt and TPS) not classified as held to maturity securities and are reported at fair value as determined by quoted market prices. Unrealized holding gains and losses, net of tax, are reported as a net amount in AOCI until realized. Investment securities held to maturity consist of residential mortgage-backed securities (MBS), bonds, notes, debentures for which the Company has the positive intent and ability to hold to maturity and are reported at cost, adjusted for amortization or accretion of premiums and discounts. Premiums and discounts, adjusted for prepayments as applicable, are recognized in interest income. Other than temporary declines in the fair value of individual investment securities held to maturity and available for sale are charged against earnings. Gains and losses on disposal of investment securities are determined using the specific identification method. Other-than-temporary-impairment (OTTI) on debt securities is separated between the amount that is credit related (credit loss component) and the amount due to all other factors. The credit loss component is recognized in earnings and is the difference between a security’s amortized cost basis and the discounted present value of expected future cash flows. The amount due to all other factors is recognized in other comprehensive income (loss) (OCI). See Note 3 – Investments.
Bank Stocks	Bank Stocks — Federal Home Loan Bank of Topeka (FHLB), Federal Reserve Bank and other correspondent bank stocks are accounted for under the cost method. See Note 3 – Investments.
Loans Held for Investment	Loans Held for Investment — Loans that the Company has the intent and ability to hold for the foreseeable future or until maturity or pay-off are reported at their outstanding principal balance adjusted for any charge-offs, the allowance for loan losses, deferred fees and costs on originated loans, and unamortized premiums or discounts on purchased loans. Interest is accrued and credited to income daily based on the principal balance outstanding. Loans that are 30 days or more past due based on payments received and applied to the loan are considered delinquent, excluding loans that are cash-secured. The accrual of interest income is generally discontinued when a loan becomes 90 days past due as to principal and interest. When a loan is designated as nonaccrual, the current period’s accrued interest receivable is charged against current earnings while any portions relating to prior periods are charged against the allowance for loan losses. Interest payments received on nonaccrual loans are generally applied to the principal balance of the loan. Loans are returned to accrual status when all the principal and interest amounts contractually due are brought current and future payments are reasonably assured and there has been demonstrated performance in accordance with contractual terms. The Company may elect to continue the accrual of interest when the loan is in the process of collection and the realizable value of collateral is sufficient to cover the principal balance and accrued interest.
Loans Held for Sale	Loans Held for Sale — Loans held for sale include loans the Company has demonstrated the ability and intent to sell. Loans held for sale are primarily nonperforming loans. Loans held for sale are carried at the lower of cost or fair value and are evaluated on a loan-by-loan basis.
Impaired Loans	Impaired Loans — Impaired loans, with the exception of groups of smaller-balance homogenous loans that are collectively evaluated for impairment, are defined as loans for which, based on current information and events, it is probable that the Company will be unable to collect the scheduled payments of principal or interest when due according to the contractual terms of the loan agreement. Factors considered by management in determining impairment include payment status, collateral value, and the probability of collecting scheduled principal and interest payments when due. Loans that experience insignificant payment delays of less than 90 days and monthly payment shortfalls of less than 10% of the contractual payment on a consumer loan generally are not classified as impaired if the Company ultimately expects to recover its full investment. The Company determines the significance of payment delays and payment shortfalls on a case-by-case basis, taking into consideration all of the circumstances surrounding the loan and the borrower, including the length of the delay, the reasons for the delay, the borrower’s prior payment record, and the amount of the shortfall in relation to the principal and interest owed. Impairment is measured on a loan-by-loan basis by the present value of expected future cash flows discounted at the loan’s effective interest rate, the loan’s obtainable market price or the fair value of the collateral if the loan is collateral dependent. Loans that are deemed to be impaired are evaluated in accordance with Accounting Standards Codification (ASC) Topic 310-10-35, Receivables – Subsequent Measurement (ASC 310) and ASC Topic 450-20, Loss Contingencies (ASC 450). Included in impaired loans are troubled debt restructurings. A troubled debt restructuring is a formal restructure of a loan where the Company, for economic or legal reasons related to the borrower’s financial difficulties, grants a concession to the borrower. The concessions may be granted in various forms, including but not limited to reduction in the stated interest rate, reduction in the loan balance or accrued interest, or extension of the maturity date. Troubled debt restructurings are evaluated in accordance with ASC Topic 310-40, Troubled Debt Restructurings by Creditors. Interest payments on impaired loans are typically applied to principal unless collectability of principal is reasonably assured. Loans that have been modified in a formal restructuring are typically returned to accrual status when there has been a sustained period of performance (generally six months) under the modified terms, the borrower has shown the ability and willingness to repay and the Company expects to collect all amounts due under the modified terms.
Loan Origination Fees and Costs	Loan Origination Fees and Costs — Loan fees and certain costs of originating loans are deferred and the net amount is amortized over the contractual life of the related loans in accordance with ASC Topic 310-20, Nonrefundable Fees and Other Costs.
Allowance for Loan Losses	Allowance for Loan Losses — The allowance for loan losses (ALL) is established as losses are estimated to have occurred through a provision for loan losses charged against earnings. Loan losses are charged against the allowance when management believes the uncollectability of a loan balance is confirmed. Subsequent recoveries, if any, are credited to the allowance. The ALL is evaluated on a regular basis by management and is based upon management’s periodic review of the collectability of the loans in light of historical experience, the nature and volume of the loan portfolio, adverse situations that may affect the borrower’s ability to repay, estimated value of any underlying collateral, and prevailing economic conditions. This evaluation is inherently subjective as it requires estimates that are susceptible to significant revision as new information becomes available.
Allowance for Credit Losses	Allowance for Credit Losses — The allowance for credit losses is established as losses are estimated to have occurred through a provision for credit losses charged to earnings. The allowance for credit losses represents management’s recognition of a separate reserve for off-balance sheet loan commitments and letters of credit. While the allowance for loan losses is recorded as a contra-asset to the loan portfolio on the consolidated balance sheets, the allowance for credit losses is recorded under the caption “Accrued interest and other liabilities”. Although the allowances are presented separately on the balance sheets, any losses incurred from credit losses would be reported as a charge-off in the allowance for loan losses, as any loss would be recorded after the off-balance sheet commitment had been funded. See Note 4 – Loans.
Intangible Assets	Intangible Assets — Intangible assets, primarily consisting of customer contracts and relationships, are being amortized by the straight-line method over 10 to 15 years. See Note 6 – Intangible Assets.
Bank-Owned Life Insurance (BOLI)	Bank-Owned Life Insurance (BOLI) – The Bank invested in BOLI policies to fund certain future employee benefit costs and are recorded at net realizable value. Changes in the amount that could be realized, including death benefits in excess of the carrying amount, are recorded in the consolidated statements of income under the caption “Other Income.”
Premises and Equipment	Premises and Equipment – Premises and equipment are stated at cost less accumulated depreciation and amortization, which is calculated using the straight-line method over the estimated useful lives of generally three to ten years. Leasehold improvements are capitalized and amortized using the straight-line method over the terms of the respective leases or the estimated useful lives of the improvements, whichever is shorter. The Company reviews the carrying value of property and equipment for indications of impairment in accordance with ASC Topic 360-10-35, Impairment or Disposal of Long-Lived Assets. See Note 5 – Premises and Equipment.
Other Assets	Other Assets – Included in other assets are certain investments (Funds), where the Company has the ability to exercise significant influence or has ownership between 20% and 50% that are accounted for under the equity method. The Funds are equity method investments licensed as Small Business Investment Companies that invest primarily in subordinated debt securities. In certain circumstances, the Funds may also receive warrants or other equity positions as part of their investments. There were no significant transactions between the Company and the Funds for the years ended December 31, 2017, 2016, and 2015. The Company recognized income from the Funds of $1.2 million, $2.5 million, and $1.3 million for the years ended December 31, 2017, 2016, and 2015, respectively, which is included in “Other Income” in the consolidated statements of income.
Repossessed Assets	Repossessed Assets – Assets acquired through repossession are held for sale and initially recorded at estimated fair value at the date of repossession. Subsequent to repossession, valuations are periodically performed by management and the assets are carried at the lower of carrying amount or fair value less costs to sell. Repossessed assets are reported in the consolidated balance sheets under the caption “Other Assets.” There were no repossessed assets at December 31, 2017 and 2016.
Other Real Estate Owned (OREO)	Other Real Estate Owned (OREO) – OREO held for sale acquired through foreclosure, physical possession or in settlement of debt is valued at estimated fair value, less estimated costs to sell, at the date of receipt. Subsequent to foreclosure, OREO is carried at the lower of carrying amount or fair value less costs to sell. Subsequent declines in value are charged to operations. There was no significant activity in the valuation allowance on OREO for the years ended December 31, 2017, 2016, and 2015.
Securities Sold Under Agreements to Repurchase	Securities Sold Under Agreements to Repurchase – The Company sells certain securities under agreements to repurchase with its customers. The agreements transacted with its customers are utilized as an overnight investment product. These agreements are treated as secured borrowings, where the agreements are reflected as a liability of the Company and the securities underlying the agreements are reflected as a Company asset in accordance with ASC Topic 860, Transfers and Servicing. See Note 8 – Borrowed Funds.
Derivative Instruments	Derivative Instruments — Derivative financial instruments are accounted for at fair value. The Company utilizes interest rate swaps to hedge a portion of its exposure to interest rate changes. These instruments are accounted for as cash flow hedges, as defined by ASC Topic 815, Derivatives and Hedging (ASC 815). The Company also uses interest rate swaps to hedge against adverse changes in fair value on fixed-rate loans. These instruments are accounted for as fair value hedges in accordance with ASC 815. The net cash flows from the cash flow and fair value hedges are classified in operating activities within the consolidated statements of cash flows with the hedged items. The Company also offers an interest rate hedge program that includes various derivative products, including swaps, to customers of the Bank. The fair value amounts recognized for derivative instruments and the fair value amounts recognized for the right to reclaim or obligation to return cash collateral are not offset when represented under a master netting arrangement. The Company also uses foreign currency forward contracts (FX forwards) giving it the right to sell underlying currencies at specified future dates and predetermined prices in order to mitigate foreign exchange risk associated with long positions. FX forwards are carried at fair value with changes in value recognized in current earnings as the contracts are not designated as hedging instruments. See Note 10 – Derivatives.
Self-Insurance Reserves	Self-Insurance Reserves – The Company self-insures a portion of its employee medical costs. The Company maintains a liability for incurred-but-not-reported claims based on assumptions as to eligible employees, historical claims experience and lags in claims reporting.
Investment Advisory Income	Investment Advisory Income – Fees earned from providing investment advisory services are based on the market value of assets under management and are collected at the end of each quarter.
Insurance Income	Insurance Income – Insurance income includes commissions on the sale of life and property and casualty insurance policies, and other employee benefit products earned as an agent for unaffiliated insurance underwriters. Property and casualty income is primarily recognized upon policy origination and renewal dates. Benefits brokerage income is recognized on a monthly basis as the customer pays their insurance premiums .
Loss From Discontinued Operations, Net of Income Taxes	Loss From Discontinued Operations, Net of Income Taxes – Loss from discontinued operations, net of income taxes for the year ended December 31, 2017, 2016 and 2015 includes the closure of GMB, which is discussed in Note 2 – Discontinued Operations.
Income Taxes	Income Taxes – A deferred income tax liability or asset is recognized for temporary differences which exist in the recognition of certain income and expense items for financial statement reporting purposes in periods different than for tax reporting purposes. The provision for income taxes is based on the amount of current and deferred income taxes payable or refundable at the date of the financial statements as measured by the provisions of current tax laws. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized. The ultimate realization of deferred tax assets depends on the generation of future taxable income during the period in which related temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, taxes paid in prior carryback years, projected future taxable income and tax planning strategies in its assessment of a valuation allowance. See Note 11 – Income Taxes.
Stock-Based Compensation	Stock-Based Compensation — Pursuant to ASC Topic 718, Compensation – Stock Compensation (ASC 718), the Company recognizes the fair value of stock-based awards to employees as compensation cost over the requisite service period. See Note 15 – Employee Benefit and Stock Compensation Plans.
Earnings Per Common Share	Earnings Per Common Share — Basic and diluted earnings per share is based on the two-class method prescribed in ASC Topic 260, Earnings Per Share (ASC 260). The weighted-average number of shares outstanding used to compute diluted earnings per share include the number of additional common shares that would be outstanding if the potential dilutive common shares and common share equivalents had been issued at the beginning of the period. See Note 14 – Earnings per Common Share.
Segment Information	Segment Information - The Company has disclosed separately the results of operations relating to its segments in Note 19 – Segments.
Fair Value Measurements	Fair Value Measurements — The Company measures financial assets, financial liabilities, nonfinancial assets and nonfinancial liabilities pursuant to ASC Topic 820, Fair Value Measurements and Disclosures (ASC 820). ASC 820 defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. See Note 18 - Fair Value Measurements.
Recent Accounting Pronouncements	Recent Accounting Pronouncements — In May 2014, the FASB issued ASU 2014-09 (ASU 2014-09), Revenue from Contracts with Customers. The core principle of ASU 2014-09 is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The guidance also specifies the accounting for some costs to obtain or fulfill a contract with a customer, as well as enhanced disclosure requirements. In August 2015, the FASB issued ASU 2015-14 which deferred the effective date of ASU 2014-09 to fiscal years, and interim reporting periods within those fiscal years, beginning after December 15, 2017. In March 2016, the FASB issued ASU 2016-08 which clarified the revenue recognition implementation guidance on principal versus agent considerations and is effective during the same period as ASU 2014-09. In April 2016, the FASB issued ASU 2016-10 which clarified the revenue recognition guidance regarding the identification of performance obligations and the licensing implementation and is effective during the same period as ASU 2014-09. In May 2016, the FASB issued ASU 2016-12 which narrowly amended the revenue recognition guidance regarding collectability, noncash consideration, presentation of sales tax and transition. ASU 2016-12 is effective during the same period as ASU 2014-09. In evaluating the effects of these ASUs on its financial statements and disclosures, the Company has determined the following: · The primary revenue lines subject to these ASUs are deposit service charges, investment advisory income and insurance income, which totaled $26.0 million in 2017. · The adoption of these ASUs did not have a material impact on the Company’s financial statements. The Company’s first quarter interim filing will be updated with the new required disclosures. · The Company will adopt ASU 2014-09 using the modified retrospective method. In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) (ASU 2016-02). ASU 2016-02 is intended to increase transparency and comparability among organizations by recognizing lease assets and liabilities on the balance sheet and disclosing key information about lease arrangements. For public business entities, this ASU is effective for annual periods and interim periods within those annual periods beginning after December 15, 2018. The Company is currently evaluating the effects of ASU 2016-02 on its financial statements and disclosures by taking inventory of all existing lease arrangements. Preliminarily, the Company expects the primary impact of ASU 2016-02 will relate to its office locations, all of which are designated as operating leases. The Company has future operating lease obligations for its locations of $30.4 million that are being evaluated as potential lease assets and liabilities, as defined in ASU 2016-02. The Company has formed a lease implementation team that includes members of accounting, facilities and operations to review lease contracts and the requirements of ASU 2016-02. In June 2016, the FASB issued ASU 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (ASU 2016-13). The objective of ASU 2016-13 is to provide financial statement users with decision-useful information about the expected credit losses on financial instruments and other commitments to extend credit. ASU 2016-13 includes provisions that require financial assets measured at amortized cost (such as loans and held to maturity (HTM) debt securities) to be presented at the net amount expected to be collected. This will be accomplished through recognition of an estimate of all current expected credit losses. The estimate will include forecasted information for the timeframe that an entity is able to develop reasonable and supportable forecasts. This is a change from the current practice of recognizing incurred losses based on the probable initial recognition threshold under current GAAP. In addition, credit losses AFS debt securities will be recorded through an allowance for credit losses rather than as a write-down. Under ASU 2016-13, an entity will be able to record reversals of credit losses in current period income when the estimate of credit losses declines, whereas current GAAP prohibits reflecting those improvements in current period earnings. ASU 2016-13 is effective for annual periods and interim periods within those annual periods beginning after December 15, 2019, and early adoption is permitted for fiscal years, including interim periods, beginning after December 15, 2018. ASU 2016-13 will be applied through a cumulative effect adjustment to retained earnings (modified-retrospective approach), except for debt securities for which an other-than-temporary impairment had been recognized before the effective date. A prospective transition approach is required for these debt securities. The Company is currently evaluating the effects of ASU 2016-13 on its financial statements and disclosures, and expects ASU 2016-13 to add complexity and costs to its current credit loss evaluation process. In planning for the implementation of ASU 2016-13, the Company has formed a CECL implementation team that includes the CFO, Chief Credit Officer and members of credit, accounting, finance, information technology. The team meets on a weekly basis and is currently evaluating software solutions, data requirements and loss methodologies. In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (ASU 2016-15), regarding how certain cash receipts and cash payments are presented and classified in the statements of cash flows. ASU 2016-15 addresses eight specific cash flow issues with the objective of reducing the existing diversity in practice. The amendments of ASU 2016-15 are effective for public business entities for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. Amendments in this ASU should be applied using a retrospective transition method to each period presented. The Company is evaluating the effects ASU 2016-15 will have on its financial statements and disclosures, and does not expect these effects to be material. In December 2016, the FASB issued ASU 2016-20, Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customers (ASU 2016-20). The amendments in ASU 2016-20 affect certain aspects of the guidance issued in ASU 2014-06 including loan guarantee fees, contract costs, provisions for losses on construction-type and production-type contracts, disclosure of remaining performance obligations, contract modifications, contract asset vs. receivable, refund liability, advertising costs, fixed odds wagering contracts in the casino industry, and costs capitalized for advisors to private funds and public funds. The effective date of these amendments are at the same date that ASU 2014-09, which is discussed above, is effective. In February 2017, the FASB issued ASU 2017-05, Other Income – Gains and Losses from the Derecognition of Nonfinancial Assets (Subtopic 610-20) (ASU 2017-05). ASU 2017-05 is intended to clarify that Subtopic 610-20 applies to the derecognition of nonfinancial assets and in substance nonfinancial assets unless other specific guidance applies. ASU 2017-05 also adds guidance for partial sales of nonfinancial assets and eliminates rules specifically addressing sales of real estate. For public business entities, this ASU is effective for annual periods and interim periods within those annual periods beginning after December 15, 2017. The Company is currently evaluating the effects of ASU 2017-05 on its financial statements and disclosures. In March 2017, the FASB issued ASU 2017-08, Receivables – Nonrefundable Fees and Other Costs (Subtopic 310-20) (ASU 2017-08). ASU 2017-08 amends the amortization period for certain purchased callable debt securities held at a premium. Prior to the issuance of this guidance, premiums were amortized as an adjustment of yield over the contractual life of the instrument. ASU 2017-08 requires premiums on purchased callable debt securities that have explicit, noncontingent call features that are callable at fixed prices to be amortized to the earliest call date. There are no accounting changes for securities held at a discount. This ASU is effective for annual periods and interim periods within those annual periods beginning after December 15, 2018, and early adoption is permitted. ASU 2017-08 will be applied through a cumulative effect adjustment through equity (modified-retrospective approach). The Company is currently evaluating the effects of ASU 2017-08 on its financial statements and disclosures. In May 2017, the FASB issued ASU 2017-09, Compensation – Stock Compensation (Topic 718), Scope of Modification Accounting (ASU 2017-09). ASU 2017-09 clarifies when changes to the terms and conditions of share-based payment awards must be treated as modifications. Specifically, the new guidance permits companies to make certain changes to awards without accounting for them as modifications. ASU 2017-09 is effective for annual periods beginning after December 31, 2017 and will be applied prospectively to an award modified after the effective date. The Company is currently evaluating the effects of ASU 2017-09 on its financial statements and disclosures. In August 2017, the FASB issued ASU 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities (ASU 2017-12). The purpose of this updated guidance is to better align a company’s financial reporting for hedging activities with the economic objectives of those activities. ASU 2017-12 is effective for annual periods and interim periods within those annual periods beginning after December 15, 2018, and early adoption is permitted. ASU 2017-12 requires the modified-retrospective approach for adoption. The Company is currently evaluating the effects of ASU 2017-12 on its financial statements and disclosures and is considering early adoption in 2018.

Nature of Operations and Sign32

Nature of Operations and Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2017
Nature of Operations and Significant Accounting Policies
Schedule of Cash Flow, Supplemental Disclosures	For the year ended December 31, (in thousands) 2017 2016 2015 Cash paid during the period for: Interest $ 12,574 $ 11,826 $ 9,256 Income taxes, net 14,742 8,950 9,919 Other noncash activities: Loans transferred to held for sale 1,726 60 1,628 Conversion or exchange of AFS securities 18,023 - - Trade date accounting for investment securities - 1,553 795 Available for sale securities transferred to held to maturity - - 288,598 Lessor-paid tenant improvement allowance 358 - -

Discontinued Operations (Tables

Discontinued Operations (Tables)	12 Months Ended
	Dec. 31, 2017
Discontinued Operations
Schedule Of Discontinued Operations	For the year ended December 31, (in thousands) 2015 Noninterest income $ 623 Noninterest expense 736 Loss before income taxes (113) Benefit for income taxes (42) Loss from discontinued operations $ (71)

Investments (Tables)

Investments (Tables)	12 Months Ended
	Dec. 31, 2017
Investments
Summary of amortized cost and estimated fair values of investment securities	December 31, 2017 December 31, 2016 Gross Gross Gross Gross Amortized unrealized unrealized Fair Amortized unrealized unrealized Fair (in thousands) cost gains losses value cost gains losses value Available for sale securities (AFS): Trust preferred securities $ 20,318 $ 1,870 $ 205 $ 21,983 $ 36,450 $ 1,707 $ 533 $ 37,624 Corporate debt securities 140,445 1,153 103 141,495 90,593 1,505 21 92,077 Municipal securities 3,249 41 15 3,275 3,265 33 18 3,280 Total AFS $ 164,012 $ 3,064 $ 323 $ 166,753 $ 130,308 $ 3,245 $ 572 $ 132,981 Held to maturity securities (HTM): Mortgage-backed securities $ 318,128 $ 118 $ 3,262 $ 314,984 $ 319,978 $ 186 $ 2,531 $ 317,633 Trust preferred securities 10,721 783 18 11,486 10,620 522 267 10,875 Municipal securities 33,695 73 167 33,601 35,443 10 783 34,670 Total HTM $ 362,544 $ 974 $ 3,447 $ 360,071 $ 366,041 $ 718 $ 3,581 $ 363,178
Schedule Of Proceeds and Gains (Losses) From Securities Sold Or Called	For the year ended December 31, (in thousands) 2017 2016 2015 Proceeds $ - $ - $ - Gains 254 100 343 Losses (5) (6) (25)
Investments Classified By Contractual Maturity Date	Available for sale Held to maturity Amortized Fair Amortized Fair (in thousands) cost value cost value Due in one year or less $ 8,385 $ 8,390 $ 1,718 $ 1,712 Due after one year through five years 99,998 100,948 23,578 23,572 Due after five years through ten years 29,446 29,975 - - Due after ten years 26,183 27,440 19,120 19,803 Mortgage-backed securities - - 318,128 314,984 $ 164,012 $ 166,753 $ 362,544 $ 360,071
Schedule of Securities in an Unrealized Loss Position	December 31, 2017 Less than 12 months 12 months or greater Total Fair Unrealized Fair Unrealized Fair Unrealized (in thousands) value loss value loss value loss AFS Trust preferred securities $ 700 $ 43 $ 7,020 $ 162 $ 7,720 $ 205 Corporate debt securities 40,068 94 1,216 9 41,284 103 Municipal securities 1,252 15 - - 1,252 15 Total AFS $ 42,020 $ 152 $ 8,236 $ 171 $ 50,256 $ 323 HTM Mortgage-backed securities $ 182,974 $ 1,457 $ $ $ 287,438 $ 3,262 Trust preferred securities - - 864 18 864 18 Municipal securities 20,445 163 684 4 21,129 167 Total HTM $ 203,419 $ 1,620 $ $ $ 309,431 $ 3,447 December 31, 2016 Less than 12 months 12 months or greater Total Fair Unrealized Fair Unrealized Fair Unrealized (in thousands) value loss value loss value loss AFS Trust preferred securities $ 14,979 $ 526 $ 995 $ 7 $ 15,974 $ 533 Corporate debt securities 14,482 21 - - 14,482 21 Municipal securities 1,214 18 - - 1,214 18 Total AFS $ 30,675 $ 565 $ 995 $ 7 $ 31,670 $ 572 HTM Mortgage-backed securities $ 217,604 $ 2,107 $ $ 424 $ 269,936 $ 2,531 Trust preferred securities 4,175 94 700 173 4,875 267 Municipal securities 30,207 783 - - 30,207 783 Total HTM $ 251,986 $ 2,984 $ $ 597 $ 305,018 $ 3,581
Schedule Of Other Investments	December 31, (in thousands) 2017 2016 Bank stocks — at cost $ 7,945 $ 9,192 Investment in statutory trusts — equity method 2,174 2,173 $ 10,119 $ 11,365

Loans (Tables)

Loans (Tables)	12 Months Ended
	Dec. 31, 2017
Loans
Schedule Of Loan Portfolio Segments	December 31, (in thousands) 2017 2016 Commercial $ 1,250,356 $ 1,217,001 Real estate - mortgage 1,250,423 1,171,596 Construction & land 266,081 175,738 Consumer 282,101 266,947 Other 98,916 103,616 Loans held for investment 3,147,877 2,934,898 Allowance for loan losses (37,941) (33,293) Unearned net loan fees (2,314) (793) Total net loans $ 3,107,622 $ 2,900,812
Schedule Of Major Portfolio Segment And Non Classified And Classified Loan Class	At December 31, 2017 (in thousands) Non-classified Classified Total Commercial Manufacturing $ 82,275 $ 2,912 $ 85,187 Finance and insurance 40,796 1,722 42,518 Health care 161,162 2,623 163,785 Real estate services 124,861 3,986 128,847 Construction 67,232 758 67,990 Public administration 239,230 847 240,077 Other 468,562 53,390 521,952 1,184,118 66,238 1,250,356 Real estate - mortgage Residential & commercial owner-occupied 481,061 3,574 484,635 Residential & commercial investor 765,210 578 765,788 1,246,271 4,152 1,250,423 Construction & land 266,081 - 266,081 Consumer 279,191 2,910 282,101 Other 97,542 1,374 98,916 Total loans held for investment $ 3,073,203 $ 74,674 $ 3,147,877 Unearned net loan fees (2,314) Net loans held for investment $ 3,145,563 At December 31, 2016 (in thousands) Non-classified Classified Total Commercial Manufacturing $ 96,465 $ 153 $ 96,618 Finance and insurance 49,764 587 50,351 Health care 153,468 555 154,023 Real estate services 125,531 513 126,044 Construction 55,471 3,247 58,718 Public administration 254,861 1,136 255,997 Other 437,219 38,031 475,250 1,172,779 44,222 1,217,001 Real estate - mortgage Residential & commercial owner-occupied 469,027 6,496 475,523 Residential & commercial investor 695,170 903 696,073 1,164,197 7,399 1,171,596 Construction & land 172,816 2,922 175,738 Consumer 265,307 1,640 266,947 Other 101,894 1,722 103,616 Total loans held for investment $ 2,876,993 $ 57,905 $ 2,934,898 Unearned net loan fees (793) Net loans held for investment $ 2,934,105
Schedule Of Allowance For Loan Losses	For the year ended December 31, (in thousands) 2017 2016 2015 Allowance for loan losses, beginning of period Commercial $ 15,398 $ 24,215 $ 14,614 Real estate - mortgage 11,475 10,372 12,463 Construction & land 1,997 2,111 2,316 Consumer 2,803 2,592 2,329 Other 945 643 488 Unallocated 675 753 555 Total 33,293 40,686 32,765 Provision Commercial $ 1,237 $ (2,334) $ 9,950 Real estate - mortgage 1,029 1,072 (3,017) Construction & land 998 (1,279) (1,253) Consumer (122) 216 374 Other (119) 302 168 Unallocated 262 (78) 198 Total 3,285 (2,101) 6,420 Charge-offs Commercial $ (823) $ (7,767) $ (588) Real estate - mortgage - - (186) Construction & land - - (107) Consumer (99) (37) (130) Other - - (285) Total (922) (7,804) (1,296) Recoveries Commercial $ 1,025 $ 1,284 $ 239 Real estate - mortgage 186 31 1,112 Construction & land 1,039 1,165 1,155 Consumer 35 32 19 Other - - 272 Total 2,285 2,512 2,797 Allowance for loan losses, end of period Commercial $ 16,837 $ 15,398 $ 24,215 Real estate - mortgage 12,690 11,475 10,372 Construction & land 4,034 1,997 2,111 Consumer 2,617 2,803 2,592 Other 826 945 643 Unallocated 937 675 753 Total $ 37,941 $ 33,293 $ 40,686
Schedule Of Loans Held For Investment And ALL On The Basis Of Impairment Method	At December 31, 2017 At December 31, 2016 Individually Individually evaluated for Collectively evaluated for evaluated for Collectively evaluated for impairment impairment impairment impairment Loans Allowance Loans Allowance Loans Allowance Loans Allowance held for for loan held for for loan held for for loan held for for loan (in thousands) investment losses investment losses investment losses investment losses Commercial $ 56,566 $ 5,862 $ 1,194,005 $ 10,975 $ 20,279 $ 2,220 $ 1,197,453 $ 13,178 Real estate - mortgage 1,331 109 1,248,166 12,581 3,758 147 1,167,365 11,328 Construction & land 1,071 91 263,330 3,943 1,919 109 172,532 1,888 Consumer 1,366 148 280,783 2,469 294 98 266,719 2,705 Other - - 98,945 826 - - 103,786 945 Unallocated - - - 937 - - - 675 Total $ 60,334 $ 6,210 $ 3,085,229 $ 31,731 $ 26,250 $ 2,574 $ 2,907,855 $ 30,719
Schedule Of Impaired Loans	At December 31, 2017 Recorded Recorded Recorded investment investment Unpaid investment with a with no principal in impaired related related Related (in thousands) balance loans allowance allowance allowance Commercial Manufacturing $ 3,302 $ 3,302 $ 3,302 $ - $ 238 Finance and insurance 473 473 17 456 17 Healthcare 718 718 459 259 207 Real estate services 7,982 7,982 7,982 - 544 Construction 1,689 1,457 977 480 71 Public administration 313 313 313 - 27 Other 42,660 42,321 41,030 1,291 4,758 57,137 56,566 54,080 2,486 5,862 Real estate - mortgage Residential & commercial owner-occupied 1,159 1,159 1,102 57 94 Residential & commercial investor 172 172 172 - 15 1,331 1,331 1,274 57 109 Construction & land 1,071 1,071 1,071 - 91 Consumer 1,366 1,366 212 1,154 148 Total $ 60,905 $ 60,334 $ 56,637 $ 3,697 $ 6,210 At December 31, 2016 Recorded Recorded Recorded investment investment Unpaid investment with a with no principal in impaired related related Related (in thousands) balance loans allowance allowance allowance Commercial Manufacturing $ 2,095 $ 2,072 $ 2,071 $ 1 $ 114 Finance and insurance 25 25 25 - 25 Healthcare 189 189 189 - 11 Real estate services 6,268 6,268 6,268 - 350 Construction 2,166 2,166 1,932 234 149 Other 10,716 9,559 9,066 493 1,571 21,459 20,279 19,551 728 2,220 Real estate - mortgage Residential & commercial owner-occupied 1,391 1,391 1,122 269 64 Residential & commercial investor 2,367 2,367 2,367 - 83 3,758 3,758 3,489 269 147 Construction & land 1,919 1,919 1,919 - 109 Consumer 294 294 195 99 98 Total $ 27,430 $ 26,250 $ 25,154 $ 1,096 $ 2,574 For the year ended December 31, 2017 2016 2015 Average Average Average recorded recorded recorded investment Interest investment Interest investment Interest in impaired income in impaired income in impaired income (in thousands) loans recognized loans recognized loans recognized Commercial Manufacturing $ 2,455 $ 138 $ 3,383 $ 234 $ 5,643 $ 306 Finance and insurance 380 16 30 - 164 24 Healthcare 503 43 194 12 33 11 Real estate services 6,355 262 6,996 261 8,006 283 Construction 1,558 104 1,873 140 1,666 106 Public administration 105 5 - - - - Other 22,896 1,435 12,804 619 7,507 1,034 34,252 2,003 25,280 1,266 23,019 1,764 Real estate - mortgage Residential & commercial owner-occupied 1,217 41 1,777 114 1,762 130 Residential & commercial investor 1,547 55 3,722 127 5,104 182 2,764 96 5,499 241 6,866 312 Construction & land 1,655 55 2,336 93 2,935 104 Consumer 489 5 448 19 1,444 202 Other 36 5 - - 26 11 Total $ 39,196 $ 2,164 $ 33,563 $ 1,619 $ 34,290 $ 2,393
Schedule Of Transactions Related To Troubled Debt Restructurings	(in thousands) Performing Nonperforming Total Balance at December 31, 2015 $ 28,196 $ 13,837 $ 42,033 New restructurings 8,563 3,266 11,829 Change in accrual status (912) 912 - Paydowns (12,235) (7,883) (20,118) Net charge-offs - (7,591) (7,591) Balance at December 31, 2016 23,612 2,541 26,153 New restructurings 38,958 2,402 41,360 Change in accrual status 269 (269) - Paydowns (10,022) (951) (10,973) Net charge-offs - (41) (41) Balance at December 31, 2017 $ 52,817 $ 3,682 $ 56,499
Schedule Of Troubled Debt Restructurings	For the year ended December 31, 2017 For the year ended December 31, 2016 Pre-modification Post-modification Pre-modification Post-modification outstanding outstanding outstanding outstanding Number of recorded recorded Number of recorded recorded ($ in thousands) contracts investment investment contracts investment investment Commercial Manufacturing 1 $ 1,366 $ 1,366 1 $ 50 $ 22 Finance and insurance 1 456 456 - - - Health care 3 577 522 1 100 100 Real estate services 1 3,274 2,899 - - - Construction - - - 4 1,995 1,844 Public administration 1 320 313 - - - Other 17 37,032 34,065 9 7,388 5,275 24 43,025 39,621 15 9,533 7,241 Consumer 1 83 72 1 77 72 Total 25 $ 43,108 $ 39,693 16 $ 9,610 $ 7,313 For the year ended December 31, 2015 Pre-modification Post-modification outstanding outstanding Number of recorded recorded ($ in thousands) contracts investment investment Commercial Manufacturing 2 $ 491 $ 437 Health care 1 200 125 Construction 3 1,738 1,029 Other 15 19,809 15,975 21 22,238 17,566 Real estate - mortgage Residential & commercial owner-occupied 1 1,000 1,000 Consumer 1 148 130 Total 23 $ 23,386 $ 18,696
Schedule Of Nonaccrual Loans	At December 31, (in thousands) 2017 2016 Commercial Manufacturing $ - $ 2 Finance and insurance 473 25 Health care 718 - Construction 681 234 Other 4,313 1,941 Total commercial 6,185 2,202 Real estate - mortgage Residential & commercial owner-occupied 57 269 Total real estate - mortgage 57 269 Consumer 1,275 167 Total nonaccrual loans $ 7,517 $ 2,638
Schedule Of Aging Of The Company's Loan Portfolio	At December 31, 2017 Recorded investment in loans 30 - 59 60 - 89 90 days or more Days past Days past 90+ Days Total past past due and (in thousands) due due past due due Current Total loans accruing Commercial Manufacturing $ - $ - $ - $ - $ 85,187 $ 85,187 $ - Finance and insurance - 456 213 669 41,849 42,518 213 Health care 370 - 113 483 163,302 163,785 - Real estate services 1,503 - 135 1,638 127,209 128,847 135 Construction 721 600 681 2,002 65,988 67,990 - Public administration - - - - 240,077 240,077 - Other 3,463 459 2,302 6,224 515,728 521,952 - 6,057 1,239,340 1,250,356 348 Real estate - mortgage Residential & commercial owner-occupied 426 689 - 1,115 483,520 484,635 - Residential & commercial investor 875 299 - 1,174 764,614 765,788 - 1,301 988 - 2,289 1,248,134 1,250,423 - Construction & land 730 - - 730 265,351 266,081 - Consumer 1,423 15 1,107 2,545 279,556 282,101 - Other - 2 - 2 98,914 98,916 - Total loans held for investment $ 9,511 $ $ $ $ 3,131,295 $ 3,147,877 $ 348 Unearned net loan fees (2,314) Net loans held for investment $ 3,145,563 At December 31, 2016 Recorded investment in loans 30 - 59 60 - 89 90 days or more Days past Days past 90+ Days Total past past due and (in thousands) due due past due due Current Total loans accruing Commercial Manufacturing $ - $ - $ - $ - $ 96,618 $ 96,618 $ - Finance and insurance 456 - 25 481 49,870 50,351 - Health care 500 - - 500 153,523 154,023 - Real estate services - - - - 126,044 126,044 - Construction 260 - - 260 58,458 58,718 - Public administration - - - - 255,997 255,997 - Other 2,941 200 - 3,141 472,109 475,250 - 4,157 200 25 4,382 1,212,619 1,217,001 - Real estate - mortgage Residential & commercial owner-occupied 204 161 - 365 475,158 475,523 - Residential & commercial investor - 225 - 225 695,848 696,073 - 204 386 - 590 1,171,006 1,171,596 - Construction & land - - 657 657 175,081 175,738 657 Consumer 4 63 75 142 266,805 266,947 - Other - - - - 103,616 103,616 - Total loans held for investment $ 4,365 $ 649 $ 757 $ 5,771 $ 2,929,127 $ 2,934,898 $ 657 Unearned net loan fees (793) Net loans held for investment $ 2,934,105
Schedule Of Loans And Leases Receivable, Related Parties	(in thousands) 2017 2016 Balance - beginning of year $ 34,995 $ 34,301 New loan and advances 56,859 48,110 Principal paydowns and payoffs (57,789) (47,416) Balance - end of year $ 34,065 $ 34,995

Premises And Equipment (Tables)

Premises And Equipment (Tables)	12 Months Ended
	Dec. 31, 2017
Premises And Equipment
Schedule Of Premises And Equipment	(in thousands) 2017 2016 Land $ - $ 230 Buildings - 230 Leasehold improvements 11,104 10,425 Furniture, fixtures, and equipment 37,182 38,403 Premises and equipment, gross 48,286 49,288 Accumulated depreciation (37,459) (38,269) Premises and equipment, net $ 10,827 $ 11,019

Intangible Assets (Tables)

Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2017
Intangible Assets
Schedule of Finite-Lived Intangible Assets	Customer contracts, lists (in thousands) and relationships At December 31, 2015 $ 1,926 Amortization (600) At December 31, 2016 1,326 Amortization (600) At December 31, 2017 $ 726
Schedule Of Expected Amortization Expense	(in thousands) 2018 $ 206 2019 201 2020 136 2021 91 2022 40 Total $ 674

Deposits (Tables)

Deposits (Tables)	12 Months Ended
	Dec. 31, 2017
Deposits
Schedule Of Certificates Of Deposit, By Contractual Maturity	(in thousands) Amount Maturing in: 2018 $ 105,586 2019 6,038 2020 2,283 2021 1,701 2022 639 Total $ 116,247

Borrowed Funds (Tables)

Borrowed Funds (Tables)	12 Months Ended
	Dec. 31, 2017
Borrowed Funds
Schedule of short-term borrowings	At December 31, (in thousands) 2017 2016 Securities sold under agreements to repurchase (secured by pledge of mortgage-backed securities with an estimated fair value of $54,018 and $28,192, respectively) $ 52,959 $ 27,639 Other short-term borrowings 77,640 106,230

Long-Term Debt (Tables)

Long-Term Debt (Tables)	12 Months Ended
	Dec. 31, 2017
Long-Term Debt
Schedule of long-term debt	At December 31, (in thousands) 2017 2016 Interest rate Maturity date Earliest call date Junior subordinated debentures: CoBiz Statutory Trust I $ $ 3-month LIBOR + 2.95% September 17, 2033 March 17, 2018 CoBiz Capital Trust II 3-month LIBOR + 2.60% July 23, 2034 January 23, 2018 CoBiz Capital Trust III 3-month LIBOR + 1.45% September 30, 2035 March 30, 2018 Total junior subordinated debentures $ $ Other long-term debt: Subordinated notes payable ($60,000 face amount) $ 59,195 $ 59,111 Fixed 5.625% June 25, 2030 June 25, 2025

Derivatives (Tables)

Derivatives (Tables)	12 Months Ended
	Dec. 31, 2017
Derivatives
Schedule Of Derivative Instruments In The Statements Of Financial Position	Asset derivatives Liability derivatives Fair value at December 31, Fair value at December 31, Balance sheet Balance sheet (in thousands) classification 2017 2016 classification 2017 2016 Derivatives designated as hedging instruments under ASC 815: Cash flow hedge - interest rate swap Other assets $ 113 $ - Accrued interest and other liabilities $ 6,732 $ 7,639 Fair value hedge - interest rate swap Other assets 628 476 Accrued interest and other liabilities 633 845 Derivatives not designated as hedging instruments under ASC 815: Interest rate swap Other assets $ 2,081 $ 2,755 Accrued interest and other liabilities $ 2,176 $ 2,736 Foreign exchange forward contracts Other assets 28 52 Accrued interest and other liabilities 44 5
Schedule Of Fair Value Of Derivative Financial Instruments And Their Classification On Condensed Consolidated Balance Sheets	At December 31, 2017 Gross Gross Gross amounts not offset amounts of amounts Financial Net (in thousands) recognized assets offset Net amounts Instruments Collateral Amount Derivatives designated as hedges (1) $ 741 $ - $ 741 $ (741) $ - $ - Derivatives not designated as hedges (1) 2,109 - 2,109 (1,222) - 887 Total $ 2,850 $ - $ 2,850 $ (1,963) $ - $ 887 At December 31, 2017 Gross Gross Gross amounts not offset amounts of amounts Financial Net (in thousands) recognized liabilities offset Net amounts Instruments Collateral Amount Derivatives designated as hedges (2) $ (7,365) $ - $ (7,365) $ 741 $ 6,624 $ - Derivatives not designated as hedges (2) (2,220) - (2,220) 1,222 968 (30) Securities sold under agreements to repurchase (3) (52,959) - (52,959) - 52,959 - Total $ (62,544) $ - $ (62,544) $ 1,963 $ 60,551 $ (30) At December 31, 2016 Gross Gross Gross amounts not offset amounts of amounts Financial Net (in thousands) recognized assets offset Net amounts Instruments Collateral Amount Derivatives designated as hedges (1) $ 476 $ - $ 476 $ (476) $ - $ - Derivatives not designated as hedges (1) 2,807 - 2,807 (967) - 1,840 Total $ 3,283 $ - $ 3,283 $ (1,443) $ - $ 1,840 At December 31, 2016 Gross Gross Gross amounts not offset amounts of amounts Financial Net (in thousands) recognized liabilities offset Net amounts Instruments Collateral Amount Derivatives designated as hedges (2) $ (8,484) $ - $ (8,484) $ 476 $ 8,008 $ - Derivatives not designated as hedges (2) (2,741) - (2,741) 967 1,668 (106) Securities sold under agreements to repurchase (3) (27,639) - (27,639) - 27,639 - Total $ (38,864) $ - $ (38,864) $ 1,443 $ 37,315 $ (106) (1) Included in other assets (2) Included in accrued interest and other liabilities (3) Separately stated in consolidated balance sheets
Schedule Of Notional Amounts Of Outstanding Derivative Positions	(in thousands) Notional Fixed-rate Termination date Hedged item - Junior subordinated debentures issued by: CoBiz Statutory Trust I $ 20,000 4.99 % March 17, 2022 CoBiz Capital Trust II $ 30,000 5.99 % April 23, 2020 CoBiz Capital Trust III $ 20,000 5.02 % March 30, 2024

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2017
Income Taxes
Schedule Of Components Of Income Tax Expense (Benefit)	For the year ended December 31, (in thousands) 2017 2016 2015 Current tax provision: Federal tax $ 11,332 $ 6,823 $ 11,346 State tax 1,928 1,374 668 Total current tax provision 13,260 8,197 12,014 Deferred tax provision (benefit): Federal tax 82 3,532 (2,793) State tax (14) 453 (248) Net deferred tax asset remeasurement 7,150 - - Net operating loss carryforward - - 633 Total deferred tax provision (benefit) 7,218 3,985 (2,408) Provision for income taxes $ 20,478 $ 12,182 $ 9,606 Benefit related to discontinued operations $ - $ - $ (42)
Schedule Of Deferred Tax Assets And Liabilities	At December 31, (in thousands) 2017 2016 Deferred tax assets: Allowance for loan and credit losses $ 9,342 $ 12,625 Intangible assets 858 1,403 Other real estate owned 2,120 3,276 Deferred loan fees 201 185 Other accrued liabilities 1,206 1,709 Stock-based compensation 582 971 Interest on nonaccrual loans 97 216 Employee bonus 526 2,271 Investment securities and derivatives 54 - Other 268 710 Total deferred tax assets $ 15,254 $ 23,366 Deferred tax liabilities: Deferred initial direct loan costs $ (1,061) $ (1,602) Property, plant and equipment (651) (1,106) Prepaid assets (363) (356) FHLB stock dividends (65) (53) Investment securities and derivatives - (348) Total deferred tax liabilities $ (2,140) $ (3,465) Net deferred tax assets $ 13,114 $ 19,901
Schedule Of Effective Income Tax Rate Reconciliation	For the year ended December 31, (in thousands) 2017 2016 2015 Statutory rate 35.00 % 35.00 % 35.00 % Increase (decrease) resulting from: State income taxes - net of federal income tax effect 2.37 % 2.64 % 2.57 % Tax exempt income (12.08) % (11.69) % (11.55) % Nondeductible compensation 0.20 % 0.19 % 0.25 % Meals and entertainment 0.38 % 0.42 % 0.64 % Share-based compensation (1.14) % (0.62) % - % Other - net 0.24 % (0.06) % (0.03) % Net deferred tax asset remeasurement 13.39 % - % - % Effective income tax rate 38.36 % 25.88 % 26.88 %
Summary Of Income Tax Examinations	Jurisdiction Tax year United States Colorado Arizona

Shareholders' Equity (Tables)

Shareholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2017
Shareholders' Equity
Schedule Of Stock Reserved For Future Issuance	At December 31, 2017 2016 Exercise of outstanding stock options 199,946 285,999 Exercise of outstanding stock warrants - 895,968 Future granting of option and stock awards 2,311,829 2,421,120 Future stock purchases through ESPP 167,099 197,066 2,678,874 3,800,153

Accumulated Other Comprehensi44

Accumulated Other Comprehensive Income (Loss) Reclassifications (Tables)	12 Months Ended
	Dec. 31, 2017
Accumulated Other Comprehensive Income (Loss) Reclassifications
Schedule of reclassifications out of accumulated comprehensive income	Year ended December 31, AOCI component (in thousands) 2017 2016 2015 Affected line item in the consolidated statements of income Available for sale securities: Realized gain $ 249 $ 94 $ 318 Net (gain) loss on securities, other assets and OREO Taxes (94) (36) (121) Provision for income taxes Subtotal 155 58 197 Held to maturity securities: Amortization of net unrealized gain on HTM securities 1,658 1,831 1,904 Interest on taxable / nontaxable securities Taxes (629) (696) (724) Provision for income taxes Subtotal 1,029 1,135 1,180 Cash flow hedges: Loans 668 630 927 Interest and fees on loans Debt (1,319) (1,690) (2,009) Interest on subordinated debentures and notes payable Realized loss (651) (1,060) (1,082) Taxes 246 404 411 Provision for income taxes Subtotal (405) (656) (671) Total reclassifications for the period $ 779 $ 537 $ 706
Schedule of beginning and ending balances of AOCI and changes during the period	Accumulated other comprehensive income (in thousands) Available for sale securities Held to maturity securities Cash flow hedges Total Balance at December 31, 2014 $ 7,168 $ - $ (2,840) $ 4,328 Other comprehensive income (loss) items 222 - (561) (339) Reclassifications (197) (1,180) 671 (706) Transfers (5,469) 5,469 - - Other comprehensive income (loss), net of tax (5,444) 4,289 110 (1,045) Balance at December 31, 2015 1,724 4,289 (2,730) 3,283 Other comprehensive loss items (8) - (2,172) (2,180) Reclassifications (58) (1,135) 656 (537) Other comprehensive loss, net of tax (66) (1,135) (1,516) (2,717) Balance at December 31, 2016 1,658 3,154 (4,246) 566 Other comprehensive income (loss) items 197 - (125) 72 Reclassifications (155) (1,029) 405 (779) Other comprehensive income (loss), net of tax 42 (1,029) 280 (707) Balance at December 31, 2017 $ 1,700 $ 2,125 $ (3,966) $ (141)

Earnings per Common Share (Tabl

Earnings per Common Share (Tables)	12 Months Ended
	Dec. 31, 2017
Earnings per Common Share
Schedule Of Weighted Average Shares Outstanding Used In Calculation Of Basic And Diluted Earnings Per Share	Year ended December 31, (in thousands, except share amounts) 2017 2016 2015 Net income from continuing operations $ 32,918 $ 34,899 $ 26,140 Net loss from discontinued operations - - (71) Net income 32,918 34,899 26,069 Preferred stock dividends - - (320) Net income available to common shareholders 32,918 34,899 25,749 Dividends and undistributed earnings allocated to participating securities (326) (397) (331) Earnings allocated to common shares (1) $ 32,592 $ 34,502 $ 25,418 Weighted average common shares - issued 41,819,903 41,379,894 40,991,762 Average unvested restricted share awards (413,042) (470,414) (522,238) Weighted average common shares outstanding - basic 41,406,861 40,909,480 40,469,524 Dilutive potential common shares 340,707 215,433 255,524 Weighted average common shares outstanding - diluted 41,747,568 41,124,913 40,725,048 Weighted average antidilutive securities outstanding (2) 22,794 125,022 154,714 Earnings per common share: Basic - continuing $ 0.79 $ 0.84 $ 0.63 Diluted - continuing $ 0.78 $ 0.84 $ 0.62 Basic - discontinued $ - $ - $ - Diluted - discontinued $ - $ - $ - Basic $ 0.79 $ 0.84 $ 0.63 Diluted $ 0.78 $ 0.84 $ 0.62 (1) Earnings allocated to common shareholders for basic EPS under the two-class method may differ from earnings allocated for diluted EPS when use of the treasury method results in greater dilution than the two-class method. (2) Antidilutive stock options and restricted share awards excluded from the diluted earnings per share computation.

Employee Benefit and Stock Co46

Employee Benefit and Stock Compensation Plans (Tables)	12 Months Ended
	Dec. 31, 2017
Employee Benefit and Stock Compensation Plans
Schedule Of Stock Option Valuation Assumptions	2017 2016 2015 Range Range Range Weighted Weighted Weighted average Low High average Low High average Low High Risk-free interest rate 1.83 % 1.60 % 2.18 % 1.38 % 0.87 % 1.99 % 1.38 % 0.99 % 1.84 % Expected dividend yield 1.19 % 1.08 % 1.28 % 1.47 % 1.27 % 1.66 % 1.36 % 1.25 % 1.41 % Expected volatility 26.08 % 25.80 % 27.03 % 28.61 % 25.92 % 34.27 % 33.15 % 25.90 % 37.65 % Expected life (years) 4.8 3.9 4.0
Summary Of Changes In Option Awards	2017 Weighted average Stock Option Awards Shares exercise price Outstanding - beginning of year 285,999 $ 10.45 Granted 45,333 17.57 Exercised (109,136) 9.93 Forfeited (22,250) 12.28 Outstanding - end of year 199,946 $ 12.14 Exercisable - end of year 108,702 $ 10.16
Schedule Of Stock Options Outstanding By Exercise Price Range	Options outstanding Options exercisable Weighted Weighted Weighted average average average Number exercise remaining Number exercise Range of exercise price outstanding price life (years) exercisable price $6.00 - $9.56 46,200 $ 46,200 $ $9.87 - $11.34 48,000 35,001 $11.45 - $12.59 40,667 9,584 $12.70 - $16.89 43,746 17,917 $17.20 - $21.14 21,333 - - 199,946 $ 108,702 $
Summary Of Changes In Restricted Stock Awards	2017 Weighted average grant date Restricted Stock Awards Shares fair value Unvested - beginning of year 467,203 $ 11.50 Granted 207,841 17.14 Vested (253,530) 11.93 Forfeited (50,999) 13.77 Unvested - end of year 370,515 $ 13.98
Schedule Of Employee Stock Purchase Plan Activity	For the year ended December 31, 2017 2016 2015 Available ESPP shares - beginning of year 197,066 233,879 273,188 Purchases (29,967) (36,813) (39,309) Available ESPP shares - end of year 167,099 197,066 233,879

Commitments and Contingencies (

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2017
Commitments and Contingencies
Schedule Of Lease Commitments	Year ending December 31, (in thousands) Amount 2018 $ 5,493 2019 4,476 2020 3,756 2021 2,375 2022 2,343 Thereafter 11,998 Total $ 30,441
Schedule Of Financial Instruments With Off-Balance Sheet Risk	At December 31, (in thousands) 2017 2016 Commitments to originate commercial or real estate construction loans and unused lines of credit granted to customers $ 975,903 $ 887,627 Commitments to originate consumer loans — personal lines of credit and equity lines $ 40,682 $ 41,376 Overdraft protection plans $ 21,188 $ 22,919 Letters of credit $ 30,032 $ 26,631 Unfunded commitments for unconsolidated investments $ 5,916 $ 6,664 Company guarantees $ 4,249 $ 3,127

Regulatory Matters (Tables)

Regulatory Matters (Tables)	12 Months Ended
	Dec. 31, 2017
Regulatory Matters
Schedule Of Regulatory Capital Ratios Of The Company And The Bank	At December 31, 2017 At December 31, 2016 Capitalized ratio Ratios Ratios Minimum ratio plus (in thousands) Bank Company Bank Company Well(1) fully phased-in CCB Common equity tier 1 capital 12.2 % 9.9 % 11.9 % 9.8 % 6.5 % 7.0 % Tier 1 capital 12.2 % 11.8 % 11.9 % 11.6 % 8.0 % 8.5 % Total capital 13.2 % 14.6 % 12.9 % 14.5 % 10.0 % 10.5 % Tier 1 leverage 10.5 % 10.1 % 10.4 % 10.2 % 5.0 % 4.0 % (1) The ratios for the well-capitalized requirement are only applicable to the Bank. However, the Company manages its capital position as if the requirement applies to the consolidated entity and has presented the ratios as if they also applied to the Company.

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
	Dec. 31, 2017
Fair Value Measurements
Financial Assets And Liabilities Measured At Fair Value On Recurring Basis	Fair value measurements using: Quoted prices in Significant other Significant active markets for observable unobservable Balance at identical assets inputs inputs (in thousands) December 31, 2017 (Level 1) (Level 2) (Level 3) Assets Available for sale securities: Trust preferred securities $ 21,983 $ 363 $ 12,521 $ 9,099 Corporate debt securities 141,495 - 141,495 - Municipal securities 3,275 - 3,275 - Total available for sale securities $ 166,753 $ 363 $ 157,291 $ 9,099 Derivatives: Cash flow hedge $ 113 $ - $ 113 $ - Fair value hedge 628 - 628 - Non-designated hedges 2,081 - 2,081 - Foreign exchange forward contracts 28 - 28 - Total derivative assets $ 2,850 $ - $ 2,850 $ - Liabilities Derivatives: Cash flow hedge $ 6,732 $ - $ 6,732 $ - Fair value hedge 633 - 633 - Non-designated hedges 2,176 - 2,176 - Foreign exchange forward contracts 44 - 44 - Total derivative liabilities $ 9,585 $ - $ 9,585 $ - Fair value measurements using: Quoted prices in Significant other Significant active markets for observable unobservable Balance at identical assets inputs inputs (in thousands) December 31, 2016 (Level 1) (Level 2) (Level 3) Assets Available for sale securities: Trust preferred securities $ 37,624 $ 4,283 $ 23,893 $ 9,448 Corporate debt securities 92,077 - 92,077 - Municipal securities 3,280 - 3,280 - Total available for sale securities $ 132,981 $ 4,283 $ 119,250 $ 9,448 Derivatives: Fair value hedge $ 476 $ - $ 476 $ - Non-designated hedges 2,755 - 2,755 - Foreign exchange forward contracts 52 - 52 - Total derivative assets $ 3,283 $ - $ 3,283 $ - Liabilities Derivatives: Cash flow hedge $ 7,639 $ - $ 7,639 $ - Fair value hedge 845 - 845 - Non-designated hedges 2,736 - 2,736 - Foreign exchange forward contracts 5 - 5 - Total derivative liabilities $ 11,225 $ - $ 11,225 $ -
Reconciliation Of Financial Assets Measured At Fair Value On Recurring Basis Using Significant Unobservable Inputs	For the year ended December 31, (in thousands) 2017 2016 Beginning balance $ 9,448 $ 5,810 Transfers and purchases - 3,276 Net accretion 117 89 Sales / calls / maturities (1,000) - Unrealized gain included in comprehensive income 534 273 Ending balance $ 9,099 $ 9,448
Schedule Of Assets Measured At Fair Value On A Nonrecurring Basis	Fair value measurements using: Quoted prices in Significant other Significant active markets for observable unobservable identical assets inputs inputs (in thousands) Total (Level 1) (Level 2) (Level 3) At December 31, 2017 Impaired loans $ 3,792 $ - $ - $ 3,792 OREO $ 5,351 $ - $ - $ 5,351 At December 31, 2016 Impaired loans $ 1,425 $ - $ - $ 1,425 OREO $ 5,351 $ - $ - $ 5,351
Schedule of Gains And Losses Recorded In Relation To Assets And Liabilities Measured On Nonrecurring Basis	Gain (loss) for the year ended December 31, (in thousands) 2017 2016 2015 Impaired loans $ 398 $ 2,831 $ (5,980) OREO - - 69
Reconciliation Of Other Real Estate Owned Fair Value Measurement	At December 31, (in thousands) 2017 2016 OREO recorded at fair value $ 5,351 $ 5,351 Estimated selling costs (272) (272) OREO $ 5,079 $ 5,079
Fair Value Measurements, Recurring And Nonrecurring, Valuation Techniques	At December 31, 2017 Fair Value Weighted Category (in thousands) Valuation Technique Unobservable Input Average Range Trust preferred securities $ 9,099 Market approach Discount to carrying value using broker quotes or observable prices on similar securities 7% 5% - 15% Impaired loans: Commercial $ 2,581 Sales comparison (1) Management discount for asset type 59% 0% - 98% Real estate - mortgage 57 Sales comparison (2) Sales comparison adjustments (4)% NA Consumer 1,154 Sales comparison (2) Sales comparison adjustments (11)% (7)% - (20)% Total impaired loans $ 3,792 OREO: Commercial $ 190 Property appraisals (2) Management discount for property type 0% NA Construction & land 5,161 Property appraisals (2) Management discount for property type 17% NA Total OREO $ 5,351 At December 31, 2016 Fair Value Weighted Category (in thousands) Valuation Technique Unobservable Input Average Range Trust preferred securities $ 9,448 Market approach Discount to carrying value using broker quotes or observable prices on similar securities 13% 1% - 28% Impaired loans: Commercial $ 1,057 Sales comparison (1) Management discount for asset type 59% 0% - 76% Real estate - mortgage 269 Sales comparison (2) Sales comparison adjustments 18% NA Consumer 99 Sales comparison (2) Sales comparison adjustments (1)% (11)% - 10% Total impaired loans $ 1,425 OREO: Commercial $ 190 Property appraisals (2) Management discount for property type 0% NA Construction & land 5,161 Property appraisals (2) Management discount for property type 17% NA Total OREO $ 5,351 (1) Discount represents management discounts applied to market valuation of various business assets, including accounts receivable and inventory. (2) The fair value of OREO and collateral-dependent impaired loans is based on third-party property appraisals. The majority of the appraisals utilize at least two valuation approaches or a combination of approaches including a market approach, where prices and other relevant information generated by market transactions involving similar or comparable properties are used to determine fair value. Appraisals may include an ‘as is’ and ‘upon completion’ valuation scenarios. Adjustments are routinely made in the appraisal process by third-party appraisers to adjust for differences between the comparable sales and income data. Adjustments also result from the consideration of relevant economic and demographic factors with the potential to affect property values. Also, prospective values are based on the market conditions which exist at the date of inspection combined with informed forecasts based on current trends in supply and demand for the property types under appraisal. Positive adjustments disclosed in this table represent increases to the sales comparison and negative adjustment represent decreases.
Schedule Of Estimated Fair Value Of Financial Instruments	December 31, 2017 December 31, 2016 Carrying Estimated Carrying Estimated (in thousands) value fair value value fair value Financial assets: Cash and cash equivalents $ 80,180 $ 80,180 $ 96,050 $ 96,050 Investment securities available for sale 166,753 166,753 132,981 132,981 Investment securities held to maturity 362,544 360,071 366,041 363,178 Other investments 2,174 2,174 2,173 2,173 Loans — net 3,107,622 3,080,935 2,900,812 2,868,091 Accrued interest receivable 14,150 14,150 12,223 12,223 Derivatives 2,850 2,850 3,283 3,283 Financial liabilities: Deposits $ 3,225,220 $ 3,224,417 $ 3,029,783 $ 3,029,226 Securities sold under agreements to repurchase 52,959 49,436 27,639 26,101 Short-term borrowings 77,640 77,640 106,230 106,230 Accrued interest payable 1,077 1,077 1,038 1,038 Subordinated notes payable 59,195 58,451 59,111 58,681 Junior subordinated debentures 72,166 72,166 72,166 72,166 Derivatives 9,585 9,585 11,225 11,225

Segments (Tables)

Segments (Tables)	12 Months Ended
	Dec. 31, 2017
Segments
Summary Of Results Of Operations By Operating Segment	For the year ended December 31, 2017 Corporate Commercial Fee-Based Support and (in thousands) Banking Lines Other Consolidated Income Statement Total interest income $ 142,845 $ 2 $ 340 $ 143,187 Total interest expense 5,265 14 7,334 12,613 Provision for loan losses 3,425 - (140) 3,285 Noninterest income 13,811 19,401 789 34,001 Noninterest expense 34,116 17,248 56,530 107,894 Management fees and allocations 32,982 1,269 (34,251) - Provision (benefit) for income taxes 41,866 1,269 (22,657) 20,478 Net income (loss) $ 39,002 $ (397) $ (5,687) $ 32,918 Depreciation and amortization $ 2,764 $ 573 $ 320 $ 3,909 Identifiable assets at December 31, 2017 $ 3,812,546 $ 8,341 $ 25,385 $ 3,846,272 For the year ended December 31, 2016 Corporate Commercial Fee-Based Support and (in thousands) Banking Lines Other Consolidated Income Statement Total interest income $ 127,403 $ 2 $ 377 $ 127,782 Total interest expense 4,427 25 7,279 11,731 Provision for loan losses (1,816) - (285) (2,101) Noninterest income 14,050 18,282 1,828 34,160 Noninterest expense 38,159 17,422 49,650 105,231 Management fees and allocations 27,912 1,673 (29,585) - Provision (benefit) for income taxes 32,606 372 (20,796) 12,182 Net income (loss) from continuing operations 40,165 (1,208) (4,058) 34,899 Loss from discontinued operations, net of tax - - - - Net income (loss) $ 40,165 $ (1,208) $ (4,058) $ 34,899 Depreciation and amortization $ 2,613 $ 807 $ 112 $ 3,532 Identifiable assets at December 31, 2016 $ 3,593,528 $ 11,053 $ 25,732 $ 3,630,313 For the year ended December 31, 2015 Corporate Commercial Fee-Based Support and (in thousands) Banking Lines Other Consolidated Income Statement Total interest income $ 119,896 $ 2 $ 1,368 $ 121,266 Total interest expense 3,947 44 5,599 9,590 Provision for loan losses 6,837 - (417) 6,420 Noninterest income 11,427 17,879 1,361 30,667 Noninterest expense 37,849 16,331 45,997 100,177 Management fees and allocations 25,225 1,334 (26,559) - Provision (benefit) for income taxes 27,679 643 (18,716) 9,606 Net income (loss) from continuing operations 29,786 (471) (3,175) 26,140 Income from discontinued operations, net of tax - (71) - (71) Net income (loss) $ 29,786 $ (542) $ (3,175) $ 26,069 Depreciation and amortization $ 2,430 $ 792 $ 33 $ 3,255 Identifiable assets at December 31, 2015 $ 3,317,977 $ 10,554 $ 23,236 $ 3,351,767

Condensed Financial Statement51

Condensed Financial Statements Of Parent Company (Tables)	12 Months Ended
	Dec. 31, 2017
Condensed Financial Statements Of Parent Company
Condensed Balance Sheets	Condensed Balance Sheets At December 31, (in thousands) 2017 2016 Assets: Cash on deposit at subsidiary bank $ 17,639 $ 16,588 Investment in bank subsidiary 406,474 377,104 Investment in non-bank subsidiaries 21,830 25,792 Accounts receivable from bank subsidiary 7,238 7,916 Accounts receivable from non-bank subsidiaries 443 1,398 Other 14,540 17,350 Total assets $ 468,164 $ 446,148 Liabilities and shareholders' equity: Liabilities: Accounts payable to bank subsidiary $ 2,657 $ 3,902 Accounts payable to non-bank subsidiaries 290 4,306 Subordinated notes payable 59,195 59,111 Junior subordinated debentures 72,166 72,166 Other liabilities 4,572 4,353 Total liabilities 138,880 143,838 Shareholders' equity 329,284 302,310 Total liabilities and shareholders' equity $ 468,164 $ 446,148
Condensed Statements Of Operations	Condensed Statements of Income For the years ended December 31, (in thousands) 2017 2016 2015 Income: Management fees $ 1,050 $ 3,908 $ 3,872 Dividends from bank subsidiary 10,649 8,861 8,221 Dividends from non-bank subsidiaries 5,054 1,070 2,962 Interest income 131 171 195 Other income 807 1,847 1,380 Total income 17,691 15,857 16,630 Expense: Salaries and employee benefits 1,471 4,147 4,518 Interest expense 7,389 7,383 5,737 Other expense 1,752 2,260 2,614 Total expense 10,612 13,790 12,869 Income before income taxes 7,079 2,067 3,761 Benefit for income taxes (2,020) (2,898) (2,751) Net income before equity in undistributed earnings of subsidiaries 9,099 4,965 6,512 Equity in undistributed earnings of subsidiaries 23,819 29,934 19,557 Net income $ 32,918 $ 34,899 $ 26,069
Condensed Statements Of Cash Flows	Condensed Statements of Cash Flows For the years ended December 31, (in thousands) 2017 2016 2015 Cash flows from operating activities: Net income $ 32,918 $ 34,899 $ 26,069 Equity in undistributed earnings of subsidiaries (23,819) (29,934) (19,557) Stock-based compensation 402 631 620 Change in other assets and liabilities (438) 2,509 (7,480) Net cash provided by (used in) operating activities 9,063 8,105 (348) Cash flows from investing activities: Net advances (to) from subsidiaries 766 (2,162) 1,095 Other (448) (2,829) (27) Net cash provided by (used in) investing activities 318 (4,991) 1,068 Cash flows from financing activities: Proceeds from issuance of common stock, net 1,581 2,118 1,733 Taxes paid in net settlement of restricted stock (1,126) (891) (1,207) Proceeds from issuance of notes payable - - 59,250 Redemption of preferred stock - - (57,366) Dividends paid on common stock (8,785) (7,858) (6,953) Dividends paid on preferred stock - - (463) Other - - (104) Net cash used in financing activities (8,330) (6,631) (5,110) Net increase (decrease) in cash and cash equivalents 1,051 (3,517) (4,390) Cash and cash equivalents - beginning of year 16,588 20,105 24,495 Cash and cash equivalents - end of year $ 17,639 $ 16,588 $ 20,105

Supplemental Financial Data (Ta

Supplemental Financial Data (Tables)	12 Months Ended
	Dec. 31, 2017
Supplemental Financial Data
Schedule Of Other Income And Other Expense	Other noninterest income Year ended December 31, (in thousands) 2017 2016 2015 Loan fees $ 2,515 $ 2,853 $ 1,787 Other customer service fees 2,900 2,704 2,497 Bank-owned life insurance 1,366 1,367 1,334 Other investments 1,234 2,477 1,312 Derivative valuation (175) 281 (24) Other 136 137 20 Total $ 7,976 $ 9,819 $ 6,926 Other noninterest expense Year ended December 31, (in thousands) 2017 2016 2015 Marketing and business development $ 2,699 $ 2,879 $ 2,799 Service contracts 5,506 5,281 4,545 Professional fees 3,519 2,917 2,818 Office supplies and delivery 1,175 1,357 1,461 Other 3,839 4,189 3,905 Total $ 16,738 $ 16,623 $ 15,528

Selected Quarterly Financial 53

Selected Quarterly Financial Data (Unaudited) (Tables)	12 Months Ended
	Dec. 31, 2017
Selected Quarterly Financial Data
Schedule Of Quarterly Financial Information	2017 2016 (in thousands) Q4(1) Q3 Q2 Q1 Q4 Q3(2) Q2 Q1 Interest income $ 37,753 $ 36,947 $ 35,406 $ 33,081 $ 32,779 $ 32,308 $ 31,500 $ 31,195 Interest expense 3,031 3,178 3,401 3,003 2,891 2,907 2,967 2,966 Net interest income 34,722 33,769 32,005 30,078 29,888 29,401 28,533 28,229 Income before income taxes 14,411 15,312 12,988 10,685 11,825 13,812 11,729 9,715 Net income $ 3,622 $ 11,193 $ 9,489 $ 8,614 $ 8,733 $ 10,269 $ 8,532 $ 7,365 Basic earnings per share(3) $ 0.09 $ 0.27 $ 0.23 $ 0.21 $ 0.21 $ 0.25 $ 0.21 $ 0.18 Diluted earnings per share(3) $ 0.09 $ 0.27 $ 0.23 $ 0.20 $ 0.21 $ 0.25 $ 0.21 $ 0.18 (1) Net income for the fourth quarter of 2017 was reduced due to a $7.2 million increase to income tax expense as a result of the TCJA. (2) Net income for the third quarter of 2016 benefited from noninterest income of $1.4 million on other investments and a $1.2 million provision for loan loss reversal. (3) Due to rounding, the sum of the quarterly earnings per share amounts may not equal earnings per share for the year as disclosed elsewhere in this report.

Nature of Operations and Sign54

Nature of Operations and Significant Accounting Policies - Organization (Details)	12 Months Ended
	Dec. 31, 2017location
Denver, Colorado
Organization
Number of branches	7
Boulder, Colorado
Organization
Number of branches	1
Vail, Colorado
Organization
Number of branches	1
Colorado Springs, Colorado
Organization
Number of branches	1
Fort Collins, Colorado
Organization
Number of branches	1
Phoenix, Arizona
Organization
Number of branches	4

Nature of Operations and Sign55

Nature of Operations and Significant Accounting Policies - Cash and Cash Equivalents to Impaired Loans (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Supplemental disclosure of certain cash and cash equivalents
Interest	$ 12,574	$ 11,826	$ 9,256
Income taxes, net	14,742	8,950	9,919
Loans transferred to held for sale	1,726	60	1,628
Conversion or exchange of AFS securities	18,023
Trade date accounting for investment securities		1,553	795
Available for sale securities transferred to held to maturity			$ 288,598
Lessor-paid tenant improvement allowance	358
Investments
Trading Securities	$ 0	0
Impaired loans
Impaired Loans, Threshold for payment shortfall to be considered for impairment, percentage of contractual payment	10.00%
Cash and Cash Equivalents
Supplemental disclosure of certain cash and cash equivalents
Regulatory reserve requirement, balance	$ 17,100	$ 24,300
Tarp Warrant
Warrant
Warrant term (in years)	10 years
Number of shares issuable under warrant terms	895,968
Exercise price per share	$ 10.79

Nature Of Operations and Sign56

Nature Of Operations and Significant Accounting Policies - Intangible Assets to Other Assets (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Minimum
Intangible Assets
Finite-lived intangible asset, useful life	10 years
Premises and Equipment
Useful life	3 years
Maximum
Intangible Assets
Finite-lived intangible asset, useful life	15 years
Premises and Equipment
Useful life	10 years
The Funds
Other Assets
Income from the Funds	$ 1.2	$ 2.5	$ 1.3
The Funds | Minimum
Other Assets
Ownership percentage (as a percent)	20.00%
The Funds | Maximum
Other Assets
Ownership percentage (as a percent)	50.00%

Nature Of Operations and Sign57

Nature Of Operations and Significant Accounting Policies - Repossessed Assets and Recent Accounting Pronouncements (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Repossessed Assets
Repossessed assets		$ 0	$ 0
Recent Accounting Pronouncements
Casualty brokerage income, employee benefit brokerage income and investment advisory income		$ 26,000,000
Accounting Standards Update 2016-02 | Forecast
Recent Accounting Pronouncements
Future operating lease obligations	$ 30,400,000

Discontinued Operations - Narra

Discontinued Operations - Narrative (Details) $ in Millions	Mar. 31, 2015USD ($)
Discontinued Operations, Disposed of by Means Other than Sale [Member] | GMB
Discontinued Operations
Carrying value of discontinued operations	$ 0.8

Discontinued Operations - Sched

Discontinued Operations - Schedule Of Discontinued Operations (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2015USD ($)
Discontinued Operations
Noninterest income	$ 623
Noninterest expense	736
Loss before income taxes	(113)
Benefit for income taxes	(42)
Net loss from discontinued operations	$ (71)

Investments - Reconciliation fr

Investments - Reconciliation from Amortized Cost to Fair Value of Investment Securities (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Available for sale securities (AFS):
Amortized cost	$ 164,012	$ 130,308
Gross unrealized gains	3,064	3,245
Gross unrealized losses	323	572
Fair value	166,753	132,981
Held to maturity securities (HTM):
Amortized cost	362,544	366,041
Gross unrealized gains	974	718
Gross unrealized losses	3,447	3,581
Fair value	360,071	363,178
Mortgage-backed securities
Held to maturity securities (HTM):
Amortized cost	318,128	319,978
Gross unrealized gains	118	186
Gross unrealized losses	3,262	2,531
Fair value	314,984	317,633
Trust preferred securities
Available for sale securities (AFS):
Amortized cost	20,318	36,450
Gross unrealized gains	1,870	1,707
Gross unrealized losses	205	533
Fair value	21,983	37,624
Held to maturity securities (HTM):
Amortized cost	10,721	10,620
Gross unrealized gains	783	522
Gross unrealized losses	18	267
Fair value	11,486	10,875
Corporate debt securities
Available for sale securities (AFS):
Amortized cost	140,445	90,593
Gross unrealized gains	1,153	1,505
Gross unrealized losses	103	21
Fair value	141,495	92,077
Municipal securities
Available for sale securities (AFS):
Amortized cost	3,249	3,265
Gross unrealized gains	41	33
Gross unrealized losses	15	18
Fair value	3,275	3,280
Held to maturity securities (HTM):
Amortized cost	33,695	35,443
Gross unrealized gains	73	10
Gross unrealized losses	167	783
Fair value	$ 33,601	$ 34,670

Investments - Transfers (Detail

Investments - Transfers (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2017	Dec. 31, 2016
Investment securities
AFS securities transferred to held-to-maturity, fair value		$ 0	$ 0
Unrealized holding gains at time of transfer retained in AOCI		(141)	566
Unrealized (gain) loss on securities
Investment securities
Unrealized holding gains at time of transfer retained in AOCI		3,400	$ 5,100
MBS and municipal securities
Investment securities
AFS securities transferred to held-to-maturity, book value	$ 279,800
AFS securities transferred to held-to-maturity, fair value	$ 288,600
Held to maturity securities
Investment securities
Unrealized holding gains at time of transfer retained in AOCI		$ 8,800

Investments - Schedule of Proce

Investments - Schedule of Proceeds and Gains (Losses) from Securities Sold or Called (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Investments
Gains	$ 254	$ 100	$ 343
Losses	$ (5)	$ (6)	$ (25)

Investments - Schedule of Amort

Investments - Schedule of Amortized Cost and Estimated Fair Value of Investment Securities by Contractual Maturities (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Available-for-sale, Amortized cost
Available for sale securities, Amortized cost, Due in one year or less	$ 8,385
Available for sale securities, Amortized cost, Due after one year through five years	99,998
Available for sale securities, Amortized cost, Due after five years through ten years	29,446
Available for sale securities, Amortized cost, Due after ten years	26,183
Available for sale securities, Amortized cost, Amortized cost	164,012
Available-for-sale, Fair value
Available for sale securities, Estimated fair value, Due in one year or less	8,390
Available for sale securities, Estimated fair value, Due after one year through five years	100,948
Available for sale securities, Estimated fair value, Due after five years through ten years	29,975
Available for sale securities, Estimated fair value, Due after ten years	27,440
Fair value	166,753	$ 132,981
Held-to-maturity, Amortized cost
Held to maturity securities, Amortized cost, Due in one year or less	1,718
Held to maturity securities, Amortized cost, Due after one year through five years	23,578
Held to maturity securities, Amortized cost, Due after ten years	19,120
Held to maturity securities, Amortized cost, Mortgage-backed securities	318,128
Held-to-maturity Securities, Total	362,544	366,041
Held-to-maturity, Fair value
Held to maturity securities, Estimated fair value, Due in one year or less	1,712
Held to maturity securities, Estimated fair value, Due after one year through five years	23,572
Held to maturity securities, Estimated fair value, Due after ten years	19,803
Held to maturity securities, Estimated fair value, Mortgage-backed securities	314,984
Fair value	$ 360,071	$ 363,178

Investments - Narrative (Detail

Investments - Narrative (Details) - USD ($) $ in Millions	Dec. 31, 2017	Dec. 31, 2016
Investments
Investment securities pledged to secure public and governmental deposits	$ 164.4	$ 143.6
Public and governmental deposits	$ 116.5	$ 95.8

Investments - Schedule of Secur

Investments - Schedule of Securities Related to Unrecognized OTTI (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2017USD ($)security	Dec. 31, 2016USD ($)security	Dec. 31, 2015USD ($)
Securities in Continuous Unrealized Loss Positions
Securities in unrealized loss position | security	181	165
Available for sale securities in continuous unrealized loss position, Fair Value, Less than 12 months	$ 42,020	$ 30,675
Available for sale securities in continuous unrealized loss position, Fair Value, 12 months or greater	8,236	995
Available for sale securities in continuous unrealized loss position, Fair Value	50,256	31,670
Available for sale securities in continuous unrealized loss position, Unrealized loss, Less than 12 months	152	565
Available for sale securities in continuous unrealized loss position, Unrealized loss, 12 months or greater	171	7
Available for sale securities in continuous unrealized loss position, Unrealized loss	323	572
HTM securities in continuous unrealized loss position, Fair Value, Less than 12 months	203,419	251,986
HTM securities in continuous unrealized loss position, Fair value, 12 months or greater	106,012	53,032
HTM securities in continuous unrealized loss position, Fair Value, Total	309,431	305,018
HTM securities in continuous unrealized loss position, Unrealized loss, Less than 12 months	1,620	2,984
HTM securities in continuous unrealized loss position, Unrealized loss, 12 months or greater	1,827	597
HTM securities in continuous unrealized loss position, Unrealized loss, Total	3,447	3,581
Mortgage-backed securities
Securities in Continuous Unrealized Loss Positions
HTM securities in continuous unrealized loss position, Fair Value, Less than 12 months	182,974	217,604
HTM securities in continuous unrealized loss position, Fair value, 12 months or greater	104,464	52,332
HTM securities in continuous unrealized loss position, Fair Value, Total	287,438	269,936
HTM securities in continuous unrealized loss position, Unrealized loss, Less than 12 months	1,457	2,107
HTM securities in continuous unrealized loss position, Unrealized loss, 12 months or greater	1,805	424
HTM securities in continuous unrealized loss position, Unrealized loss, Total	3,262	2,531
Trust preferred securities
Securities in Continuous Unrealized Loss Positions
Available for sale securities in continuous unrealized loss position, Fair Value, Less than 12 months	700	14,979
Available for sale securities in continuous unrealized loss position, Fair Value, 12 months or greater	7,020	995
Available for sale securities in continuous unrealized loss position, Fair Value	7,720	15,974
Available for sale securities in continuous unrealized loss position, Unrealized loss, Less than 12 months	43	526
Available for sale securities in continuous unrealized loss position, Unrealized loss, 12 months or greater	162	7
Available for sale securities in continuous unrealized loss position, Unrealized loss	205	533
HTM securities in continuous unrealized loss position, Fair Value, Less than 12 months		4,175
HTM securities in continuous unrealized loss position, Fair value, 12 months or greater	864	700
HTM securities in continuous unrealized loss position, Fair Value, Total	864	4,875
HTM securities in continuous unrealized loss position, Unrealized loss, Less than 12 months		94
HTM securities in continuous unrealized loss position, Unrealized loss, 12 months or greater	18	173
HTM securities in continuous unrealized loss position, Unrealized loss, Total	18	267
Corporate debt securities
Securities in Continuous Unrealized Loss Positions
Available for sale securities in continuous unrealized loss position, Fair Value, Less than 12 months	40,068	14,482
Available for sale securities in continuous unrealized loss position, Fair Value, 12 months or greater	1,216
Available for sale securities in continuous unrealized loss position, Fair Value	41,284	14,482
Available for sale securities in continuous unrealized loss position, Unrealized loss, Less than 12 months	94	21
Available for sale securities in continuous unrealized loss position, Unrealized loss, 12 months or greater	9
Available for sale securities in continuous unrealized loss position, Unrealized loss	103	21
Municipal securities
Securities in Continuous Unrealized Loss Positions
Available for sale securities in continuous unrealized loss position, Fair Value, Less than 12 months	1,252	1,214
Available for sale securities in continuous unrealized loss position, Fair Value	1,252	1,214
Available for sale securities in continuous unrealized loss position, Unrealized loss, Less than 12 months	15	18
Available for sale securities in continuous unrealized loss position, Unrealized loss	15	18
HTM securities in continuous unrealized loss position, Fair Value, Less than 12 months	20,445	30,207
HTM securities in continuous unrealized loss position, Fair value, 12 months or greater	684
HTM securities in continuous unrealized loss position, Fair Value, Total	21,129	30,207
HTM securities in continuous unrealized loss position, Unrealized loss, Less than 12 months	163	783
HTM securities in continuous unrealized loss position, Unrealized loss, 12 months or greater	4
HTM securities in continuous unrealized loss position, Unrealized loss, Total	167	783
Debt securities
Securities in Continuous Unrealized Loss Positions
Credit component of OTTI recognized in earnings	$ 0	$ 0	$ 0

Investments - Schedule of Other

Investments - Schedule of Other Investments (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Investments
Bank stocks - at cost	$ 7,945	$ 9,192
Investment in statutory trusts - equity method	2,174	2,173
Total	$ 10,119	$ 11,365

Loans - Schedule of Loan Portfo

Loans - Schedule of Loan Portfolio Segments (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Loan portfolio segments
Loans held for investment	$ 3,147,877	$ 2,934,898
Allowance for loan losses	(37,941)	(33,293)	$ (40,686)	$ (32,765)
Unearned net loan fees	(2,314)	(793)
Total net loans	3,107,622	2,900,812
Commercial
Loan portfolio segments
Loans held for investment	1,250,356	1,217,001
Allowance for loan losses	(16,837)	(15,398)	(24,215)	(14,614)
Real estate - mortgage
Loan portfolio segments
Loans held for investment	1,250,423	1,171,596
Allowance for loan losses	(12,690)	(11,475)	(10,372)	(12,463)
Construction and land
Loan portfolio segments
Loans held for investment	266,081	175,738
Allowance for loan losses	(4,034)	(1,997)	(2,111)	(2,316)
Consumer
Loan portfolio segments
Loans held for investment	282,101	266,947
Allowance for loan losses	(2,617)	(2,803)	(2,592)	(2,329)
Other
Loan portfolio segments
Loans held for investment	98,916	103,616
Allowance for loan losses	$ (826)	$ (945)	$ (643)	$ (488)

Loans - Acquired loans and recl

Loans - Acquired loans and reclassifications (Details) - USD ($) $ in Millions	Dec. 31, 2017	Dec. 31, 2016
Loans
Overdraft demand deposits reclassified from deposits to loans	$ 0.2	$ 0.6

Loans - Schedule of Major Portf

Loans - Schedule of Major Portfolio Segment and Non-Classified and Classified Loan Class (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Loan portfolio segments
Loans held for investment	$ 3,147,877	$ 2,934,898
Unearned net loan fees	(2,314)	(793)
Total loans	3,145,563	2,934,105
Non-classified
Loan portfolio segments
Loans held for investment	3,073,203	2,876,993
Classified
Loan portfolio segments
Loans held for investment	74,674	57,905
Commercial
Loan portfolio segments
Loans held for investment	1,250,356	1,217,001
Commercial | Non-classified
Loan portfolio segments
Loans held for investment	1,184,118	1,172,779
Commercial | Classified
Loan portfolio segments
Loans held for investment	66,238	44,222
Commercial | Manufacturing
Loan portfolio segments
Loans held for investment	85,187	96,618
Commercial | Manufacturing | Non-classified
Loan portfolio segments
Loans held for investment	82,275	96,465
Commercial | Manufacturing | Classified
Loan portfolio segments
Loans held for investment	2,912	153
Commercial | Finance and insurance
Loan portfolio segments
Loans held for investment	42,518	50,351
Commercial | Finance and insurance | Non-classified
Loan portfolio segments
Loans held for investment	40,796	49,764
Commercial | Finance and insurance | Classified
Loan portfolio segments
Loans held for investment	1,722	587
Commercial | Health care
Loan portfolio segments
Loans held for investment	163,785	154,023
Commercial | Health care | Non-classified
Loan portfolio segments
Loans held for investment	161,162	153,468
Commercial | Health care | Classified
Loan portfolio segments
Loans held for investment	2,623	555
Commercial | Real estate services
Loan portfolio segments
Loans held for investment	128,847	126,044
Commercial | Real estate services | Non-classified
Loan portfolio segments
Loans held for investment	124,861	125,531
Commercial | Real estate services | Classified
Loan portfolio segments
Loans held for investment	3,986	513
Commercial | Construction
Loan portfolio segments
Loans held for investment	67,990	58,718
Commercial | Construction | Non-classified
Loan portfolio segments
Loans held for investment	67,232	55,471
Commercial | Construction | Classified
Loan portfolio segments
Loans held for investment	758	3,247
Commercial | Wholesale and retail trade
Loan portfolio segments
Loans held for investment		255,997
Commercial | Public administration
Loan portfolio segments
Loans held for investment	240,077	255,997
Commercial | Public administration | Non-classified
Loan portfolio segments
Loans held for investment	239,230	254,861
Commercial | Public administration | Classified
Loan portfolio segments
Loans held for investment	847	1,136
Commercial | Commercial - Other
Loan portfolio segments
Loans held for investment	521,952	475,250
Commercial | Commercial - Other | Non-classified
Loan portfolio segments
Loans held for investment	468,562	437,219
Commercial | Commercial - Other | Classified
Loan portfolio segments
Loans held for investment	53,390	38,031
Real estate - mortgage
Loan portfolio segments
Loans held for investment	1,250,423	1,171,596
Real estate - mortgage | Residential and commercial owner-occupied
Loan portfolio segments
Loans held for investment	484,635	475,523
Real estate - mortgage | Residential and commercial investor
Loan portfolio segments
Loans held for investment	765,788	696,073
Real estate - mortgage | Real estate - mortgage - Other
Loan portfolio segments
Loans held for investment		1,171,596
Real estate - mortgage | Non-classified
Loan portfolio segments
Loans held for investment	1,246,271
Real estate - mortgage | Non-classified | Residential and commercial owner-occupied
Loan portfolio segments
Loans held for investment	481,061	469,027
Real estate - mortgage | Non-classified | Residential and commercial investor
Loan portfolio segments
Loans held for investment	765,210	695,170
Real estate - mortgage | Non-classified | Real estate - mortgage - Other
Loan portfolio segments
Loans held for investment		1,164,197
Real estate - mortgage | Classified
Loan portfolio segments
Loans held for investment	4,152
Real estate - mortgage | Classified | Residential and commercial owner-occupied
Loan portfolio segments
Loans held for investment	3,574	6,496
Real estate - mortgage | Classified | Residential and commercial investor
Loan portfolio segments
Loans held for investment	578	903
Real estate - mortgage | Classified | Real estate - mortgage - Other
Loan portfolio segments
Loans held for investment		7,399
Construction and land
Loan portfolio segments
Loans held for investment	266,081	175,738
Construction and land | Non-classified
Loan portfolio segments
Loans held for investment	266,081	172,816
Construction and land | Classified
Loan portfolio segments
Loans held for investment		2,922
Consumer
Loan portfolio segments
Loans held for investment	282,101	266,947
Consumer | Non-classified
Loan portfolio segments
Loans held for investment	279,191	265,307
Consumer | Classified
Loan portfolio segments
Loans held for investment	2,910	1,640
Other
Loan portfolio segments
Loans held for investment	98,916	103,616
Other | Non-classified
Loan portfolio segments
Loans held for investment	97,542	101,894
Other | Classified
Loan portfolio segments
Loans held for investment	$ 1,374	$ 1,722

Loans - Schedule of Allowance f

Loans - Schedule of Allowance for Loan Losses (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Sep. 30, 2016	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Allowance for loan losses
Allowance for loan losses, beginning of period		$ 33,293	$ 40,686	$ 32,765
Provision	$ 1,200	3,285	(2,101)	6,420
Charge-offs		(922)	(7,804)	(1,296)
Net recoveries of impaired loans		2,285	2,512	2,797
Allowance for loan losses, end of period		37,941	33,293	40,686
Commercial
Allowance for loan losses
Allowance for loan losses, beginning of period		15,398	24,215	14,614
Provision		1,237	(2,334)	9,950
Charge-offs		(823)	(7,767)	(588)
Net recoveries of impaired loans		1,025	1,284	239
Allowance for loan losses, end of period		16,837	15,398	24,215
Real estate - mortgage
Allowance for loan losses
Allowance for loan losses, beginning of period		11,475	10,372	12,463
Provision		1,029	1,072	(3,017)
Charge-offs				(186)
Net recoveries of impaired loans		186	31	1,112
Allowance for loan losses, end of period		12,690	11,475	10,372
Construction and land
Allowance for loan losses
Allowance for loan losses, beginning of period		1,997	2,111	2,316
Provision		998	(1,279)	(1,253)
Charge-offs				(107)
Net recoveries of impaired loans		1,039	1,165	1,155
Allowance for loan losses, end of period		4,034	1,997	2,111
Consumer
Allowance for loan losses
Allowance for loan losses, beginning of period		2,803	2,592	2,329
Provision		(122)	216	374
Charge-offs		(99)	(37)	(130)
Net recoveries of impaired loans		35	32	19
Allowance for loan losses, end of period		2,617	2,803	2,592
Other
Allowance for loan losses
Allowance for loan losses, beginning of period		945	643	488
Provision		(119)	302	168
Charge-offs				(285)
Net recoveries of impaired loans				272
Allowance for loan losses, end of period		826	945	643
Unallocated
Allowance for loan losses
Allowance for loan losses, beginning of period		675	753	555
Provision		262	(78)	198
Allowance for loan losses, end of period		$ 937	$ 675	$ 753

Loans - Schedule of Loans Held

Loans - Schedule of Loans Held for Investment and ALL on the basis of Impairment Method (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Allowance for loan losses
Loans held for investment, Individually evaluated for impairment	$ 60,334	$ 26,250
Allowance for loan losses, Individually evaluated for impairment	6,210	2,574
Loans held for investment, Collectively evaluated for impairment	3,085,229	2,907,855
Allowance for loan losses, Collectively evaluated for impairment	31,731	30,719
Commercial
Allowance for loan losses
Loans held for investment, Individually evaluated for impairment	56,566	20,279
Allowance for loan losses, Individually evaluated for impairment	5,862	2,220
Loans held for investment, Collectively evaluated for impairment	1,194,005	1,197,453
Allowance for loan losses, Collectively evaluated for impairment	10,975	13,178
Real estate - mortgage
Allowance for loan losses
Loans held for investment, Individually evaluated for impairment	1,331	3,758
Allowance for loan losses, Individually evaluated for impairment	109	147
Loans held for investment, Collectively evaluated for impairment	1,248,166	1,167,365
Allowance for loan losses, Collectively evaluated for impairment	12,581	11,328
Construction and land
Allowance for loan losses
Loans held for investment, Individually evaluated for impairment	1,071	1,919
Allowance for loan losses, Individually evaluated for impairment	91	109
Loans held for investment, Collectively evaluated for impairment	263,330	172,532
Allowance for loan losses, Collectively evaluated for impairment	3,943	1,888
Consumer
Allowance for loan losses
Loans held for investment, Individually evaluated for impairment	1,366	294
Allowance for loan losses, Individually evaluated for impairment	148	98
Loans held for investment, Collectively evaluated for impairment	280,783	266,719
Allowance for loan losses, Collectively evaluated for impairment	2,469	2,705
Other
Allowance for loan losses
Loans held for investment, Collectively evaluated for impairment	98,945	103,786
Allowance for loan losses, Collectively evaluated for impairment	826	945
Unallocated
Allowance for loan losses
Allowance for loan losses, Collectively evaluated for impairment	$ 937	$ 675

Loans - Schedule of Impaired Lo

Loans - Schedule of Impaired Loans (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Impaired receivables with and without related allowance
Unpaid principal balance	$ 60,905	$ 27,430
Recorded investment on impaired loans	60,334	26,250
Recorded investment with a related allowance	56,637	25,154
Recorded investment with no related allowance	3,697	1,096
Related allowance	6,210	2,574
Commercial
Impaired receivables with and without related allowance
Unpaid principal balance	57,137	21,459
Recorded investment on impaired loans	56,566	20,279
Recorded investment with a related allowance	54,080	19,551
Recorded investment with no related allowance	2,486	728
Related allowance	5,862	2,220
Real estate - mortgage
Impaired receivables with and without related allowance
Unpaid principal balance	1,331	3,758
Recorded investment on impaired loans	1,331	3,758
Recorded investment with a related allowance	1,274	3,489
Recorded investment with no related allowance	57	269
Related allowance	109	147
Construction and land
Impaired receivables with and without related allowance
Unpaid principal balance	1,071	1,919
Recorded investment on impaired loans	1,071	1,919
Recorded investment with a related allowance	1,071	1,919
Related allowance	91	109
Consumer
Impaired receivables with and without related allowance
Unpaid principal balance	1,366	294
Recorded investment on impaired loans	1,366	294
Recorded investment with a related allowance	212	195
Recorded investment with no related allowance	1,154	99
Related allowance	148	98
Manufacturing | Commercial
Impaired receivables with and without related allowance
Unpaid principal balance	3,302	2,095
Recorded investment on impaired loans	3,302	2,072
Recorded investment with a related allowance	3,302	2,071
Recorded investment with no related allowance		1
Related allowance	238	114
Finance and insurance | Commercial
Impaired receivables with and without related allowance
Unpaid principal balance	473	25
Recorded investment on impaired loans	473	25
Recorded investment with a related allowance	17	25
Recorded investment with no related allowance	456
Related allowance	17	25
Health care | Commercial
Impaired receivables with and without related allowance
Unpaid principal balance	718	189
Recorded investment on impaired loans	718	189
Recorded investment with a related allowance	459	189
Recorded investment with no related allowance	259
Related allowance	207	11
Real estate services | Commercial
Impaired receivables with and without related allowance
Unpaid principal balance	7,982	6,268
Recorded investment on impaired loans	7,982	6,268
Recorded investment with a related allowance	7,982	6,268
Related allowance	544	350
Construction | Commercial
Impaired receivables with and without related allowance
Unpaid principal balance	1,689	2,166
Recorded investment on impaired loans	1,457	2,166
Recorded investment with a related allowance	977	1,932
Recorded investment with no related allowance	480	234
Related allowance	71	149
Public administration | Commercial
Impaired receivables with and without related allowance
Unpaid principal balance	313
Recorded investment on impaired loans	313
Recorded investment with a related allowance	313
Related allowance	27
Commercial - Other | Commercial
Impaired receivables with and without related allowance
Unpaid principal balance	42,660	10,716
Recorded investment on impaired loans	42,321	9,559
Recorded investment with a related allowance	41,030	9,066
Recorded investment with no related allowance	1,291	493
Related allowance	4,758	1,571
Residential and commercial owner-occupied | Real estate - mortgage
Impaired receivables with and without related allowance
Unpaid principal balance	1,159	1,391
Recorded investment on impaired loans	1,159	1,391
Recorded investment with a related allowance	1,102	1,122
Recorded investment with no related allowance	57	269
Related allowance	94	64
Residential and commercial investor | Real estate - mortgage
Impaired receivables with and without related allowance
Unpaid principal balance	172	2,367
Recorded investment on impaired loans	172	2,367
Recorded investment with a related allowance	172	2,367
Related allowance	$ 15	$ 83

Loans - Schedule of Impaired 73

Loans - Schedule of Impaired Loans (Average Recorded Investment in Impaired Loans and Interest Income Recognized) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Impaired Loans: Average recorded investment and interest income
Average recorded investment in impaired loans	$ 39,196	$ 33,563	$ 34,290
Interest income recognized	2,164	1,619	2,393
Commercial
Impaired Loans: Average recorded investment and interest income
Average recorded investment in impaired loans	34,252	25,280	23,019
Interest income recognized	2,003	1,266	1,764
Real estate - mortgage
Impaired Loans: Average recorded investment and interest income
Average recorded investment in impaired loans	2,764	5,499	6,866
Interest income recognized	96	241	312
Construction and land
Impaired Loans: Average recorded investment and interest income
Average recorded investment in impaired loans	1,655	2,336	2,935
Interest income recognized	55	93	104
Consumer
Impaired Loans: Average recorded investment and interest income
Average recorded investment in impaired loans	489	448	1,444
Interest income recognized	5	19	202
Other
Impaired Loans: Average recorded investment and interest income
Average recorded investment in impaired loans	36		26
Interest income recognized	5		11
Manufacturing | Commercial
Impaired Loans: Average recorded investment and interest income
Average recorded investment in impaired loans	2,455	3,383	5,643
Interest income recognized	138	234	306
Finance and insurance | Commercial
Impaired Loans: Average recorded investment and interest income
Average recorded investment in impaired loans	380	30	164
Interest income recognized	16		24
Health care | Commercial
Impaired Loans: Average recorded investment and interest income
Average recorded investment in impaired loans	503	194	33
Interest income recognized	43	12	11
Real estate services | Commercial
Impaired Loans: Average recorded investment and interest income
Average recorded investment in impaired loans	6,355	6,996	8,006
Interest income recognized	262	261	283
Construction | Commercial
Impaired Loans: Average recorded investment and interest income
Average recorded investment in impaired loans	1,558	1,873	1,666
Interest income recognized	104	140	106
Public administration | Commercial
Impaired Loans: Average recorded investment and interest income
Average recorded investment in impaired loans	105
Interest income recognized	5
Commercial - Other | Commercial
Impaired Loans: Average recorded investment and interest income
Average recorded investment in impaired loans	22,896	12,804	7,507
Interest income recognized	1,435	619	1,034
Residential and commercial owner-occupied | Real estate - mortgage
Impaired Loans: Average recorded investment and interest income
Average recorded investment in impaired loans	1,217	1,777	1,762
Interest income recognized	41	114	130
Residential and commercial investor | Real estate - mortgage
Impaired Loans: Average recorded investment and interest income
Average recorded investment in impaired loans	1,547	3,722	5,104
Interest income recognized	$ 55	$ 127	$ 182

Loans - Schedule of Transaction

Loans - Schedule of Transactions Related to Troubled Debt Restructurings (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Troubled debt restructurings
Balance	$ 26,153	$ 42,033
New restructurings	41,360	11,829
Net paydowns	(10,973)	(20,118)
Charge-offs	(41)	(7,591)
Balance	56,499	26,153
Performing
Troubled debt restructurings
Balance	23,612	28,196
New restructurings	38,958	8,563
Change in accrual status	269	(912)
Net paydowns	(10,022)	(12,235)
Balance	52,817	23,612
Nonperforming
Troubled debt restructurings
Balance	2,541	13,837
New restructurings	2,402	3,266
Change in accrual status	(269)	912
Net paydowns	(951)	(7,883)
Charge-offs	(41)	(7,591)
Balance	$ 3,682	$ 2,541

Loans - Schedule of Troubled De

Loans - Schedule of Troubled Debt Restructurings (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2017USD ($)contract	Dec. 31, 2016USD ($)contract	Dec. 31, 2015USD ($)contract
Troubled debt restructurings
Number of contracts | contract	25	16	23
Pre-modification outstanding recorded investment	$ 43,108	$ 9,610	$ 23,386
Post-modification outstanding recorded investment	$ 39,693	7,313	$ 18,696
Charge-offs		$ 1,100
Commercial
Troubled debt restructurings
Number of contracts | contract	24	15	21
Pre-modification outstanding recorded investment	$ 43,025	$ 9,533	$ 22,238
Post-modification outstanding recorded investment	$ 39,621	$ 7,241	$ 17,566
Consumer
Troubled debt restructurings
Number of contracts | contract	1	1	1
Pre-modification outstanding recorded investment	$ 83	$ 77	$ 148
Post-modification outstanding recorded investment	$ 72	$ 72	$ 130
Manufacturing | Commercial
Troubled debt restructurings
Number of contracts | contract	1	1	2
Pre-modification outstanding recorded investment	$ 1,366	$ 50	$ 491
Post-modification outstanding recorded investment	$ 1,366	$ 22	$ 437
Finance and insurance | Commercial
Troubled debt restructurings
Number of contracts | contract	1
Pre-modification outstanding recorded investment	$ 456
Post-modification outstanding recorded investment	$ 456
Health care | Commercial
Troubled debt restructurings
Number of contracts | contract	3	1	1
Pre-modification outstanding recorded investment	$ 577	$ 100	$ 200
Post-modification outstanding recorded investment	$ 522	$ 100	$ 125
Real estate services | Commercial
Troubled debt restructurings
Number of contracts | contract	1
Pre-modification outstanding recorded investment	$ 3,274
Post-modification outstanding recorded investment	$ 2,899
Construction | Commercial
Troubled debt restructurings
Number of contracts | contract		4	3
Pre-modification outstanding recorded investment		$ 1,995	$ 1,738
Post-modification outstanding recorded investment		$ 1,844	$ 1,029
Public administration | Commercial
Troubled debt restructurings
Number of contracts | contract	1
Pre-modification outstanding recorded investment	$ 320
Post-modification outstanding recorded investment	$ 313
Commercial - Other | Commercial
Troubled debt restructurings
Number of contracts | contract	17	9	15
Pre-modification outstanding recorded investment	$ 37,032	$ 7,388	$ 19,809
Post-modification outstanding recorded investment	$ 34,065	$ 5,275	$ 15,975
Residential and commercial owner-occupied | Real estate - mortgage
Troubled debt restructurings
Number of contracts | contract			1
Pre-modification outstanding recorded investment			$ 1,000
Post-modification outstanding recorded investment			$ 1,000

Loans - Schedule of Troubled 76

Loans - Schedule of Troubled Debt Restructurings that Subsequently Defaulted (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Loans
Outstanding commitments on restructured loans	$ 4	$ 1.6

Loans - Schedule of Nonaccrual

Loans - Schedule of Nonaccrual Loans (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Nonaccrual loans
Total nonaccrual loans	$ 7,517	$ 2,638
Commercial
Nonaccrual loans
Total nonaccrual loans	6,185	2,202
Real estate - mortgage
Nonaccrual loans
Total nonaccrual loans	57	269
Consumer
Nonaccrual loans
Total nonaccrual loans	1,275	167
Manufacturing | Commercial
Nonaccrual loans
Total nonaccrual loans		2
Finance and insurance | Commercial
Nonaccrual loans
Total nonaccrual loans	473	25
Health care | Commercial
Nonaccrual loans
Total nonaccrual loans	718
Construction | Commercial
Nonaccrual loans
Total nonaccrual loans	681	234
Commercial - Other | Commercial
Nonaccrual loans
Total nonaccrual loans	4,313	1,941
Residential and commercial owner-occupied | Real estate - mortgage
Nonaccrual loans
Total nonaccrual loans	$ 57	$ 269

Loans - Schedule of Aging of Co

Loans - Schedule of Aging of Company's Loan Portfolio (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Nonaccrual loans
Total past due	$ 16,582	$ 5,771
Current	3,131,295	2,929,127
Total loans, excluding fees and costs	3,147,877	2,934,898
Unearned net loan fees	(2,314)	(793)
Total loans	3,145,563	2,934,105
Recorded investment in loans 90 days or more past due and accruing	348	657
30 - 59 Days past due
Nonaccrual loans
Total past due	9,511	4,365
60 - 89 Days past due
Nonaccrual loans
Total past due	2,520	649
90+ Days past due
Nonaccrual loans
Total past due	4,551	757
Commercial
Nonaccrual loans
Total past due	11,016	4,382
Current	1,239,340	1,212,619
Total loans, excluding fees and costs	1,250,356	1,217,001
Recorded investment in loans 90 days or more past due and accruing	348
Commercial | 30 - 59 Days past due
Nonaccrual loans
Total past due	6,057	4,157
Commercial | 60 - 89 Days past due
Nonaccrual loans
Total past due	1,515	200
Commercial | 90+ Days past due
Nonaccrual loans
Total past due	3,444	25
Real estate - mortgage
Nonaccrual loans
Total past due	2,289	590
Current	1,248,134	1,171,006
Total loans, excluding fees and costs	1,250,423	1,171,596
Real estate - mortgage | 30 - 59 Days past due
Nonaccrual loans
Total past due	1,301	204
Real estate - mortgage | 60 - 89 Days past due
Nonaccrual loans
Total past due	988	386
Construction and land
Nonaccrual loans
Total past due	730	657
Current	265,351	175,081
Total loans, excluding fees and costs	266,081	175,738
Recorded investment in loans 90 days or more past due and accruing		657
Construction and land | 30 - 59 Days past due
Nonaccrual loans
Total past due	730
Construction and land | 90+ Days past due
Nonaccrual loans
Total past due		657
Consumer
Nonaccrual loans
Total past due	2,545	142
Current	279,556	266,805
Total loans, excluding fees and costs	282,101	266,947
Consumer | 30 - 59 Days past due
Nonaccrual loans
Total past due	1,423	4
Consumer | 60 - 89 Days past due
Nonaccrual loans
Total past due	15	63
Consumer | 90+ Days past due
Nonaccrual loans
Total past due	1,107	75
Other
Nonaccrual loans
Total past due	2
Current	98,914	103,616
Total loans, excluding fees and costs	98,916	103,616
Other | 60 - 89 Days past due
Nonaccrual loans
Total past due	2
Manufacturing | Commercial
Nonaccrual loans
Current	85,187	96,618
Total loans, excluding fees and costs	85,187	96,618
Finance and insurance | Commercial
Nonaccrual loans
Total past due	669	481
Current	41,849	49,870
Total loans, excluding fees and costs	42,518	50,351
Recorded investment in loans 90 days or more past due and accruing	213
Finance and insurance | Commercial | 30 - 59 Days past due
Nonaccrual loans
Total past due		456
Finance and insurance | Commercial | 60 - 89 Days past due
Nonaccrual loans
Total past due	456
Finance and insurance | Commercial | 90+ Days past due
Nonaccrual loans
Total past due	213	25
Health care | Commercial
Nonaccrual loans
Total past due	483	500
Current	163,302	153,523
Total loans, excluding fees and costs	163,785	154,023
Health care | Commercial | 30 - 59 Days past due
Nonaccrual loans
Total past due	370	500
Health care | Commercial | 90+ Days past due
Nonaccrual loans
Total past due	113
Real estate services | Commercial
Nonaccrual loans
Total past due	1,638
Current	127,209	126,044
Total loans, excluding fees and costs	128,847	126,044
Recorded investment in loans 90 days or more past due and accruing	135
Real estate services | Commercial | 30 - 59 Days past due
Nonaccrual loans
Total past due	1,503
Real estate services | Commercial | 90+ Days past due
Nonaccrual loans
Total past due	135
Construction | Commercial
Nonaccrual loans
Total past due	2,002	260
Current	65,988	58,458
Total loans, excluding fees and costs	67,990	58,718
Construction | Commercial | 30 - 59 Days past due
Nonaccrual loans
Total past due	721	260
Construction | Commercial | 60 - 89 Days past due
Nonaccrual loans
Total past due	600
Construction | Commercial | 90+ Days past due
Nonaccrual loans
Total past due	681
Public administration | Commercial
Nonaccrual loans
Current	240,077
Total loans, excluding fees and costs	240,077	255,997
Wholesale and retail trade | Commercial
Nonaccrual loans
Current		255,997
Total loans, excluding fees and costs		255,997
Commercial - Other | Commercial
Nonaccrual loans
Total past due	6,224	3,141
Current	515,728	472,109
Total loans, excluding fees and costs	521,952	475,250
Commercial - Other | Commercial | 30 - 59 Days past due
Nonaccrual loans
Total past due	3,463	2,941
Commercial - Other | Commercial | 60 - 89 Days past due
Nonaccrual loans
Total past due	459	200
Commercial - Other | Commercial | 90+ Days past due
Nonaccrual loans
Total past due	2,302
Residential and commercial owner-occupied | Real estate - mortgage
Nonaccrual loans
Total past due	1,115	365
Current	483,520	475,158
Total loans, excluding fees and costs	484,635	475,523
Residential and commercial owner-occupied | Real estate - mortgage | 30 - 59 Days past due
Nonaccrual loans
Total past due	426	204
Residential and commercial owner-occupied | Real estate - mortgage | 60 - 89 Days past due
Nonaccrual loans
Total past due	689	161
Residential and commercial investor | Real estate - mortgage
Nonaccrual loans
Total past due	1,174	225
Current	764,614	695,848
Total loans, excluding fees and costs	765,788	696,073
Residential and commercial investor | Real estate - mortgage | 30 - 59 Days past due
Nonaccrual loans
Total past due	875
Residential and commercial investor | Real estate - mortgage | 60 - 89 Days past due
Nonaccrual loans
Total past due	$ 299	225
Real estate - mortgage - Other | Real estate - mortgage
Nonaccrual loans
Total loans, excluding fees and costs		$ 1,171,596

Loans - Schedule Of Loans And L

Loans - Schedule Of Loans And Leases Receivable, Related Parties (Details) - Officers and Directors - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Related party loans
Balance - beginning of year	$ 34,995	$ 34,301
New loan and advances	56,859	48,110
Principal paydowns and payoffs	(57,789)	(47,416)
Balance - end of year	$ 34,065	$ 34,995

Premises And Equipment - Schedu

Premises And Equipment - Schedule Of Premises And Equipment (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Premises and equipment
Premises and equipment, gross	$ 48,286	$ 49,288
Accumulated depreciation	(37,459)	(38,269)
Premises and equipment, net	10,827	11,019
Land
Premises and equipment
Premises and equipment, gross		230
Building
Premises and equipment
Premises and equipment, gross		230
Leasehold improvements
Premises and equipment
Premises and equipment, gross	11,104	10,425
Furniture, fixtures, and equipment
Premises and equipment
Premises and equipment, gross	$ 37,182	$ 38,403

Premises And Equipment (Narrati

Premises And Equipment (Narrative) (Details) $ in Millions	12 Months Ended
	Dec. 31, 2017USD ($)building	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)
Premises And Equipment
Number of buildings sold | building	1
Depreciation expense | $	$ 3.3	$ 2.9	$ 2.7

Intangible Assets - Schedule of

Intangible Assets - Schedule of Finite-Lived Intangible Assets (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Intangible assets and related accumulated amortization
Amortization	$ (600)	$ (600)	$ (600)
Intangible assets, ending balance	674
Customer contracts, lists and relationships
Intangible assets and related accumulated amortization
Intangible assets, beginning balance	1,326	1,926
Amortization	(600)	(600)
Intangible assets, ending balance	$ 726	$ 1,326	$ 1,926

Intangible Assets - Schedule 83

Intangible Assets - Schedule Of Expected Amortization Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Intangible Assets
Amortization expense	$ 600	$ 600	$ 600
2,018	206
2,019	201
2,020	136
2,021	91
2,022	40
Total	$ 674

Deposits - Related Party Deposi

Deposits - Related Party Deposits (Details) - USD ($) $ in Millions	Dec. 31, 2017	Dec. 31, 2016
Deposits
Related Party Deposit Liabilities	$ 52.7	$ 80.2

Deposits - Schedule Of Certific

Deposits - Schedule Of Certificates Of Deposit, By Contractual Maturity (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Maturities of certificates of deposit by remaining maturity
2,018	$ 105,586
2,019	6,038
2,020	2,283
2,021	1,701
2,022	639
Total	116,247	$ 151,841
Amount of certificates of deposit, meet or exceed the FDIC insurance limit	49,600	55,700
Reciprocal time deposits through CDARS program	28,800	44,200
Reciprocal demand deposits through the ICS program	$ 316,100	$ 283,600

Borrowed Funds - Schedule of Se

Borrowed Funds - Schedule of Securities Sold Under Agreements to Repurchase (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2017USD ($)Counterparty	Dec. 31, 2016USD ($)
Securities sold under agreements to repurchase
Securities sold under agreements to repurchase	$ 52,959	$ 27,639
Other short-term borrowings	77,640	106,230
Fair value of securities sold under agreements to repurchase	54,018	28,192
FHLB advances, average outstanding balance during the period	$ 107,300	$ 82,800
Variable rate basis	1.47%	0.72%
Securities Sold under Agreements to Repurchase
Securities sold under agreements to repurchase
Short-term debt, average outstanding amount	$ 59,600	$ 46,000
Short-term debt, maximum amount outstanding at any month end	$ 69,900	$ 71,000
Short-term debt, weighted average interest rate	0.06%	0.07%
Revolving Line of Credit (LOC)
Securities sold under agreements to repurchase
Maximum borrowing capacity	$ 20,000
Amount outstanding	0	$ 0
Federal Fund Purchase Lines
Securities sold under agreements to repurchase
Short-term debt, average outstanding amount	1,500	2,000
Maximum borrowing capacity	180,000
Amount outstanding	$ 4,600	0
Number of banks providing line of credit | Counterparty	8
Federal Reserve Bank of Kansas Through The Discount Window Lending Program
Securities sold under agreements to repurchase
Pledged loans	$ 823,400
Amount outstanding	$ 0	$ 0
1-month LIBOR | Revolving Line of Credit (LOC)
Securities sold under agreements to repurchase
Basis spread on variable rate	2.25%

Borrowed Funds - Narrative (Det

Borrowed Funds - Narrative (Details) $ in Millions	12 Months Ended
	Dec. 31, 2017USD ($)Counterparty	Dec. 31, 2016USD ($)
Securities sold under agreements to repurchase and other short-term debt disclosures
Variable rate basis	1.47%	0.72%
Advances from Federal Home Loan Banks	$ 73	$ 106.2
FHLB advances, average outstanding balance during the period	107.3	82.8
Loans collateralized under FHLB advancement agreement	877.9	861
Lending value of loans pledged as collateral for FHLB line of credit	605.4	598.5
Securities Sold under Agreements to Repurchase
Securities sold under agreements to repurchase and other short-term debt disclosures
Short-term debt, average outstanding amount	59.6	46
Short-term debt, maximum amount outstanding at any month end	$ 69.9	$ 71
Short-term debt, weighted average interest rate	0.06%	0.07%
Revolving Line of Credit (LOC)
Securities sold under agreements to repurchase and other short-term debt disclosures
Maximum borrowing capacity	$ 20
Commitment fee, percentage	0.35%
Amount outstanding	$ 0	$ 0
Revolving Line of Credit (LOC) | 1-month LIBOR
Securities sold under agreements to repurchase and other short-term debt disclosures
Interest rate terms, spread over reference rate	2.25%
Federal Fund Purchase Lines
Securities sold under agreements to repurchase and other short-term debt disclosures
Short-term debt, average outstanding amount	$ 1.5	2
Maximum borrowing capacity	180
Amount outstanding	$ 4.6	$ 0
Number of banks providing line of credit | Counterparty	8

Long-Term Debt - Schedule Of Lo

Long-Term Debt - Schedule Of Long-term Debt Instruments (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Borrowed Funds
Junior subordinated debentures	$ 72,166	$ 72,166
CoBiz Statutory Trust I | 3-month LIBOR
Borrowed Funds
Interest rate terms, spread over reference rate	2.95%
CoBiz Capital Trust II | 3-month LIBOR
Borrowed Funds
Interest rate terms, spread over reference rate	2.60%
CoBiz Capital Trust III | 3-month LIBOR
Borrowed Funds
Interest rate terms, spread over reference rate	1.45%
Subordinated notes payable.
Borrowed Funds
Junior subordinated debentures	$ 72,166	72,166
Subordinated notes payable. | CoBiz Statutory Trust I
Borrowed Funds
Junior subordinated debentures	$ 20,619	20,619
Maturity date	Sep. 17, 2033
Earliest call date	Mar. 17, 2018
Subordinated notes payable. | CoBiz Capital Trust II
Borrowed Funds
Junior subordinated debentures	$ 30,928	30,928
Maturity date	Jul. 23, 2034
Earliest call date	Jan. 23, 2018
Subordinated notes payable. | CoBiz Capital Trust III
Borrowed Funds
Junior subordinated debentures	$ 20,619	20,619
Maturity date	Sep. 30, 2035
Earliest call date	Mar. 30, 2018
Subordinated notes payable. | Subordinated notes payable.
Borrowed Funds
Junior subordinated debentures	$ 59,195	$ 59,111
Fixed interest rate	5.625%
Maturity date	Jun. 25, 2030
Earliest call date	Jun. 25, 2025

Long-Term Debt - Narrative, Par

Long-Term Debt - Narrative, Part I (Details) - USD ($) $ in Millions	1 Months Ended			12 Months Ended
	Aug. 31, 2005	May 31, 2004	Sep. 30, 2003	Dec. 31, 2017
CoBiz Statutory Trust I
Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Line Items]
Minority interest held in statutory trust			$ 0.6
CoBiz Capital Trust II
Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Line Items]
Minority interest held in statutory trust		$ 0.9
CoBiz Capital Trust III
Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Line Items]
Minority interest held in statutory trust	$ 0.6
Trust preferred securities | CoBiz Statutory Trust I
Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Line Items]
Trust preferred securities, value			20
Trust preferred securities, settlement date				Sep. 17, 2033
Proceeds from sale of securities and minority interest			$ 20.6
Trust preferred securities | CoBiz Capital Trust II
Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Line Items]
Trust preferred securities, value		30
Trust preferred securities, settlement date				Jul. 23, 2034
Proceeds from sale of securities and minority interest		$ 30.9
Trust preferred securities | CoBiz Capital Trust III
Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Line Items]
Trust preferred securities, value	20
Trust preferred securities, settlement date				Sep. 30, 2035
Proceeds from sale of securities and minority interest	$ 20.6
Minimum | CoBiz Statutory Trust I
Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Line Items]
Period of notice required for redemption				30 days
Maximum | CoBiz Statutory Trust I
Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Line Items]
Period of notice required for redemption				60 days

Long-Term Debt - Narrative, P90

Long-Term Debt - Narrative, Part II (Details) $ in Millions	Dec. 31, 2015USD ($)
Long-Term Debt
Trust preferred securities included in Tier 1 capital	$ 70

Long-Term Debt - Subordinated N

Long-Term Debt - Subordinated Notes Payable - Terms (Details) - USD ($) $ in Thousands	Jun. 25, 2015	Dec. 31, 2017	Dec. 31, 2016	Jun. 30, 2015
Long-Term Debt
Discount and debt issuance costs		$ 805	$ 889
Subordinated notes payable
Long-Term Debt
Debt offering				$ 60,000
Fixed interest rate				5.625%
Earliest call date	Jun. 25, 2025
Discount and debt issuance costs	$ 1,100
Proceeds from debt issuance, net of discount and debt issuance costs	58,900
Debt issuance costs	$ 300
Effective interest rate (as a percent)	5.85%
Amortization period of debt issuance cost (in years)	10 years
Subordinated notes payable | Inception through June 25, 2025
Long-Term Debt
Fixed interest rate	5.625%
Subordinated notes payable | After June 25, 2025
Long-Term Debt
Quarterly percentage of principal that may be called	100.00%
Subordinated notes payable | After June 25, 2025 | 3-month LIBOR
Long-Term Debt
Interest rate terms, spread over reference rate	3.17%

Derivatives - Narrative (Detail

Derivatives - Narrative (Details) $ in Millions	1 Months Ended	3 Months Ended	12 Months Ended
	Oct. 31, 2016USD ($)contract	Mar. 31, 2016USD ($)derivative	Dec. 31, 2017USD ($)derivativecontract	Dec. 31, 2016USD ($)derivative
Cash flow, Fair value, and non-designated hedges
Fair value of derivatives in a net liability position			$ 7
Collateral already posted			7.6
Cash flow hedges
Cash flow, Fair value, and non-designated hedges
Net amount recognized for hedge ineffectiveness			0	$ 0
Interest Income
Cash flow, Fair value, and non-designated hedges
Estimated gains (losses) to be reclassified as earnings in next 12 months			0.3
Interest Expense
Cash flow, Fair value, and non-designated hedges
Estimated gains (losses) to be reclassified as earnings in next 12 months			0.8
Derivatives designated as hedging instruments | Interest rate swap | Cash flow hedges | Variable rate loan assets
Cash flow, Fair value, and non-designated hedges
Number of interest rate swaps terminated | derivative		5
Notional amount of derivative instrument	$ 100	$ 75
Unrealized gain on derivatives		$ 1.3
Period of reclassification		3 years
Number of derivative contracts entered | contract	2
Weighted average term	6 years
Fixed rate	1.20%
Derivatives designated as hedging instruments | Interest rate swap | Fair value hedges
Cash flow, Fair value, and non-designated hedges
Notional amount of derivative instrument			$ 59.2	$ 55.4
Number of interest-rate swaps held | derivative			11	10
Derivatives not designated as hedging instruments
Cash flow, Fair value, and non-designated hedges
Notional amount of derivative instrument			$ 279
Number of interest-rate swaps held | contract			102
Derivatives not designated as hedging instruments | Foreign exchange forward contracts
Cash flow, Fair value, and non-designated hedges
Notional amount of derivative instrument			$ 4.8

Derivatives - Schedule of Deriv

Derivatives - Schedule of Derivatives Instruments in Statements of Financial Position (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Other assets | Cash flow hedges
Derivatives at fair value
Asset derivatives, designated as hedging at Fair value	$ 113
Other assets | Fair value hedges
Derivatives at fair value
Asset derivatives, designated as hedging at Fair value	628	$ 476
Accrued interest and other liabilities | Cash flow hedges
Derivatives at fair value
Liability derivatives, designated as hedging at Fair value	6,732	7,639
Accrued interest and other liabilities | Fair value hedges
Derivatives at fair value
Liability derivatives, designated as hedging at Fair value	633	845
Interest rate swap | Other assets
Derivatives at fair value
Asset derivatives, not designated as hedging at Fair value	2,081	2,755
Interest rate swap | Accrued interest and other liabilities
Derivatives at fair value
Liability derivatives, not designated as hedging at Fair value	2,176	2,736
Foreign exchange forward contracts | Other assets
Derivatives at fair value
Asset derivatives, not designated as hedging at Fair value	28	52
Foreign exchange forward contracts | Accrued interest and other liabilities
Derivatives at fair value
Liability derivatives, not designated as hedging at Fair value	$ 44	$ 5

Derivatives - Schedule of Fair

Derivatives - Schedule of Fair Value of Derivative Financial Instruments and Classification on Condensed Consolidated Balance Sheets (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Derivative assets, net
Gross amounts of recognized assets	$ 2,850	$ 3,283
Net amounts included in other assets in the Condensed Consolidated Balance Sheets	2,850	3,283
Gross amounts not offset - Financial instruments	(1,963)	(1,443)
Gross amounts not offset - Net Amount	887	1,840
Securities sold under agreements to repurchase
Gross amounts of recognized liabilities	(52,959)	(27,639)
Net amounts included in accrued interest and other liabilities in the Consolidated Balance Sheets	(52,959)	(27,639)
Gross amounts not offset - Collateral	52,959	27,639
Total offsetting derivative liabilities and securities sold under agreements to repurchase
Gross amounts of recognized liabilities	(62,544)	(38,864)
Net amounts included in accrued interest and other liabilities in the Consolidated Balance Sheets	(62,544)	(38,864)
Gross amounts not offset - Financial instruments	1,963	1,443
Gross amounts not offset - Collateral	60,551	37,315
Gross amounts not offset - Net Amount	(30)	(106)
Derivatives designated as hedging instruments
Derivative assets, net
Gross amounts of recognized assets	741	476
Net amounts included in other assets in the Condensed Consolidated Balance Sheets	741	476
Gross amounts not offset - Financial instruments	(741)	(476)
Derivatives designated as hedges or not designated as hedges
Gross amounts of recognized liabilities	(7,365)	(8,484)
Net amounts included in accrued interest and other liabilities' in the condensed consolidated balance sheets	(7,365)	(8,484)
Gross amounts not offset - Financial instruments	741	476
Gross amounts not offset - Collateral	6,624	8,008
Derivatives not designated as hedging instruments
Derivative assets, net
Gross amounts of recognized assets	2,109	2,807
Net amounts included in other assets in the Condensed Consolidated Balance Sheets	2,109	2,807
Gross amounts not offset - Financial instruments	(1,222)	(967)
Gross amounts not offset - Net Amount	887	1,840
Derivatives designated as hedges or not designated as hedges
Gross amounts of recognized liabilities	(2,220)	(2,741)
Net amounts included in accrued interest and other liabilities' in the condensed consolidated balance sheets	(2,220)	(2,741)
Gross amounts not offset - Financial instruments	1,222	967
Gross amounts not offset - Collateral	968	1,668
Gross amounts not offset - Net Amount	$ (30)	$ (106)

Derivatives - Schedule of Notio

Derivatives - Schedule of Notional Amounts of Outstanding Derivative Positions (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2017USD ($)
CoBiz Statutory Trust I
Derivatives, statutory trusts
Notional amount of derivative instrument	$ 20,000
Fixed rate	4.99%
Termination date	Mar. 17, 2022
CoBiz Capital Trust II
Derivatives, statutory trusts
Notional amount of derivative instrument	$ 30,000
Fixed rate	5.99%
Termination date	Apr. 23, 2020
CoBiz Capital Trust III
Derivatives, statutory trusts
Notional amount of derivative instrument	$ 20,000
Fixed rate	5.02%
Termination date	Mar. 30, 2024

Income Taxes - Schedule Of Comp

Income Taxes - Schedule Of Components Of Income Tax Expense (Benefit) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Current tax provision (benefit):
Federal tax	$ 11,332	$ 6,823	$ 11,346
State tax	1,928	1,374	668
Total current tax provision	13,260	8,197	12,014
Deferred tax provision (benefit)
Federal tax	82	3,532	(2,793)
State tax	(14)	453	(248)
Net deferred tax asset remeasurement	7,150
Net operating loss carryforward			633
Total deferred tax provision (benefit)	7,218	3,985	(2,408)
Provision for income taxes	$ 20,478	$ 12,182	9,606
Benefit related to discontinued operations			$ (42)

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Operating loss carryforwards
Statutory rate (as a percent)		35.00%	35.00%	35.00%
Operating Loss Carryforwards		$ 0
Deferred tax benefit relating to discontinued operations				$ 800,000
Tax benefit resulting of share awards vested or exercised		$ 700,000	$ 300,000
Forecast
Operating loss carryforwards
Statutory rate (as a percent)	21.00%

Income Taxes - Schedule Of Defe

Income Taxes - Schedule Of Deferred Tax Assets And Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Income Taxes
Allowance for loan and credit losses	$ 9,342	$ 12,625
Intangible assets	858	1,403
Other real estate owned	2,120	3,276
Deferred loan fees	201	185
Other accrued liabilities	1,206	1,709
Stock-based compensation	582	971
Interest on nonaccrual loans	97	216
Employee bonus	526	2,271
Investment securities and derivatives	54
Other	268	710
Total deferred tax assets	15,254	23,366
Deferred initial direct loan costs	(1,061)	(1,602)
Property plant and equipment	(651)	(1,106)
Prepaid assets	(363)	(356)
FHLB stock dividends	(65)	(53)
Investment securities and derivatives		(348)
Total deferred tax liabilities	(2,140)	(3,465)
Net deferred tax assets	$ 13,114	$ 19,901

Income Taxes - Schedule Of Effe

Income Taxes - Schedule Of Effective Income Tax Rate Reconciliation (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Effective Income Tax Rate Reconciliation, Percent [Abstract]
Statutory rate (as a percent)	35.00%	35.00%	35.00%
State income taxes - net of federal income tax effect	2.37%	2.64%	2.57%
Tax exempt income	(12.08%)	(11.69%)	(11.55%)
Nondeductible compensation	0.20%	0.19%	0.25%
Meals and entertainment	0.38%	0.42%	0.64%
Share-based compensation	(1.14%)	(0.62%)
Other - net	0.24%	(0.06%)	(0.03%)
Net deferred tax asset remeasurement	13.39%
Effective income tax rate	38.36%	25.88%	26.88%
Unrecognized tax benefits
Unrecognized tax benefits	$ 0	$ 0	$ 0

Income Taxes - Summary Of Incom

Income Taxes - Summary Of Income Tax Examinations (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Income tax examinations by jurisdiction
Income tax interest and penalties	$ 0	$ 0	$ 0
United States
Income tax examinations by jurisdiction
Earliest tax year subject to examination	2,014
Colorado
Income tax examinations by jurisdiction
Earliest tax year subject to examination	2,013
Arizona
Income tax examinations by jurisdiction
Earliest tax year subject to examination	2,013

Shareholders' Equity - Schedule

Shareholders' Equity - Schedule Of Stock Reserved For Future Issuance (Details) - shares	Dec. 31, 2017	Dec. 31, 2016
Common Stock
Common shares reserved for future issuance	2,678,874	3,800,153
Exercise of outstanding stock options
Common Stock
Common shares reserved for future issuance	199,946	285,999
Future granting of option and stock awards
Common Stock
Common shares reserved for future issuance	2,311,829	2,421,120
Future stock purchases through ESPP
Common Stock
Common shares reserved for future issuance	167,099	197,066
Tarp Warrant
Common Stock
Common shares reserved for future issuance		895,968

Shareholders' Equity - Narrativ

Shareholders' Equity - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions	Oct. 20, 2017	Sep. 08, 2011	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Jul. 22, 2015
Preferred stock
Preferred stock, par value per share			$ 0.01	$ 0.01
Preferred stock, liquidation value per share					$ 1,000
Series C Preferred Stock
Preferred stock
Preferred stock, liquidation value per share						$ 1,000
Preferred Stock Liquidation Preference Value						$ 57.4
Small Business Lending Fund (SBLF)
Preferred stock
SBLF Fund Pool		$ 30,000
Total assets threshold for SBLF Loan qualification, maximum		10,000
Small Business Lending Fund (SBLF) | Series C Preferred Stock
Preferred stock
Shares sold, aggregate purchase price		$ 57.4
Shares sold		57,366
Preferred stock, par value per share		$ 0.01
Preferred stock, liquidation value per share		$ 1,000
Tarp Warrant
Warrant
Warrant term (in years)			10 years
Number of shares issuable under warrant terms			895,968
Exercise price per share			$ 10.79
Warrant exercised (in shares)	432,299

Shareholders' Equity - Dividend

Shareholders' Equity - Dividends (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Dividends
Earnings of bank in current and prior two years, net of dividends paid	$ 81,100
Dividends declared per share	$ 0.21	$ 0.19	$ 0.17
Dividends on preferred stock			$ 320
Series C Preferred Stock
Dividends
Dividends on preferred stock			$ 300

Accumulated Other Comprehens104

Accumulated Other Comprehensive Income (Loss) Reclassifications - Reclassifications (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Reclassifications from AOCI
Net (gain) loss on securities, other assets and other real estate owned									$ 507	$ 121	$ 369
Interest Income	$ 37,753	$ 36,947	$ 35,406	$ 33,081	$ 32,779	$ 32,308	$ 31,500	$ 31,195	143,187	127,782	121,266
Interest and fees on loans									127,995	114,612	107,622
Interest on subordinated debentures and notes payable									(7,389)	(7,383)	(5,736)
Realized loss	$ 14,411	$ 15,312	$ 12,988	$ 10,685	$ 11,825	$ 13,812	$ 11,729	$ 9,715	53,396	47,081	35,746
Provision for income taxes									(20,478)	(12,182)	(9,606)
Total reclassifications out of AOCI									32,918	34,899	25,749
Reclassification out of AOCI
Reclassifications from AOCI
Total reclassifications out of AOCI									779	537	706
Reclassification out of AOCI | Cash flow hedges | Unrealized (gain) loss on derivatives
Reclassifications from AOCI
Interest and fees on loans									668	630	927
Interest on subordinated debentures and notes payable									(1,319)	(1,690)	(2,009)
Realized loss									651	1,060	1,082
Provision for income taxes									246	404	411
Total reclassifications out of AOCI									(405)	(656)	(671)
Reclassification out of AOCI | Available for sale securities | Unrealized (gain) loss on securities
Reclassifications from AOCI
Net (gain) loss on securities, other assets and other real estate owned									249	94	318
Provision for income taxes									(94)	(36)	(121)
Total reclassifications out of AOCI									155	58	197
Reclassification out of AOCI | Held to maturity securities | Unrealized (gain) loss on securities
Reclassifications from AOCI
Interest Income									1,658	1,831	1,904
Provision for income taxes									(629)	(696)	(724)
Total reclassifications out of AOCI									$ 1,029	$ 1,135	$ 1,180

Accumulated Other Comprehens105

Accumulated Other Comprehensive Income - AOCI rollforward (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Changes in AOCI
BALANCE - beginning of period	$ 302,310	$ 273,536	$ 308,769
Other comprehensive loss, net of tax	(707)	(2,717)	(1,045)
BALANCE - end of period	329,284	302,310	273,536
Accumulated Comprehensive Income
Changes in AOCI
BALANCE - beginning of period	566	3,283	4,328
Other comprehensive income (loss) items	72	(2,180)	(339)
Reclassifications	(779)	(537)	(706)
Other comprehensive loss, net of tax	(707)	(2,717)	(1,045)
BALANCE - end of period	(141)	566	3,283
Unrealized (gain) loss on securities | Available for sale securities
Changes in AOCI
BALANCE - beginning of period	1,658	1,724	7,168
Other comprehensive income (loss) items	197	(8)	222
Reclassifications	(155)	(58)	(197)
Transfers			(5,469)
Other comprehensive loss, net of tax	42	(66)	(5,444)
BALANCE - end of period	1,700	1,658	1,724
Unrealized (gain) loss on securities | Held to maturity securities
Changes in AOCI
BALANCE - beginning of period	3,154	4,289
Reclassifications	(1,029)	(1,135)	(1,180)
Transfers			5,469
Other comprehensive loss, net of tax	(1,029)	(1,135)	4,289
BALANCE - end of period	2,125	3,154	4,289
Cash flow hedges | Unrealized (gain) loss on derivatives
Changes in AOCI
BALANCE - beginning of period	(4,246)	(2,730)	(2,840)
Other comprehensive income (loss) items	(125)	(2,172)	(561)
Reclassifications	405	656	671
Other comprehensive loss, net of tax	280	(1,516)	110
BALANCE - end of period	$ (3,966)	$ (4,246)	$ (2,730)

Earnings per Common Share - Sch

Earnings per Common Share - Schedule of Weighted Average Shares Outstanding Used in Calculation of Basic and Diluted Loss Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Earnings per Common Share
Net income from continuing operations									$ 32,918	$ 34,899	$ 26,140
Net loss from discontinued operations											(71)
NET INCOME	$ 3,622	$ 11,193	$ 9,489	$ 8,614	$ 8,733	$ 10,269	$ 8,532	$ 7,365	32,918	34,899	26,069
Preferred stock dividends											(320)
NET INCOME									32,918	34,899	25,749
Dividends and undistributed earnings allocated to participating securities									(326)	(397)	(331)
Earnings allocated to common shares									$ 32,592	$ 34,502	$ 25,418
Weighted average common shares - issued									41,819,903	41,379,894	40,991,762
Average unvested restricted share awards									(413,042)	(470,414)	(522,238)
Weighted average common shares outstanding - basic									41,406,861	40,909,480	40,469,524
Dilutive potential common shares									340,707	215,433	255,524
Weighted average common shares outstanding - diluted									41,747,568	41,124,913	40,725,048
Weighted average antidilutive securities outstanding									22,794	125,022	154,714
Basic earnings per common share - continuing									$ 0.79	$ 0.84	$ 0.63
Diluted earnings per common share - continuing									0.78	0.84	0.62
Basic earnings per common share	$ 0.09	$ 0.27	$ 0.23	$ 0.21	$ 0.21	$ 0.25	$ 0.21	$ 0.18	0.79	0.84	0.63
Diluted earnings per common share	$ 0.09	$ 0.27	$ 0.23	$ 0.20	$ 0.21	$ 0.25	$ 0.21	$ 0.18	$ 0.78	$ 0.84	$ 0.62

Employee Benefit And Stock C107

Employee Benefit And Stock Compensation Plans - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	May 15, 2014
Stock Options and Awards
Award expiration period	10 years
Share-based compensation expense	$ 3.1	$ 3.2	$ 3.3
Share-based compensation expense, related income tax benefit	1.1	1.2	$ 1.2
Share-based compensation expense, excess income tax benefit	$ 0.7	$ 0.3
Additional disclosures
Options vested or expected to vest	199,946
Options vested or expected to vest, weighted average exercise price	$ 12.14
Options vested or expected to vest, weighted-average remaining terms	4 years 2 months 12 days	4 years	4 years
Options vested or expected to vest and options exercisable, aggregate intrinsic value	$ 1.6	$ 1.6	$ 1.1
Weighted average grant date fair value of options granted	$ 4.05	$ 2.77	$ 2.57
Total intrinsic value of options exercised	$ 0.8	$ 1.1	$ 0.8
Weighted average grant date fair value, Granted	$ 17.14	$ 11.54	$ 11.52
Total fair value of vested shares	$ 4.3	$ 3.3	$ 4.5
2005 Plan
Stock Options and Awards
Shares authorized under plan				5,250,000
Award grant price as a percentage of the fair market value the underlying	85.00%
Number of shares available for grant	2,311,829
Additional disclosures
Total unrecognized compensation expense related to unvested share-based compensation arrangements granted under equity incentive plans	$ 3.4
Unrecognized compensation expense related to unvested share-based compensation arrangements, expected weighted average recognition period, years	1 year 9 months 18 days

Employee Benefit And Stock C108

Employee Benefit And Stock Compensation Plans - Schedule Of Stock Option Valuation Assumptions (Details) - Options	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Fair value assumptions
Risk-free interest rate	1.83%	1.38%	1.38%
Expected dividend yield	1.19%	1.47%	1.36%
Expected volatility	26.08%	28.61%	33.15%
Expected life (years)	4 years 9 months 18 days	3 years 10 months 24 days	4 years
Minimum
Fair value assumptions
Risk-free interest rate	1.60%	0.87%	0.99%
Expected dividend yield	1.08%	1.27%	1.25%
Expected volatility	25.80%	25.92%	25.90%
Maximum
Fair value assumptions
Risk-free interest rate	2.18%	1.99%	1.84%
Expected dividend yield	1.28%	1.66%	1.41%
Expected volatility	27.03%	34.27%	37.65%

Employee Benefit And Stock C109

Employee Benefit And Stock Compensation Plans - Summary Of Changes In Stock Option Awards (Details)	12 Months Ended
	Dec. 31, 2017$ / sharesshares
Changes in shares under option awards
Shares, Outstanding - beginning of year | shares	285,999
Shares, Granted | shares	45,333
Shares, Exercised | shares	(109,136)
Shares, Forfeited | shares	(22,250)
Shares, Outstanding - end of year | shares	199,946
Shares, Exercisable - end of year | shares	108,702
Weighted average exercise price, Outstanding - beginning of year | $ / shares	$ 10.45
Weighted average exercise price, Granted | $ / shares	17.57
Weighted average exercise price, Exercised | $ / shares	9.93
Weighted average exercise price, Forfeited | $ / shares	12.28
Weighted average exercise price, Outstanding - end of year | $ / shares	12.14
Weighted average exercise price, Exercisable - end of year | $ / shares	$ 10.16

Employee Benefit And Stock C110

Employee Benefit And Stock Compensation Plans - Schedule Of Stock Options Outstanding By Exercise Price Range (Details)	12 Months Ended
	Dec. 31, 2017$ / sharesshares
Stock options by exercise price ranges
Options outstanding, Number outstanding | shares	199,946
Options outstanding, Weighted average exercise price	$ 12.14
Options outstanding, Weighted average remaining life (years)	4 years 2 months 12 days
Options exercisable, Number exercisable | shares	108,702
Options exercisable, Weighted average exercise price	$ 10.16
$6.00 - $9.56
Stock options by exercise price ranges
Range of exercise price, low	6
Range of exercise price, high	$ 9.56
Options outstanding, Number outstanding | shares	46,200
Options outstanding, Weighted average exercise price	$ 7.67
Options outstanding, Weighted average remaining life (years)	1 year 6 months
Options exercisable, Number exercisable | shares	46,200
Options exercisable, Weighted average exercise price	$ 7.67
$9.87 - $11.34
Stock options by exercise price ranges
Range of exercise price, low	9.87
Range of exercise price, high	$ 11.34
Options outstanding, Number outstanding | shares	48,000
Options outstanding, Weighted average exercise price	$ 10.98
Options outstanding, Weighted average remaining life (years)	3 years 10 months 24 days
Options exercisable, Number exercisable | shares	35,001
Options exercisable, Weighted average exercise price	$ 11.03
$11.45 - $12.59
Stock options by exercise price ranges
Range of exercise price, low	11.45
Range of exercise price, high	$ 12.59
Options outstanding, Number outstanding | shares	40,667
Options outstanding, Weighted average exercise price	$ 12.28
Options outstanding, Weighted average remaining life (years)	5 years
Options exercisable, Number exercisable | shares	9,584
Options exercisable, Weighted average exercise price	$ 12.37
$12.70 - $12.89
Stock options by exercise price ranges
Range of exercise price, low	12.70
Range of exercise price, high	$ 16.89
Options outstanding, Number outstanding | shares	43,746
Options outstanding, Weighted average exercise price	$ 14.93
Options outstanding, Weighted average remaining life (years)	5 years 3 months 18 days
Options exercisable, Number exercisable | shares	17,917
Options exercisable, Weighted average exercise price	$ 13.67
$17.20 - $21.14
Stock options by exercise price ranges
Range of exercise price, low	17.20
Range of exercise price, high	$ 21.14
Options outstanding, Number outstanding | shares	21,333
Options outstanding, Weighted average exercise price	$ 18.44
Options outstanding, Weighted average remaining life (years)	6 years 7 months 6 days

Employee Benefit And Stock C111

Employee Benefit And Stock Compensation Plans - Summary Of Changes In Restricted Stock Awards (Details) - $ / shares	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Employee Benefit and Stock Compensation Plans
Shares, Unvested - beginning of year	467,203
Shares, Granted	207,841
Shares, Vested	(253,530)
Shares, Forfeited	(50,999)
Shares, Unvested - end of year	370,515	467,203
Weighted average grant date fair value, Unvested - beginning of year	$ 11.50
Weighted average grant date fair value, Granted	17.14	$ 11.54	$ 11.52
Weighted average grant date fair value, Vested	11.93
Weighted average grant date fair value, Forfeited	13.77
Weighted average grant date fair value, Unvested - end of year	$ 13.98	$ 11.50

Employee Benefit And Stock C112

Employee Benefit And Stock Compensation Plans - Schedule Of Employee Stock Purchase Plan Activity (Details) - ESPP - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Stock Options and Awards
Discretionary contribution maximum match, as a percent of employee deductions	50.00%
Matching contributions made to plan	$ 0	$ 0	$ 0
Available ESPP shares - beginning of year	197,066	233,879	273,188
Purchases	(29,967)	(36,813)	(39,309)
Available ESPP shares - end of year	167,099	197,066	233,879

Employee Benefit And Stock C113

Employee Benefit And Stock Compensation Plans - Narrative II (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Employee Benefit and Stock Compensation Plans
Employer matching contribution, percent	4.50%	4.50%	3.00%
Employer contributions charged to expense	$ 2.2	$ 1.8	$ 1.3

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2017USD ($)location$ / sharesshares	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)
Lease commitments
Rent expense	$ 4,700	$ 5,800	$ 4,900
Number of locations subleased | location	2
Future minimum sublease payments	$ 800
Future minimum lease payments	$ 30,441
Federal Reserve Bank stock, shares | shares	83,553
Federal Reserve Bank stock, value	$ 4,200
Federal Reserve Bank stock, par value | $ / shares	$ 50
Investment held as a percentage of total subscription amount due	50.00%
Percentage of investment that may be callable by the Federal Reserve	50.00%
Federal Reserve Bank stock, remaining membership subscription obligation	$ 4,200
Director
Lease commitments
Rent expense	200	$ 2,100	$ 2,100
Future minimum lease payments	$ 100

Commitments and Contingencie115

Commitments and Contingencies - Schedule Of Lease Commitments (Details) $ in Thousands	1 Months Ended
	Jan. 31, 2016USD ($)ft²	Dec. 31, 2017USD ($)
2,018		$ 5,493
2,019		4,476
2,020		3,756
2,021		2,375
2,022		2,343
Thereafter		11,998
Total		$ 30,441
Lease term	12 years
Base rent	$ 1,500
Annual lease escalation percentage	2.00%
Cancelable duration	9 years
Termination fee	$ 1,600
Office space
Area of Land | ft²	44,000
Ground level retail space
Area of Land | ft²	4,000

Commitments and Contingencie116

Commitments and Contingencies - Schedule Of Financial Instruments With Off-Balance Sheet Risk (Details) $ in Thousands	Dec. 31, 2017USD ($)entity	Dec. 31, 2016USD ($)
Commitments to originate commercial or real estate construction loans and unused lines of credit granted to customers
Commitments
Financial Instruments With Off-Balance Sheet Risk	$ 975,903	$ 887,627
Commitments to originate consumer loans - personal lines of credit and equity lines
Commitments
Financial Instruments With Off-Balance Sheet Risk	40,682	41,376
Overdraft protection plans
Commitments
Financial Instruments With Off-Balance Sheet Risk	21,188	22,919
Letters of credit
Commitments
Financial Instruments With Off-Balance Sheet Risk	30,032	26,631
Unfunded commitments for unconsolidated investments
Commitments
Financial Instruments With Off-Balance Sheet Risk	5,916	6,664
Company guarantees
Commitments
Financial Instruments With Off-Balance Sheet Risk	4,249	$ 3,127
Commitments For Unconsolidated Investments
Commitments
Financial Instruments With Off-Balance Sheet Risk	$ 11,500
Number of entities | entity	4
Unfunded commitments	$ 5,900

Regulatory Matters - Schedule o

Regulatory Matters - Schedule of Regulatory Capital Amounts and Ratios of Company and Bank (Details)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Regulatory matters
Minimum Capital Conservation Buffer (as percent)	0.625%
Annual increase in minimum Capital Conservation Buffer (as percent)	0.625%
Increased Capital Conservation Buffer (as percent)	2.50%
Common Tier 1, Risk-based, Capital ratios (as a percent)	9.90%	9.80%
Common Tier 1, Risk-based, Well-capitalized requirement (as a percent)	6.50%
Common Tier 1, Risk-based, Minimum capital requirement (as a percent)	7.00%
Tier I, Risk-based, Capital ratios (as a percent)	11.80%	11.60%
Tier I, Risk-based, Well-capitalized requirement (as a percent)	8.00%
Tier I, Risk-based, Minimum capital requirement (as a percent)	8.50%
Total capital, Risk-based, Capital ratios (as a percent)	14.60%	14.50%
Total capital, Risk-based, Well-capitalized requirement (as a percent)	10.00%
Total capital, Risk-based, Minimum capital requirement (as a percent)	10.50%
Tier I, Leverage, Capital ratios (as a percent)	10.10%	10.20%
Tier I, Leverage, Well-capitalized requirement (as a percent)	5.00%
Tier I, Leverage, Minimum capital requirement (as a percent)	4.00%
Bank
Regulatory matters
Common Tier 1, Risk-based, Capital ratios (as a percent)	12.20%	11.90%
Tier I, Risk-based, Capital ratios (as a percent)	12.20%	11.90%
Total capital, Risk-based, Capital ratios (as a percent)	13.20%	12.90%
Tier I, Leverage, Capital ratios (as a percent)	10.50%	10.40%

Fair Value Measurements - Finan

Fair Value Measurements - Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Assets and liabilities measured at fair value
Investment securities available for sale	$ 166,753	$ 132,981
Total derivative assets	2,850	3,283
Trust preferred securities
Assets and liabilities measured at fair value
Investment securities available for sale	21,983	37,624
Corporate debt securities
Assets and liabilities measured at fair value
Investment securities available for sale	141,495	92,077
Derivatives designated as hedging instruments
Assets and liabilities measured at fair value
Total derivative assets	741	476
Total derivative liabilities	7,365	8,484
Derivatives not designated as hedging instruments
Assets and liabilities measured at fair value
Total derivative assets	2,109	2,807
Total derivative liabilities	2,220	2,741
Recurring
Assets and liabilities measured at fair value
Investment securities available for sale	166,753	132,981
Total derivative assets	2,850	3,283
Total derivative liabilities	9,585	11,225
Recurring | Fair value hedges
Assets and liabilities measured at fair value
Total derivative liabilities	633
Recurring | Quoted prices in active markets for identical assets (Level 1)
Assets and liabilities measured at fair value
Investment securities available for sale	363	4,283
Recurring | Significant other observable inputs (Level 2)
Assets and liabilities measured at fair value
Investment securities available for sale	157,291	119,250
Total derivative assets	2,850	3,283
Total derivative liabilities	9,585	11,225
Recurring | Significant other observable inputs (Level 2) | Fair value hedges
Assets and liabilities measured at fair value
Total derivative liabilities	633
Recurring | Significant unobservable inputs (Level 3)
Assets and liabilities measured at fair value
Investment securities available for sale	9,099	9,448
Recurring | Trust preferred securities
Assets and liabilities measured at fair value
Investment securities available for sale	21,983	37,624
Recurring | Trust preferred securities | Quoted prices in active markets for identical assets (Level 1)
Assets and liabilities measured at fair value
Investment securities available for sale	363	4,283
Recurring | Trust preferred securities | Significant other observable inputs (Level 2)
Assets and liabilities measured at fair value
Investment securities available for sale	12,521	23,893
Recurring | Trust preferred securities | Significant unobservable inputs (Level 3)
Assets and liabilities measured at fair value
Investment securities available for sale	9,099	9,448
Recurring | Corporate debt securities
Assets and liabilities measured at fair value
Investment securities available for sale	141,495	92,077
Recurring | Corporate debt securities | Significant other observable inputs (Level 2)
Assets and liabilities measured at fair value
Investment securities available for sale	141,495	92,077
Recurring | Municipal securities
Assets and liabilities measured at fair value
Investment securities available for sale	3,275	3,280
Recurring | Municipal securities | Significant other observable inputs (Level 2)
Assets and liabilities measured at fair value
Investment securities available for sale	3,275	3,280
Recurring | Foreign exchange forward contracts
Assets and liabilities measured at fair value
Total derivative assets	28	52
Total derivative liabilities	44	5
Recurring | Foreign exchange forward contracts | Significant other observable inputs (Level 2)
Assets and liabilities measured at fair value
Total derivative assets	28	52
Total derivative liabilities	44	5
Recurring | Derivatives designated as hedging instruments | Cash flow hedges
Assets and liabilities measured at fair value
Total derivative assets	113
Total derivative liabilities	6,732	7,639
Recurring | Derivatives designated as hedging instruments | Fair value hedges
Assets and liabilities measured at fair value
Total derivative assets	628	476
Recurring | Derivatives designated as hedging instruments | Significant other observable inputs (Level 2) | Cash flow hedges
Assets and liabilities measured at fair value
Total derivative assets	113
Total derivative liabilities	6,732	7,639
Recurring | Derivatives designated as hedging instruments | Significant other observable inputs (Level 2) | Fair value hedges
Assets and liabilities measured at fair value
Total derivative assets	628	476
Recurring | Derivatives not designated as hedging instruments
Assets and liabilities measured at fair value
Total derivative assets	2,081	2,755
Total derivative liabilities	2,176	2,736
Recurring | Derivatives not designated as hedging instruments | Fair value hedges
Assets and liabilities measured at fair value
Total derivative liabilities		845
Recurring | Derivatives not designated as hedging instruments | Significant other observable inputs (Level 2)
Assets and liabilities measured at fair value
Total derivative assets	2,081	2,755
Total derivative liabilities	$ 2,176	2,736
Recurring | Derivatives not designated as hedging instruments | Significant other observable inputs (Level 2) | Fair value hedges
Assets and liabilities measured at fair value
Total derivative liabilities		$ 845

Fair Value Measurements - Recon

Fair Value Measurements - Reconciliation of the Beginning and Ending Balance of Financial Assets Measured At Fair Value On Recurring Basis Using Level 3 Inputs (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Reconciliation of Level 3 inputs
Beginning balance	$ 9,448	$ 5,810
Transfers and purchases		3,276
Net accretion	117	89
Sales/calls/maturities	(1,000)
Unrealized gain included in comprehensive income	534	273
Ending balance	$ 9,099	$ 9,448

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Financial Assets Measured at Fair Value on Nonrecurring Basis (OREO and Impaired Loans) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Assets and liabilities measured at fair value
OREO recorded at fair value	$ 5,351	$ 5,351
Provision for loan losses	3,285	(2,101)	$ 6,420
OREO
Assets and liabilities measured at fair value
OREO recorded at fair value	5,351	5,351
Impaired Loans
Assets and liabilities measured at fair value
Impaired loans, net of specific reserve	3,792	1,425
Nonrecurring | OREO
Assets and liabilities measured at fair value
Impaired loans, net of specific reserve	5,351
OREO recorded at fair value		5,351
Year to date gain (loss)			69
Nonrecurring | OREO | Significant unobservable inputs (Level 3)
Assets and liabilities measured at fair value
Impaired loans, net of specific reserve	5,351
OREO recorded at fair value		5,351
Nonrecurring | Impaired Loans
Assets and liabilities measured at fair value
Impaired loans, net of specific reserve	3,792	1,425
Provision for loan losses	398	2,831	$ (5,980)
Nonrecurring | Impaired Loans | Significant unobservable inputs (Level 3)
Assets and liabilities measured at fair value
Impaired loans, net of specific reserve	$ 3,792	$ 1,425

Fair Value Measurements - Sc121

Fair Value Measurements - Schedule of Reconciliation of Fair Value Measurement of Other Real Estate Owned (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Fair Value Measurements
OREO recorded at fair value	$ 5,351	$ 5,351
Estimated selling costs	(272)	(272)
OREO	$ 5,079	$ 5,079

Fair Value Measurements - Sc122

Fair Value Measurements - Schedule of Valuation Process Used to Determine Fair Value Measurement within Level 3 (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Fair value valuation processes
Investment securities available for sale	$ 166,753	$ 132,981
OREO recorded at fair value	5,351	5,351
Impaired Loans
Fair value valuation processes
Impaired loans	3,792	1,425
OREO
Fair value valuation processes
OREO recorded at fair value	5,351	5,351
Market approach | Trust preferred securities
Fair value valuation processes
Investment securities available for sale	$ 9,099	$ 9,448
Valuation technique	Market approach	Market approach
Unobservable input	Discount to carrying value using broker quotes or observable prices on similar securities	Discount to carrying value using broker quotes or observable prices on similar securities
Market approach | Weighted average | Trust preferred securities
Fair value valuation processes
Discount rate	7.00%	13.00%
Market approach | Minimum | Trust preferred securities
Fair value valuation processes
Discount rate	5.00%	1.00%
Market approach | Maximum | Trust preferred securities
Fair value valuation processes
Discount rate	15.00%	28.00%
Commercial | Sales comparison | Impaired Loans
Fair value valuation processes
Impaired loans	$ 2,581	$ 1,057
Valuation technique	Sales comparison	Sales comparison
Unobservable input	Management discount for asset type	Management discount for asset type
Commercial | Sales comparison | Weighted average | Impaired Loans
Fair value valuation processes
Discount rate	59.00%	59.00%
Commercial | Sales comparison | Minimum | Impaired Loans
Fair value valuation processes
Discount rate	0.00%	0.00%
Commercial | Sales comparison | Maximum | Impaired Loans
Fair value valuation processes
Discount rate	98.00%	76.00%
Commercial | Property appraisals | OREO
Fair value valuation processes
OREO recorded at fair value	$ 190	$ 190
Valuation technique	Property appraisals	Property appraisals
Unobservable input	Management discount for property type	Management discount for property type
Commercial | Property appraisals | Weighted average | OREO
Fair value valuation processes
Discount rate	0.00%	0.00%
Real estate - mortgage | Sales comparison | Impaired Loans
Fair value valuation processes
Impaired loans	$ 57	$ 269
Valuation technique	Sales comparison	Sales comparison
Unobservable input	Sales comparison adjustments	Sales comparison adjustments
Real estate - mortgage | Sales comparison | Weighted average | Impaired Loans
Fair value valuation processes
Discount rate		18.00%
Sales comparison adjustments	(4.00%)
Construction and land | Property appraisals | OREO
Fair value valuation processes
OREO recorded at fair value	$ 5,161	$ 5,161
Valuation technique	Property appraisals	Property appraisals
Unobservable input	Management discount for property type	Management discount for property type
Construction and land | Property appraisals | Weighted average | OREO
Fair value valuation processes
Discount rate	17.00%	17.00%
Consumer | Sales comparison | Impaired Loans
Fair value valuation processes
Impaired loans	$ 1,154	$ 99
Valuation technique	Sales comparison	Sales comparison
Unobservable input	Sales comparison adjustments	Sales comparison adjustments
Consumer | Sales comparison | Weighted average | Impaired Loans
Fair value valuation processes
Sales comparison adjustments	(11.00%)	(1.00%)
Consumer | Sales comparison | Minimum | Impaired Loans
Fair value valuation processes
Sales comparison adjustments	(7.00%)	(11.00%)
Consumer | Sales comparison | Maximum | Impaired Loans
Fair value valuation processes
Sales comparison adjustments	(20.00%)	10.00%

Fair Value Measurements - Sc123

Fair Value Measurements - Schedule of Estimated Fair Value of Other Financial Instruments (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Fair value of financial instruments
Cash and cash equivalents	$ 80,180	$ 96,050	$ 67,312	$ 91,565
Investment securities available for sale	166,753	132,981
Investment securities held to maturity	362,544	366,041
Other investments	10,119	11,365
Loans - net	3,107,622	2,900,812
Accrued interest receivable	14,150	12,223
Derivatives assets	2,850	3,283
Deposits	3,225,220	3,029,783
Securities sold under agreements to repurchase	52,959	27,639
Other short-term borrowings	77,640	106,230
Subordinated notes payable	59,195	59,111
Junior subordinated debentures	72,166	72,166
Carrying Value
Fair value of financial instruments
Cash and cash equivalents	80,180	96,050
Investment securities available for sale	166,753	132,981
Investment securities held to maturity	362,544	366,041
Other investments	2,174	2,173
Loans - net	3,107,622	2,900,812
Accrued interest receivable	14,150	12,223
Derivatives assets	2,850	3,283
Deposits	3,225,220	3,029,783
Securities sold under agreements to repurchase	52,959	27,639
Other short-term borrowings	77,640	106,230
Accrued interest payable	1,077	1,038
Subordinated notes payable	59,195	59,111
Junior subordinated debentures	72,166	72,166
Derivatives liabilities	9,585	11,225
Total Fair Value
Fair value of financial instruments
Cash and cash equivalents	80,180	96,050
Investment securities available for sale	166,753	132,981
Investment securities held to maturity	360,071	363,178
Other investments	2,174	2,173
Loans - net	3,080,935	2,868,091
Accrued interest receivable	14,150	12,223
Derivatives assets	2,850	3,283
Deposits	3,224,417	3,029,226
Securities sold under agreements to repurchase	49,436	26,101
Other short-term borrowings	77,640	106,230
Accrued interest payable	1,077	1,038
Subordinated notes payable	58,451	58,681
Junior subordinated debentures	72,166	72,166
Derivatives liabilities	$ 9,585	$ 11,225

Segments - Summary Of Operating

Segments - Summary Of Operating And Selected Financial Information By Operating Segment (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated
Total interest income	$ 37,753	$ 36,947	$ 35,406	$ 33,081	$ 32,779	$ 32,308	$ 31,500	$ 31,195	$ 143,187	$ 127,782	$ 121,266
Total interest expense	3,031	3,178	3,401	3,003	2,891	2,907	2,967	2,966	12,613	11,731	9,590
Provision for loan losses						1,200			3,285	(2,101)	6,420
Noninterest income									34,001	34,160	30,667
Noninterest expense									107,894	105,231	100,177
Provision for income taxes									20,478	12,182	9,606
NET INCOME FROM CONTINUING OPERATIONS									32,918	34,899	26,140
Income (Loss) from discontinued operations, net of tax											(71)
Net income (loss)	3,622	$ 11,193	$ 9,489	$ 8,614	8,733	$ 10,269	$ 8,532	$ 7,365	32,918	34,899	26,069
Depreciation and amortization									3,909	3,532	3,255
Identifiable assets	3,846,272				3,630,313				3,846,272	3,630,313	3,351,767
Commercial Banking
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated
Total interest income									142,845	127,403	119,896
Total interest expense									5,265	4,427	3,947
Provision for loan losses									3,425	(1,816)	6,837
Noninterest income									13,811	14,050	11,427
Noninterest expense									34,116	38,159	37,849
Management fees and allocations									32,982	27,912	25,225
Provision for income taxes									41,866	32,606	27,679
NET INCOME FROM CONTINUING OPERATIONS										40,165	29,786
Net income (loss)									39,002	40,165	29,786
Depreciation and amortization									2,764	2,613	2,430
Identifiable assets	3,812,546				3,593,528				3,812,546	3,593,528	3,317,977
Fee-Based Lines
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated
Total interest income									2	2	2
Total interest expense									14	25	44
Noninterest income									19,401	18,282	17,879
Noninterest expense									17,248	17,422	16,331
Management fees and allocations									1,269	1,673	1,334
Provision for income taxes									1,269	372	643
NET INCOME FROM CONTINUING OPERATIONS										(1,208)	(471)
Income (Loss) from discontinued operations, net of tax											(71)
Net income (loss)									(397)	(1,208)	(542)
Depreciation and amortization									573	807	792
Identifiable assets	8,341				11,053				8,341	11,053	10,554
Corporate Support and Other
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated
Total interest income									340	377	1,368
Total interest expense									7,334	7,279	5,599
Provision for loan losses									(140)	(285)	(417)
Noninterest income									789	1,828	1,361
Noninterest expense									56,530	49,650	45,997
Management fees and allocations									(34,251)	(29,585)	(26,559)
Provision for income taxes									(22,657)	(20,796)	(18,716)
NET INCOME FROM CONTINUING OPERATIONS										(4,058)	(3,175)
Net income (loss)									(5,687)	(4,058)	(3,175)
Depreciation and amortization									320	112	33
Identifiable assets	25,385				25,732				25,385	25,732	23,236
CoBiz Financial Inc.
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated
Total interest expense									7,389	7,383	5,737
Provision for income taxes									(2,020)	(2,898)	(2,751)
Net income (loss)									32,918	34,899	$ 26,069
Identifiable assets	$ 468,164				$ 446,148				$ 468,164	$ 446,148

Condensed Financial Statemen125

Condensed Financial Statements Of Parent Company - Condensed Balance Sheets (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Condensed Financial Statements of Parent Company
Cash on deposit at subsidiary bank	$ 78,735	$ 69,333
Other	20,118	19,842
TOTAL ASSETS	3,846,272	3,630,313	$ 3,351,767
Subordinated notes payable	59,195	59,111
Junior subordinated debentures	72,166	72,166
TOTAL LIABILITIES	3,516,988	3,328,003
Shareholders' equity	329,284	302,310	$ 273,536	$ 308,769
TOTAL LIABILITIES AND EQUITY	3,846,272	3,630,313
CoBiz Financial Inc.
Condensed Financial Statements of Parent Company
Cash on deposit at subsidiary bank	17,639	16,588
Investment in bank subsidiary	406,474	377,104
Investment in non-bank subsidiaries	21,830	25,792
Accounts receivable from bank subsidiary	7,238	7,916
Accounts receivable from non-bank subsidiaries	443	1,398
Other	14,540	17,350
TOTAL ASSETS	468,164	446,148
Accounts payable to bank subsidiary	2,657	3,902
Accounts payable to non-bank subsidiaries	290	4,306
Subordinated notes payable	59,195	59,111
Junior subordinated debentures	72,166	72,166
Other liabilities	4,572	4,353
TOTAL LIABILITIES	138,880	143,838
Shareholders' equity	329,284	302,310
TOTAL LIABILITIES AND EQUITY	$ 468,164	$ 446,148

Condensed Financial Statemen126

Condensed Financial Statements Of Parent Company - Condensed Statements Of Operations (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Condensed Financial Statements of Parent Company
Other income									$ 7,976	$ 9,819	$ 6,926
Salaries and employee benefits									75,088	71,471	69,526
Interest expense	$ 3,031	$ 3,178	$ 3,401	$ 3,003	$ 2,891	$ 2,907	$ 2,967	$ 2,966	12,613	11,731	9,590
Other expense									16,738	16,623	15,528
INCOME BEFORE INCOME TAXES	14,411	15,312	12,988	10,685	11,825	13,812	11,729	9,715	53,396	47,081	35,746
Provision for income taxes									20,478	12,182	9,606
NET INCOME	$ 3,622	$ 11,193	$ 9,489	$ 8,614	$ 8,733	$ 10,269	$ 8,532	$ 7,365	32,918	34,899	26,069
CoBiz Financial Inc.
Condensed Financial Statements of Parent Company
Management fees									1,050	3,908	3,872
Dividends from bank subsidiary									10,649	8,861	8,221
Dividends from non-bank subsidiaries									5,054	1,070	2,962
Interest income									131	171	195
Other income									807	1,847	1,380
Total income									17,691	15,857	16,630
Salaries and employee benefits									1,471	4,147	4,518
Interest expense									7,389	7,383	5,737
Other expense									1,752	2,260	2,614
Total expense									10,612	13,790	12,869
INCOME BEFORE INCOME TAXES									7,079	2,067	3,761
Provision for income taxes									(2,020)	(2,898)	(2,751)
Net income before equity in undistributed earnings of subsidiaries									9,099	4,965	6,512
Equity in undistributed earnings of subsidiaries									23,819	29,934	19,557
NET INCOME									$ 32,918	$ 34,899	$ 26,069

Condensed Financial Statemen127

Condensed Financial Statements Of Parent Company - Condensed Statements Of Cash Flows (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Condensed Financial Statements of Parent Company
Net income (loss)	$ 3,622	$ 11,193	$ 9,489	$ 8,614	$ 8,733	$ 10,269	$ 8,532	$ 7,365	$ 32,918	$ 34,899	$ 26,069
Stock-based compensation									3,093	3,213	3,324
Net cash provided by operating activities									45,939	43,542	34,123
Other									653	348
Net cash used in investing activities									(245,646)	(250,654)	(320,255)
Proceeds from issuance of common stock									1,581	2,118	1,733
Taxes paid in net settlement of restricted stock									(1,126)	(891)	(1,207)
Net proceeds from issuance of subordinated notes payable											59,250
Redemption of preferred stock											(57,366)
Dividends paid on common stock									(8,785)	(7,858)	(6,953)
Dividends paid on preferred stock											(463)
Other											450
Net cash used in financing activities									183,837	235,850	261,879
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS									(15,870)	28,738	(24,253)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD				96,050				67,312	96,050	67,312	91,565
CASH AND CASH EQUIVALENTS, END OF PERIOD	80,180				96,050				80,180	96,050	67,312
CoBiz Financial Inc.
Condensed Financial Statements of Parent Company
Net income (loss)									32,918	34,899	26,069
Equity in undistributed earnings of subsidiaries									(23,819)	(29,934)	(19,557)
Stock-based compensation									402	631	620
Change in other assets and liabilities									(438)	2,509	(7,480)
Net cash provided by operating activities									9,063	8,105	(348)
Net advances (to) from subsidiaries									766	(2,162)	1,095
Other									(448)	(2,829)	(27)
Net cash used in investing activities									318	(4,991)	1,068
Proceeds from issuance of common stock									1,581	2,118	1,733
Taxes paid in net settlement of restricted stock									(1,126)	(891)	(1,207)
Net proceeds from issuance of subordinated notes payable											59,250
Redemption of preferred stock											(57,366)
Dividends paid on common stock									(8,785)	(7,858)	(6,953)
Dividends paid on preferred stock											(463)
Other											(104)
Net cash used in financing activities									(8,330)	(6,631)	(5,110)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS									1,051	(3,517)	(4,390)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD				$ 16,588				$ 20,105	16,588	20,105	24,495
CASH AND CASH EQUIVALENTS, END OF PERIOD	$ 17,639				$ 16,588				$ 17,639	$ 16,588	$ 20,105

Supplemental Financial Data (De

Supplemental Financial Data (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Sep. 30, 2016	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Other noninterest income
Loan fees		$ 2,515	$ 2,853	$ 1,787
Other customer service fees		2,900	2,704	2,497
Bank-owned life insurance		1,366	1,367	1,334
Other Investments	$ 1,400	1,234	2,477	1,312
Derivative valuation		(175)	281	(24)
Other		136	137	20
Total		7,976	9,819	6,926
Other noninterest expense
Marketing and business development		2,699	2,879	2,799
Service contracts		5,506	5,281	4,545
Professional fees		3,519	2,917	2,818
Office supplies and delivery		1,175	1,357	1,461
Other		3,839	4,189	3,905
Total		$ 16,738	$ 16,623	$ 15,528

Selected Quarterly Financial129

Selected Quarterly Financial Data (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Selected Quarterly Financial Data
Interest Income	$ 37,753	$ 36,947	$ 35,406	$ 33,081	$ 32,779	$ 32,308	$ 31,500	$ 31,195	$ 143,187	$ 127,782	$ 121,266
Interest expense	3,031	3,178	3,401	3,003	2,891	2,907	2,967	2,966	12,613	11,731	9,590
Net interest income	34,722	33,769	32,005	30,078	29,888	29,401	28,533	28,229	130,574	116,051	111,676
Income before income taxes	14,411	15,312	12,988	10,685	11,825	13,812	11,729	9,715	53,396	47,081	35,746
Net income	$ 3,622	$ 11,193	$ 9,489	$ 8,614	$ 8,733	$ 10,269	$ 8,532	$ 7,365	$ 32,918	$ 34,899	$ 26,069
Basic earnings per share	$ 0.09	$ 0.27	$ 0.23	$ 0.21	$ 0.21	$ 0.25	$ 0.21	$ 0.18	$ 0.79	$ 0.84	$ 0.63
Diluted earnings per share	$ 0.09	$ 0.27	$ 0.23	$ 0.20	$ 0.21	$ 0.25	$ 0.21	$ 0.18	$ 0.78	$ 0.84	$ 0.62
Increase to income tax expense as a result of the TCJA									$ 7,150
Other Investments						$ 1,400			1,234	$ 2,477	$ 1,312
Provision for loan losses						$ 1,200			$ 3,285	$ (2,101)	$ 6,420